<html>
  <head>
    <meta http-equiv="Content-Type" content="text/html; charset=UTF-8"/>
    <title>IP Review</title>
    <link rel="stylesheet" href="fhir.css"/>
  </head>
  <body>
    <h2>Unattributed Code Systems</h2>
    <ul>
      <li>
        <a href="ValueSet-designation-usage.html">
<code>http://unstats.un.org/unsd/methods/m49/m49.htm</code>        </a>
      </li>
      <li>
        <a href="CodeSystem-summary.html">
<code>urn:iso:std:iso:3166</code>        </a>
      </li>
    </ul>
    <h2>Copyright Fragment</h2>
    <p>
This fragment is available on       <a href="en/index.html">en/index.html</a>
    </p>
    <div>
      <p>This publication includes IP covered under the following statements.</p>

      <ul>

        <li>
Some content from IHE&reg; Copyright &copy; 2015           <a href="http://www.ihe.net/Governance/#Intellectual_Property">IHE International, Inc</a>

.          <div onClick="if (document.getElementById('ipp2_1').innerHTML != '') {document.getElementById('ipp_1').innerHTML = document.getElementById('ipp2_1').innerHTML; document.getElementById('ipp2_1').innerHTML = ''}" id="ipp_1" data-fhir="generated">
             <span style="cursor: pointer; border: 1px grey solid; background-color: #fcdcb3; padding-left: 3px; padding-right: 3px; color: black">Show Usage</span>
          </div>
          <div style="display: none" id="ipp2_1">

            <ul>

              <li>
                <a href="http://tx.fhir.org/r4/ValueSet/formatcode">IHE Format Code set for use with Document Sharing</a>
:                 <a href="StructureDefinition-ext-R5-Endpoint.pay.type.html">ExtensionEndpoint_Payload_Type</a>
 and                 <a href="ValueSet-ValueSet-R5-endpoint-payload-type-for-R4.html">ValueSetR5EndpointPayloadTypeForR4</a>
              </li>


            </ul>


          </div>
        </li>

        <li>
The UCUM codes, UCUM table (regardless of format), and UCUM Specification are copyright 1999-2009, Regenstrief Institute, Inc. and the Unified Codes for Units of Measures (UCUM) Organization. All rights reserved.           <a href="https://ucum.org/trac/wiki/TermsOfUse">https://ucum.org/trac/wiki/TermsOfUse</a>
          <div onClick="if (document.getElementById('ipp2_2').innerHTML != '') {document.getElementById('ipp_2').innerHTML = document.getElementById('ipp2_2').innerHTML; document.getElementById('ipp2_2').innerHTML = ''}" id="ipp_2" data-fhir="generated">
             <span style="cursor: pointer; border: 1px grey solid; background-color: #fcdcb3; padding-left: 3px; padding-right: 3px; color: black">Show Usage</span>
          </div>
          <div style="display: none" id="ipp2_2">

            <ul>

              <li>
                <a href="CodeSystem-v3-ucum.html">Unified Code for Units of Measure (UCUM)</a>
:                 <a href="ValueSet-ValueSet-R5-ucum-common-for-R4.html">ValueSetR5UcumCommonForR4</a>
              </li>


            </ul>


          </div>
        </li>

        <li>
This material contains content from           <a href="http://loinc.org">LOINC</a>
. LOINC is copyright &copy; 1995-2020, Regenstrief Institute, Inc. and the Logical Observation Identifiers Names and Codes (LOINC) Committee and is available at no cost under the           <a href="http://loinc.org/license">license</a>
. LOINC&reg; is a registered United States trademark of Regenstrief Institute, Inc.          <div onClick="if (document.getElementById('ipp2_3').innerHTML != '') {document.getElementById('ipp_3').innerHTML = document.getElementById('ipp2_3').innerHTML; document.getElementById('ipp2_3').innerHTML = ''}" id="ipp_3" data-fhir="generated">
             <span style="cursor: pointer; border: 1px grey solid; background-color: #fcdcb3; padding-left: 3px; padding-right: 3px; color: black">Show Usage</span>
          </div>
          <div style="display: none" id="ipp2_3">

            <ul>

              <li>
LOINC:                 <a href="ValueSet-ValueSet-R5-v3-LoincDocumentOntologyInternational-for-R4.html">ValueSetR5V3LoincDocumentOntologyInternationalForR4</a>
              </li>


            </ul>


          </div>
        </li>

        <li>
This material contains content that is copyright of SNOMED International. Implementers of these specifications must have the appropriate SNOMED CT Affiliate license - for more information contact           <a href="https://www.snomed.org/get-snomed">https://www.snomed.org/get-snomed</a>
 or           <a href="mailto:info@snomed.org">info@snomed.org</a>
.          <div onClick="if (document.getElementById('ipp2_4').innerHTML != '') {document.getElementById('ipp_4').innerHTML = document.getElementById('ipp2_4').innerHTML; document.getElementById('ipp2_4').innerHTML = ''}" id="ipp_4" data-fhir="generated">
             <span style="cursor: pointer; border: 1px grey solid; background-color: #fcdcb3; padding-left: 3px; padding-right: 3px; color: black">Show Usage</span>
          </div>
          <div style="display: none" id="ipp2_4">

            <ul>

              <li>
                <a href="http://hl7.org/fhir/R4/codesystem-snomedct.html">SNOMED Clinical Terms&amp;reg; (SNOMED CT&amp;reg;)</a>
:                 <a href="CodeSystem-v3-ActCode.html">ActCode</a>
,                 <a href="CodeSystem-summary.html">CodeSystemSummaryExampleACMEBodySites</a>
,                 <a href="CodeSystem-v3-RoleClass.html">RoleClass</a>
,                 <a href="CodeSystem-v3-RoleCode.html">RoleCode</a>
 and                 <a href="CodeSystem-v3-RouteOfAdministration.html">RouteOfAdministration</a>
              </li>


            </ul>


          </div>
        </li>

        <li>
This material derives from the HL7 Terminology (THO). THO is copyright &copy;1989+ Health Level Seven International and is made available under the CC0 designation. For more licensing information see:           <a href="https://terminology.hl7.org/license.html">https://terminology.hl7.org/license.html</a>
          <div onClick="if (document.getElementById('ipp2_5').innerHTML != '') {document.getElementById('ipp_5').innerHTML = document.getElementById('ipp2_5').innerHTML; document.getElementById('ipp2_5').innerHTML = ''}" id="ipp_5" data-fhir="generated">
             <span style="cursor: pointer; border: 1px grey solid; background-color: #fcdcb3; padding-left: 3px; padding-right: 3px; color: black">Show Usage</span>
          </div>
          <div style="display: none" id="ipp2_5">

            <ul>

              <li>
                <a href="http://terminology.hl7.org/7.0.1/CodeSystem-attribute-estimate-type.html">StatisticAttribute Estimate Type</a>
:                 <a href="ValueSet-ValueSet-R5-attribute-estimate-type-for-R4.html">ValueSetR5AttributeEstimateTypeForR4</a>
              </li>

              <li>
                <a href="http://tx.fhir.org/r4/ValueSet/characteristic-method">CharacteristicMethod</a>
:                 <a href="ValueSet-ValueSet-R5-characteristic-method-for-R4.html">ValueSetR5CharacteristicMethodForR4</a>
              </li>

              <li>
                <a href="http://terminology.hl7.org/7.0.1/CodeSystem-directness.html">EvidenceDirectness</a>
:                 <a href="StructureDefinition-ext-R5-Evidence.variableDefinition.html">ExtensionEvidence_VariableDefinition</a>
 and                 <a href="ValueSet-ValueSet-R5-directness-for-R4.html">ValueSetR5DirectnessForR4</a>
              </li>

              <li>
                <a href="http://terminology.hl7.org/7.0.1/CodeSystem-hl7TermMaintInfra.html">HL7 Terminology Maintenance Infrastructure Vocabulary</a>
:                 <a href="CodeSystem-v2-0116.html">BedStatus</a>
,                 <a href="CodeSystem-v2-0131.html">ContactRole2</a>
                <span onClick="document.getElementById('ips_8').innerHTML = document.getElementById('ips2_8').innerHTML" id="ips_8">
... <span style="cursor: pointer; border: 1px grey solid; background-color: #fcdcb3; padding-left: 3px; padding-right: 3px; color: black">Show 8 more</span>                </span>
                <span style="display: none" id="ips2_8">
, <a href="CodeSystem-v2-0074.html">DiagnosticServiceSectionId</a>, <a href="CodeSystem-v2-0003.html">EventType</a>, <a href="CodeSystem-v2-0203.html">IdentifierType</a>, <a href="CodeSystem-v2-0354.html">MessageStructure</a>, <a href="CodeSystem-operation-outcome-tho.html">OperationOutcomeTHO</a>, <a href="CodeSystem-v2-0443.html">ProviderRole</a>, <a href="CodeSystem-v2-0092.html">ReAdmissionIndicator</a> and <a href="CodeSystem-v2-0487.html">SpecimenType</a>                </span>
              </li>

              <li>
                <a href="http://terminology.hl7.org/7.0.1/CodeSystem-statistic-type.html">StatisticStatisticType</a>
:                 <a href="StructureDefinition-ext-R5-Evidence.statistic.html">ExtensionEvidence_Statistic</a>
 and                 <a href="ValueSet-ValueSet-R5-statistic-type-for-R4.html">ValueSetR5StatisticTypeForR4</a>
              </li>

              <li>
                <a href="http://terminology.hl7.org/7.0.1/CodeSystem-subscription-error.html">Subscription Error Codes</a>
:                 <a href="StructureDefinition-ext-R5-SubscriptionStatus.html">ExtensionSubscriptionStatus</a>
 and                 <a href="ValueSet-ValueSet-R5-subscription-error-for-R4.html">ValueSetR5SubscriptionErrorForR4</a>
              </li>

              <li>
                <a href="http://terminology.hl7.org/7.0.1/CodeSystem-v3-ActClass.html">ActClass</a>
:                 <a href="CodeSystem-v3-ActCode.html">ActCode</a>
              </li>

              <li>
                <a href="http://terminology.hl7.org/7.0.1/CodeSystem-v3-EntityNamePartQualifier.html">EntityNamePartQualifier</a>
:                 <a href="ValueSet-ValueSet-R5-v3-EntityNamePartQualifier-for-R4-name-part-qualifier.html">ValueSetR5V3EntityNamePartQualifierForR4NamePartQualifier</a>
              </li>

              <li>
                <a href="http://terminology.hl7.org/7.0.1/CodeSystem-v3-HL7DocumentFormatCodes.html">HL7 Document Format Codes</a>
:                 <a href="StructureDefinition-ext-R5-Endpoint.pay.type.html">ExtensionEndpoint_Payload_Type</a>
 and                 <a href="ValueSet-ValueSet-R5-endpoint-payload-type-for-R4.html">ValueSetR5EndpointPayloadTypeForR4</a>
              </li>

              <li>
                <a href="http://terminology.hl7.org/7.0.1/CodeSystem-v3-ObservationInterpretation.html">ObservationInterpretation</a>
:                 <a href="ValueSet-ValueSet-R5-observation-interpretation-for-R4.html">ValueSetR5ObservationInterpretationForR4</a>
              </li>

              <li>
                <a href="http://terminology.hl7.org/7.0.1/CodeSystem-v3-RoleClass.html">RoleClass</a>
:                 <a href="CodeSystem-v3-RoleCode.html">RoleCode</a>
              </li>

              <li>
                <a href="http://tx.fhir.org/r4/ValueSet/v3-mediaType">Media Type</a>
:                 <a href="ValueSet-ValueSet-R5-v3-MediaType-for-R4-media-type.html">ValueSetR5V3MediaTypeForR4MediaType</a>
              </li>

              <li>
                <a href="http://terminology.hl7.org/7.0.1/CodeSystem-variable-role.html">EvidenceVariableRole</a>
:                 <a href="StructureDefinition-ext-R5-Evidence.variableDefinition.html">ExtensionEvidence_VariableDefinition</a>
 and                 <a href="ValueSet-ValueSet-R5-variable-role-for-R4.html">ValueSetR5VariableRoleForR4</a>
              </li>


            </ul>


          </div>
        </li>


      </ul>


    </div>
    <h2>Copyright and Registered Trademark Uses</h2>
    <ul>
      <li>




          IG &copy; 2025+ FHIR Infrastructure.  
          Package hl7.fhir.uv.xver-r5.r4#0.0.1-snapshot-3 based on FHIR 4.0.1.
          Generated 
  
    2026-02-06
   

          
          
                      Links: Table of Contents |
                 QA Report
                 
                
                 | Version History |
                 CC0 |
                 Propose a change
           
         (        <a href="en\toc.html">src</a>
)
      </li>
      <li>

          hl7.fhir.us.hai: Healthcare Associated Infection Implementation Guide   &reg;&copy; HL7 |
             
                CC0
         (        <a href="searchform.html">src</a>
)
      </li>
      <li>
 164.506 Uses and disclosures to carry out treatment, payment, or health care operations https://www.gpo.gov/fdsys/pkg/CFR-2017-title45-vol1/pdf/CFR-2017-title45-vol1-sec164-506.pdf, assign the HL7 Confidentiality code â€œRâ€? (restricted)." ] ;
    ( fhir:property [
fhir:code [ fhir:v "status" ] ;
fhir:value [
a fhir:Code ;
fhir:v "active"       ]     ] [
fhir:code [ fhir:v "internalId" ] ;
fhir:value [
a fhir:Code ;
fhir:v "24100"       ]     ] [
fhir:code [ fhir:v "subsumedBy" ] ;
fhir:value [
a fhir:Code ;
fhir:v "_ActUSPrivacyConsentDirective"       ]     ] )
  ] [
fhir:code [ fhir:v "CompoundResearchCD" ] ;
fhir:display [ fhir:v "Compound HIPAA Research Authorization and Informed Consent for Research" ] ;
fhir:definition [ fhir:v "A code representing an individualâ€&trade;s consent directive that complies with HIPAA Privacy rule 45 CFR Section 164.508 Uses and disclosures for which an authorization is required https://www.gpo.gov/fdsys/pkg/CFR-2017-title45-vol1/pdf/CFR-2017-title45-vol1-sec164-508.pdf, which is a US Federal law stipulating the policy elements of a valid authorization under this Section specific to disclosures for purposes of research when combined with a Common Rule or Federal Drug Administration consent to participate in research also known as a compound authorization.\r\n\r\n*Usage Note:* The Agency for Healthcare Research and Quality (AHRQ) has developed the Informed Consent and Authorization Toolkit for Minimal Risk Research to facilitate the process of obtaining informed consent and Health Insurance Portability and Accountability Act (HIPAA) authorization from potential research subjects. This toolkit contains information for people responsible for ensuring that potential research subjects are informed in a manner that is consistent with medical ethics and regulatory guidelines. From https://www.ahrq.gov/sites/default/files/publications/files/ictoolkit.pdf.\r\n\r\nUsed to indicate the legal authority for assigning security labels to governed information. In this case, where collection, access, use, or disclosure of healthcare information is governed by an individualâ€&trade;s right of access directive under 45 CFR Section 164.508 use â€œCompoundResearchCDâ€? as the security label policy code.\r\n\r\nInformation or biospecimen disclosed under the Common Rule are not protected by the HIPAA Privacy Rule. If protected under other laws such as confidentiality provisions under the Common Rule, assign the HL7 Confidentiality code â€œMâ€? (moderate).\r\n\r\nSee ActCode.\\_ActPolicyType.\\_ActPrivacyPolicy.\\_ActPrivacyLaw.\\_ActUSPrivacyLaw.HIPAAAuth (HIPAA Authorization for Disclosure). See: HIPAAAuth and NIH Sample Authorization Language for Research Uses and Disclosures of Individually Identifiable Health Information by a Covered Health Care Provider https://privacyruleandresearch.nih.gov/authorization.asp" ] ;
    ( fhir:property [
fhir:code [ fhir:v "status" ] ;
fhir:value [
a fhir:Code ;
fhir:v "active"       ]     ] [
fhir:code [ fhir:v "internalId" ] ;
fhir:value [
a fhir:Code ;
fhir:v "24105"       ]     ] [
fhir:code [ fhir:v "subsumedBy" ] ;
fhir:value [
a fhir:Code ;
fhir:v "_ActUSPrivacyConsentDirective"       ]     ] )
  ] [
fhir:code [ fhir:v "HIPAAAuthCD" ] ;
fhir:display [ fhir:v "HIPAA Authorization Consent Directive" ] ;
fhir:definition [ fhir:v "A code representing an individualâ€&trade;s consent directive that complies with HIPAA Privacy rule 45 CFR Section 164.508 Uses and disclosures for which an authorization is required https://www.gpo.gov/fdsys/pkg/CFR-2017-title45-vol1/pdf/CFR-2017-title45-vol1-sec164-508.pdf, which is a US Federal law stipulating the policy elements of a valid authorization under this Section.\r\n\r\nAn â€œauthorizationâ€? is required by the Privacy Rule for uses and disclosures of protected health information not otherwise allowed by the Rule. Where the Privacy Rule requires patient authorization, voluntary consent is not sufficient to permit a use or disclosure of protected health information unless it also satisfies the requirements of a valid authorization. An authorization is a detailed document that gives covered entities permission to use protected health information for specified purposes, which are generally other than treatment, payment, or health care operations, or to disclose protected health information to a third party specified by the individual.\r\n\r\nAn authorization must specify a number of elements, including a description of the protected health information to be used and disclosed, the person authorized to make the use or disclosure, the person to whom the covered entity may make the disclosure, an expiration date, and, in some cases, the purpose for which the information may be used or disclosed. With limited exceptions, covered entities may not condition treatment or coverage on the individual providing an authorization. https://www.hhs.gov/hipaa/for-professionals/faq/264/what-is-the-difference-between-consent-and-authorization/index.html\r\n\r\nA HIPAA Authorization must comply with 45 CFR Section164.508(c) Implementation specifications: Core elements and requirements â€“ (1) Core elements. A valid authorization under this Section must contain at least the following elements: (i) A description of the information to be used or disclosed that identifies the information in a specific and meaningful fashion. (ii) The name or other specific identification of the person(s), or class of persons, authorized to make the requested use or disclosure. (iii) The name or other specific identification of the person(s), or class of persons, to whom the covered entity may make the requested use or disclosure. (iv) A description of each purpose of the requested use or disclosure. The statement â€œat the request of the individualâ€? is a sufficient description of the purpose when an individual initiates the authorization and does not, or elects not to, provide a statement of the purpose. (v) An expiration date or an expiration event that relates to the individual or the purpose of the use or disclosure. The statement â€œend of the research study,â€? â€œnone,â€? or similar language is sufficient if the authorization is for a use or disclosure of protected health information for research, including for the creation and maintenance of a research database or research repository. (vi) Signature of the individual and date. If the authorization is signed by a personal representative of the individual, a description of such representative's authority to act for the individual must also be provided. (2)Required statements. In addition to the core elements, the authorization must contain statements adequate to place the individual on notice of all of the following: (i) The individual's right to revoke the authorization in writing, and either: (A) The exceptions to the right to revoke and a description of how the individual may revoke the authorization; or (B) To the extent that the information in paragraph (c)(2)(i)(A) of this section is included in the notice required by Section 164.520, a reference to the covered entity's notice. https://www.gpo.gov/fdsys/pkg/CFR-2017-title45-vol1/pdf/CFR-2017-title45-vol1-sec164-508.pdf\r\n\r\n*Usage Note:* Used to indicate the legal authority for assigning security labels to HIPAA governed information. In this case, where collection, access, use, or disclosure of healthcare information is governed by a an individualâ€&trade;s HIPAA Authorization for Disclosure, use â€œHIPAAAuthCDâ€? as the security label policy code.\r\n\r\nInformation governed under a HIPAA Authorization for Disclosure has the level of confidentiality protection afforded under the 45 CFR Section 164.506 - Uses and disclosures to carry out treatment, payment, or health care operations https://www.gpo.gov/fdsys/pkg/CFR-2017-title45-vol1/pdf/CFR-2017-title45-vol1-sec164-506.pdf, which is considered the â€œnormâ€?, assign the HL7 Confidentiality code â€œNâ€? (normal)." ] ;
    ( fhir:property [
fhir:code [ fhir:v "status" ] ;
fhir:value [
a fhir:Code ;
fhir:v "active"       ]     ] [
fhir:code [ fhir:v "internalId" ] ;
fhir:value [
a fhir:Code ;
fhir:v "24101"       ]     ] [
fhir:code [ fhir:v "subsumedBy" ] ;
fhir:value [
a fhir:Code ;
fhir:v "_ActUSPrivacyConsentDirective"       ]     ] )
  ] [
fhir:code [ fhir:v "HIPAAConsentCD" ] ;
fhir:display [ fhir:v "HIPAA Consent Directive" ] ;
fhir:definition [ fhir:v "A code representing U.S. Public Law 104-191 Health Insurance Portability and Accountability Act (HIPAA) Privacy Rule 45 CFR Section 164.522 Rights to request privacy protection for protected health information https://www.gpo.gov/fdsys/pkg/CFR-2017-title45-vol1/pdf/CFR-2017-title45-vol1-sec164-522.pdf, which stipulates the process by which a covered entity seeks agreement from an individual regarding how it will use and disclose the individual's protected health information for treatment, payment, and health care operations is termed a \"consent.\"\r\n\r\n*Usage Note:* Used to indicate the legal authority for assigning security labels to governed information. In this case, where collection, access, use, or disclosure of healthcare information is governed by an individualâ€&trade;s consent directive under 45 CFR Section 164.522 use â€œHIPAAConsentCDâ€? as the security label policy code.\r\n\r\nSince information governed by a 45 CFR Section 164.522 has a level of confidentiality protection that is more stringent than the normal level of protection under HIPAA 45 CFR Section 164.506 Uses and disclosures to carry out treatment, payment, or health care operations https://www.gpo.gov/fdsys/pkg/CFR-2017-title45-vol1/pdf/CFR-2017-title45-vol1-sec164-506.pdf, assign the HL7 Confidentiality code â€œRâ€? (restricted)." ] ;
    ( fhir:property [
fhir:code [ fhir:v "status" ] ;
fhir:value [
a fhir:Code ;
fhir:v "active"       ]     ] [
fhir:code [ fhir:v "internalId" ] ;
fhir:value [
a fhir:Code ;
fhir:v "24102"       ]     ] [
fhir:code [ fhir:v "subsumedBy" ] ;
fhir:value [
a fhir:Code ;
fhir:v "_ActUSPrivacyConsentDirective"       ]     ] )
  ] [
fhir:code [ fhir:v "HIPAAResearchAuthCD" ] ;
fhir:display [ fhir:v "HIPAA Authorization for Disclosure for Research Consent Directive" ] ;
fhir:definition [ fhir:v "A code representing an individualâ€&trade;s consent directive that complies with HIPAA Privacy rule 45 CFR Section 164.508 Uses and disclosures for which an authorization is required https://www.gpo.gov/fdsys/pkg/CFR-2017-title45-vol1/pdf/CFR-2017-title45-vol1-sec164-508.pdf, which is a US Federal law stipulating the policy elements of a valid authorization under this Section specific to disclosures for purposes of research.\r\n\r\n*Usage Note:* Used to indicate the legal authority for assigning security labels to governed information. In this case, where collection, access, use, or disclosure of healthcare information is governed by an individualâ€&trade;s HIPAA Authorization for Disclosure for Research under 45 CFR Section 164.508 use â€œHIPAAResearchAuthCDâ€? as the security label policy code.\r\n\r\nInformation disclosed under an individualâ€&trade;s HIPAA Authorization for Disclosure for Research are not protected by the HIPAA Privacy Rule. If protected under other laws such as confidentiality provisions under the Common Rule, assign the HL7 Confidentiality code â€œMâ€? (moderate).\r\n\r\nSee ActCode.\\_ActPolicyType.\\_ActPrivacyPolicy.\\_ActPrivacyLaw.\\_ActUSPrivacyLaw.HIPAAAuth (HIPAA Authorization for Disclosure). See: HIPAAAuth and NIH Sample Authorization Language for Research Uses and Disclosures of Individually Identifiable Health Information by a Covered Health Care Provider https://privacyruleandresearch.nih.gov/authorization.asp" ] ;
    ( fhir:property [
fhir:code [ fhir:v "status" ] ;
fhir:value [
a fhir:Code ;
fhir:v "active"       ]     ] [
fhir:code [ fhir:v "internalId" ] ;
fhir:value [
a fhir:Code ;
fhir:v "24104"       ]     ] [
fhir:code [ fhir:v "subsumedBy" ] ;
fhir:value [
a fhir:Code ;
fhir:v "_ActUSPrivacyConsentDirective"       ]     ] )
  ] [
fhir:code [ fhir:v "HIPAAROAD" ] ;
fhir:display [ fhir:v "HIPAA Right of Access Directive" ] ;
fhir:definition [ fhir:v "A code representing U.S. Public Law 104-191 Health Insurance Portability and Accountability Act (HIPAA) Privacy Rule 45 CFR Section 164.524 Access of individuals to protected health information https://www.gpo.gov/fdsys/pkg/CFR-2017-title45-vol1/pdf/CFR-2017-title45-vol1-sec164-524.pdf, stipulating the policy elements of an individualâ€&trade;s written and signed right of access directive requesting that a covered entity send the individualâ€&trade;s protected health information (PHI) to a third party.\r\n\r\nSee 45 CFR 164.524(c)(3)(ii) If an individual's request for access directs the covered entity to transmit the copy of protected health information directly to another person designated by the individual, the covered entity must provide the copy to the person designated by the individual. The individual's request must be in writing, signed by the individual, and clearly identify the designated person and where to send the copy of protected health information. https://www.gpo.gov/fdsys/pkg/CFR-2017-title45-vol1/pdf/CFR-2017-title45-vol1-sec164-524.pdf\r\n\r\nThis right applies to PHI in a designated record set, which is defined as â€œDesignated record set means: (1) A group of records maintained by or for a covered entity that is: (i) The medical records and billing records about individuals maintained by or for a covered health care provider; (ii) The enrollment, payment, claims adjudication, and case or medical management record systems maintained by or for a health plan; or (iii) Used, in whole or in part, by or for the covered entity to make decisions about individuals. \\[https://www.law.cornell.edu/cfr/text/45/164.501\\]. Also see HHS Individualsâ€&trade; Right under HIPAA to Access their Health Information 45 CFR Section 164.524 \\[https://www.hhs.gov/hipaa/for-professionals/privacy/guidance/access/index.html\\#maximumflatfee\\].\r\n\r\n*Usage Note:* Used to indicate the legal authority for assigning security labels to governed information. In this case, where collection, access, use, or disclosure of healthcare information is governed by an individualâ€&trade;s right of access directive under 45 CFR Section 164.524 use â€œHIPAAROADâ€? as the security label policy code.\r\n\r\nInformation disclosed under a HIPAA 42 CFR Section 164.524 no longer has the level of confidentiality protection afforded under the 45 CFR Section 164.506 - Uses and disclosures to carry out treatment, payment, or health care operations https://www.gpo.gov/fdsys/pkg/CFR-2017-title45-vol1/pdf/CFR-2017-title45-vol1-sec164-508.pdf, which is considered the â€œnormâ€?, assign the HL7 Confidentiality code â€œMâ€? (moderate), which may be protected under other laws such as the Federal Trade Commission privacy and security regulations." ] ;
    ( fhir:property [
fhir:code [ fhir:v "status" ] ;
fhir:value [
a fhir:Code ;
fhir:v "active"       ]     ] [
fhir:code [ fhir:v "internalId" ] ;
fhir:value [
a fhir:Code ;
fhir:v "24103"       ]     ] [
fhir:code [ fhir:v "subsumedBy" ] ;
fhir:value [
a fhir:Code ;
fhir:v "_ActUSPrivacyConsentDirective"       ]     ] )
  ] [
fhir:code [ fhir:v "MDHHS-5515" ] ;
fhir:display [ fhir:v "Michigan Consent to Share Behavioral Health Information for Care Coordination Purposes" ] ;
fhir:definition [ fhir:v "The State of Michigan standard privacy consent form for sharing of health information specific to behavioral health and substance use treatment in accordance with Public Act 129 of 2014. In Michigan, while providers are not required to use this new standard form (MDHHS-5515), they are required to accept it.\r\n\r\n*Usage Note:* For legislative background, current MDHHS-5515 consent directive form, and provider and patient FAQs see http://www.michigan.gov/mdhhs/0,5885,7-339-71550\\_2941\\_58005-343686--,00.html" ] ;
    ( fhir:property [
fhir:code [ fhir:v "status" ] ;
fhir:value [
a fhir:Code ;
fhir:v "active"       ]     ] [
fhir:code [ fhir:v "internalId" ] ;
fhir:value [
a fhir:Code ;
fhir:v "24106"       ]     ] [
fhir:code [ fhir:v "subsumedBy" ] ;
fhir:value [
a fhir:Code ;
fhir:v "_ActUSPrivacyConsentDirective"       ]     ] )
  ] [
fhir:code [ fhir:v "42CFRPart2" ] ;
fhir:display [ fhir:v "42 CFR Part2" ] ;
fhir:definition [ fhir:v "A code representing 42 CFR Part 2 Confidentiality of Substance Use Disorder Patient Records. 42 CFR Part 2 stipulates the privacy rights of an individual who has applied for or been given diagnosis or treatment for alcohol or drug abuse at a federally assisted program, which includes non-disclosure of health information relating to health care paid for by a federally assisted substance use disorder program without patient consent. https://www.gpo.gov/fdsys/pkg/CFR-2010-title42-vol1/pdf/CFR-2010-title42-vol1-part2.pdf\r\n\r\n*Usage Note:* Used to indicate the legal authority for assigning security labels to governed information. In this case, the collection, access, use, and disclosure of healthcare information is governed by 42 CFR Part 2 Confidentiality of Substance Use Disorder Patient Records https://www.gpo.gov/fdsys/pkg/CFR-2010-title42-vol1/pdf/CFR-2010-title42-vol1-part2.pdf use â€œ42CFRPart2â€? as the security label policy code.\r\n\r\nSince information governed by a 42 CFR Part 2 has a level of confidentiality protection that is more stringent than the normal level of protection under HIPAA 45 CFR Section 164.506 Uses and disclosures to carry out treatment, payment, or health care operations https://www.gpo.gov/fdsys/pkg/CFR-2017-title45-vol1/pdf/CFR-2017-title45-vol1-sec164-506.pdf assign the HL7 Confidentiality code â€œRâ€? (restricted)." ] ;
    ( fhir:property [
fhir:code [ fhir:v "status" ] ;
fhir:value [
a fhir:Code ;
fhir:v "active"       ]     ] [
fhir:code [ fhir:v "internalId" ] ;
fhir:value [
a fhir:Code ;
fhir:v "23761"       ]     ] [
fhir:code [ fhir:v "subsumedBy" ] ;
fhir:value [
a fhir:Code ;
fhir:v "_ActUSPrivacyLaw"       ]     ] )
  ] [
fhir:code [ fhir:v "CommonRule" ] ;
fhir:display [ fhir:v "Common Rule" ] ;
fhir:definition [ fhir:v "A code representing U.S. Federal laws governing research-related privacy policies known as the â€œCommon Ruleâ€?. The Common Rule is the U.S. Federal regulations governing the protection of human subjects in research (codified at Subpart A of 45 CFR part 46), which has been adopted by 15 U.S. Federal departments and agencies in an effort to promote uniformity, understanding, and compliance with human subject protections. Existing regulations governing the protection of human subjects in Food and Drug Administration (FDA)-regulated research (21 CFR parts 50, 56, 312, and 812) are separate from the Common Rule but include similar requirements.\r\n\r\n*Usage Note:* Used to indicate the legal authority for assigning security labels to governed information. In this case, where collection, access, use, or disclosure of healthcare information or biospecimen is governed by the Common Rule use â€œCOMMONRULEâ€? as the security label policy code. Information or biospecimen disclosed under the Common Rule are not protected by the HIPAA Privacy Rule. If protected under other laws such as confidentiality provisions under the Common Rule, assign the HL7 Confidentiality code â€œMâ€? (moderate)." ] ;
    ( fhir:property [
fhir:code [ fhir:v "status" ] ;
fhir:value [
a fhir:Code ;
fhir:v "active"       ]     ] [
fhir:code [ fhir:v "internalId" ] ;
fhir:value [
a fhir:Code ;
fhir:v "23762"       ]     ] [
fhir:code [ fhir:v "subsumedBy" ] ;
fhir:value [
a fhir:Code ;
fhir:v "_ActUSPrivacyLaw"       ]     ] )
  ] [
fhir:code [ fhir:v "HIPAAAuth" ] ;
fhir:display [ fhir:v "HIPAA Authorization for Disclosure" ] ;
fhir:definition [ fhir:v "A code representing U.S. Public Law 104-191 Health Insurance Portability and Accountability Act (HIPAA) Privacy Rule (45 CFR Section 164.508) Uses and disclosures for which an authorization is required https://www.gpo.gov/fdsys/pkg/CFR-2017-title45-vol1/pdf/CFR-2017-title45-vol1-sec164-508.pdf, which stipulates the process by which a covered entity seeks agreement from an individual to use or disclose protected health information for other purposes, or to authorize another covered entity to disclose protected health information to the requesting covered entity, are termed \"authorizations\".\r\n\r\nAn â€œauthorizationâ€? is required by the Privacy Rule for uses and disclosures of protected health information not otherwise allowed by the Rule. Where the Privacy Rule requires patient authorization, voluntary consent is not sufficient to permit a use or disclosure of protected health information unless it also satisfies the requirements of a valid authorization. An authorization is a detailed document that gives covered entities permission to use protected health information for specified purposes, which are generally other than treatment, payment, or health care operations, or to disclose protected health information to a third party specified by the individual.\r\n\r\nAn authorization must specify a number of elements, including a description of the protected health information to be used and disclosed, the person authorized to make the use or disclosure, the person to whom the covered entity may make the disclosure, an expiration date, and, in some cases, the purpose for which the information may be used or disclosed. With limited exceptions, covered entities may not condition treatment or coverage on the individual providing an authorization. https://www.hhs.gov/hipaa/for-professionals/faq/264/what-is-the-difference-between-consent-and-authorization/index.html\r\n\r\n*Usage Note:* Used to indicate the legal authority for assigning security labels to HIPAA governed information. In this case, where use or disclosure of healthcare information is governed by a covered entityâ€&trade;s HIPAA Authorization for Disclosure, use â€œHIPAAAuthâ€? as the security label policy code.\r\n\r\nInformation disclosed under a HIPAA Authorization for Disclosure no longer has the level of confidentiality protection afforded under the 45 CFR Section 164.506 - Uses and disclosures to carry out treatment, payment, or health care operations https://www.gpo.gov/fdsys/pkg/CFR-2017-title45-vol1/pdf/CFR-2017-title45-vol1-sec164-508.pdf, which is considered the â€œnormâ€?, assign the HL7 Confidentiality code â€œMâ€? (moderate), which may be protected under other laws such as the Federal Trade Commission privacy and security regulations." ] ;
    ( fhir:property [
fhir:code [ fhir:v "status" ] ;
fhir:value [
a fhir:Code ;
fhir:v "active"       ]     ] [
fhir:code [ fhir:v "internalId" ] ;
fhir:value [
a fhir:Code ;
fhir:v "24118"       ]     ] [
fhir:code [ fhir:v "subsumedBy" ] ;
fhir:value [
a fhir:Code ;
fhir:v "_ActUSPrivacyLaw"       ]     ] )
  ] [
fhir:code [ fhir:v "HIPAAConsent" ] ;
fhir:display [ fhir:v "HIPAA Consent" ] ;
fhir:definition [ fhir:v "A code representing U.S. Public Law 104-191 Health Insurance Portability and Accountability Act (HIPAA) Privacy Rule (45 CFR Section 164.522), which stipulates the process by which a covered entity seeks agreement from an individual regarding how it will use and disclose the individual's protected health information for treatment, payment, and health care operations is termed a \"consent\".\r\n\r\nThe Privacy Rule permits, but does not require, a covered entity to voluntarily obtain patient consent for uses and disclosures of protected health information for treatment, payment, and health care operations. Covered entities that do so have complete discretion to design a process that best suits their needs. From https://www.hhs.gov/hipaa/for-professionals/faq/264/what-is-the-difference-between-consent-and-authorization/index.html. The provisions relating to consent are largely contained in Section 164.522 Rights to request privacy protection for protected health information https://www.gpo.gov/fdsys/pkg/CFR-2017-title45-vol1/pdf/CFR-2017-title45-vol1-sec164-522.pdf.\r\n\r\n*Usage Note:* Used to indicate the legal authority for assigning security labels to governed information. In this case, where collection, access, use, or disclosure of healthcare information is governed by 45 CFR Section 164.522 use 'HIPAAConsent' as the security label policy code.\r\n\r\nSince information governed by a 45 CFR Section 164.522 has a level of confidentiality protection that is more stringent than the normal level of protection under HIPAA 45 CFR Section 164.506 Uses and disclosures to carry out treatment, payment, or health care operations https://www.gpo.gov/fdsys/pkg/CFR-2017-title45-vol1/pdf/CFR-2017-title45-vol1-sec164-506.pdf, assign the HL7 Confidentiality code 'R' (restricted)." ] ;
    ( fhir:property [
fhir:code [ fhir:v "status" ] ;
fhir:value [
a fhir:Code ;
fhir:v "active"       ]     ] [
fhir:code [ fhir:v "internalId" ] ;
fhir:value [
a fhir:Code ;
fhir:v "24135"       ]     ] [
fhir:code [ fhir:v "subsumedBy" ] ;
fhir:value [
a fhir:Code ;
fhir:v "_ActUSPrivacyLaw"       ]     ] )
  ] [
fhir:code [ fhir:v "HIPAANOPP" ] ;
fhir:display [ fhir:v "HIPAA notice of privacy practices" ] ;
fhir:definition [ fhir:v "A code representing U.S. Public Law 104-191 Health Insurance Portability and Accountability Act (HIPAA) Privacy Rule (45 CFR Section 164.520), which stipulates an individualâ€&trade;s right to adequate notice of the uses and disclosures of protected health information that may be made by the covered entity, and of the individual's rights and the covered entity's legal duties with respect to protected health information. Relevant HIPAA Privacy Rule provisions are at Section 164.520 (a) Standard: Notice of privacy practices. https://www.gpo.gov/fdsys/pkg/CFR-2017-title45-vol1/pdf/CFR-2017-title45-vol1-sec164-520.pdf\r\n\r\n*Usage Note:* Used to indicate the legal authority for assigning security labels to HIPAA governed information. In this case, if collection, access, use, or disclosure of healthcare information is governed by a covered entityâ€&trade;s HIPAA Notice of Privacy Practices, use â€œHIPAANOPPâ€? as the security label policy code.\r\n\r\nInformation governed under a HIPAA Notice of Privacy Practices has the level of confidentiality protection afforded under the 45 CFR Section 164.506 - Uses and disclosures to carry out treatment, payment, or health care operations https://www.gpo.gov/fdsys/pkg/CFR-2017-title45-vol1/pdf/CFR-2017-title45-vol1-sec164-506.pdf , which is considered the â€œnormâ€?, assign the HL7 Confidentiality code â€œNâ€? (normal)." ] ;
    ( fhir:property [
fhir:code [ fhir:v "status" ] ;
fhir:value [
a fhir:Code ;
fhir:v "active"       ]     ] [
fhir:code [ fhir:v "internalId" ] ;
fhir:value [
a fhir:Code ;
fhir:v "23763"       ]     ] [
fhir:code [ fhir:v "subsumedBy" ] ;
fhir:value [
a fhir:Code ;
fhir:v "_ActUSPrivacyLaw"       ]     ] )
  ] [
fhir:code [ fhir:v "HIPAAPsyNotes" ] ;
fhir:display [ fhir:v "HIPAA psychotherapy notes" ] ;
fhir:definition [ fhir:v "A code representing U.S. Public Law 104-191 Health Insurance Portability and Accountability Act (HIPAA) Privacy Rule (45 CFR Section 164.508), which stipulates the privacy rights of an individual who is the subject of psychotherapy notes, and requires authorization for certain uses and disclosure of that information.\r\n\r\nDefinition of Psychotherapy notes 45 CFR Section 164.501 https://www.gpo.gov/fdsys/pkg/CFR-2017-title45-vol1/pdf/CFR-2017-title45-vol1-sec164-501.pdf: Psychotherapy notes means notes recorded (in any medium) by a health care provider who is a mental health professional documenting or analyzing the contents of conversation during a private counseling session or a group, joint, or family counseling session and that are separated from the rest of the individual's medical record. Psychotherapy notes excludes medication prescription and monitoring, counseling session start and stop times, the modalities and frequencies of treatment furnished, results of clinical tests, and any summary of the following items: Diagnosis, functional status, the treatment plan, symptoms, prognosis, and progress to date.\r\n\r\nSee Section 164.508 Uses and disclosures for which an authorization is required. (2)Authorization required: Psychotherapy notes https://www.gpo.gov/fdsys/pkg/CFR-2017-title45-vol1/pdf/CFR-2017-title45-vol1-sec164-508.pdf: Notwithstanding any provision of this subpart, other than the transition provisions in Section 164.532, a covered entity must obtain an authorization for any use or disclosure of psychotherapy notes, except: (i) To carry out the following treatment, payment, or health care operations: (A) Use by the originator of the psychotherapy notes for treatment; (B) Use or disclosure by the covered entity for its own training programs in which students, trainees, or practitioners in mental health learn under supervision to practice or improve their skills in group, joint, family, or individual counseling; or (C) Use or disclosure by the covered entity to defend itself in a legal action or other proceeding brought by the individual; and (ii) A use or disclosure that is required by Section 164.502(a)(2)(ii) or permitted by Section 164.512(a); Section 164.512(d) with respect to the oversight of the originator of the psychotherapy notes; Section 164.512(g)(1); Section 164.512(j)(1)(i).\r\n\r\n*Usage Note:* Used to indicate the legal authority for assigning security labels to HIPAA governed information. In this case, the collection, access, use, or disclosure of healthcare information is governed by HIPAA 45 CFR 164.508 (2) Authorization required: Psychotherapy notes https://www.gpo.gov/fdsys/pkg/CFR-2017-title45-vol1/pdf/CFR-2017-title45-vol1-sec164-506.pdf , use â€œHIPAAPsyNotesâ€? as the security label policy code.\r\n\r\nSince information governed by a HIPAA 45 CFR 164.508 (2) has a level of confidentiality protection that is more stringent than the normal level of protection under 45 CFR Section 164.506 Uses and disclosures to carry out treatment, payment, or health care operations https://www.gpo.gov/fdsys/pkg/CFR-2017-title45-vol1/pdf/CFR-2017-title45-vol1-sec164-506.pdf, assign the HL7 Confidentiality code â€œRâ€? (restricted)." ] ;
    ( fhir:property [
fhir:code [ fhir:v "status" ] ;
fhir:value [
a fhir:Code ;
fhir:v "active"       ]     ] [
fhir:code [ fhir:v "internalId" ] ;
fhir:value [
a fhir:Code ;
fhir:v "23764"       ]     ] [
fhir:code [ fhir:v "subsumedBy" ] ;
fhir:value [
a fhir:Code ;
fhir:v "_ActUSPrivacyLaw"       ]     ] )
  ] [
fhir:code [ fhir:v "HIPAAROA" ] ;
fhir:display [ fhir:v "HIPAA Right of Access" ] ;
fhir:definition [ fhir:v "A code representing U.S. Public Law 104-191 Health Insurance Portability and Accountability Act (HIPAA) Privacy Rule 45 CFR Section 164.524 Access of individuals to protected health information https://www.govinfo.gov/app/details/CFR-2017-title45-vol1/CFR-2017-title45-vol1-sec164-524, which stipulates that an individual has a right of access to inspect and obtain a copy of protected health information about the individual in a designated record set, for as long as the protected health information is maintained in the designated record set with exceptions stipulated in HIPAA Privacy Rule Section 164.524. Exceptions include psychotherapy notes and information compiled in reasonable anticipation of, or for use in, a civil, criminal, or administrative action or proceeding.\r\n\r\nIf an individual's request for access directs the covered entity to transmit the copy of protected health information directly to another person designated by the individual, the covered entity must provide the copy to the person designated by the individual. The individual's request must be in writing, signed by the individual, and clearly identify the designated person and where to send the copy of protected health information.\r\n\r\nFor discussion on extent of right, grounds for denial, and documentation requirements see: HHS Individualsâ€&trade; Right under HIPAA to Access their Health Information 45 CFR Section 164.524 https://www.hhs.gov/hipaa/for-professionals/privacy/guidance/access/index.html and HHS FAQ on Right of Access vs. HIPAA Authorization https://www.hhs.gov/hipaa/for-professionals/faq/2041/why-depend-on-the-individuals-right/index.html\r\n\r\n*Usage Note:* Used to indicate the legal authority for assigning security labels to governed information. In this case, where collection, access, use, or disclosure of healthcare information is governed under 45 CFR Section 164.5224 use â€œHIPAAROAâ€? as the security label policy code.\r\n\r\nInformation disclosed under a HIPAA 42 CFR Section 164.524 no longer has the level of confidentiality protection afforded under the 45 CFR Section 164.506 - Uses and disclosures to carry out treatment, payment, or health care operations https://www.gpo.gov/fdsys/pkg/CFR-2017-title45-vol1/pdf/CFR-2017-title45-vol1-sec164-508.pdf, which is considered the â€œnormâ€?, assign the HL7 Confidentiality code â€œMâ€? (moderate), which may be protected under other laws such as the Federal Trade Commission privacy and security regulations." ] ;
    ( fhir:property [
fhir:code [ fhir:v "status" ] ;
fhir:value [
a fhir:Code ;
fhir:v "active"       ]     ] [
fhir:code [ fhir:v "internalId" ] ;
fhir:value [
a fhir:Code ;
fhir:v "24119"       ]     ] [
fhir:code [ fhir:v "subsumedBy" ] ;
fhir:value [
a fhir:Code ;
fhir:v "_ActUSPrivacyLaw"       ]     ] )
  ] [
fhir:code [ fhir:v "HIPAASelfPay" ] ;
fhir:display [ fhir:v "HIPAA self-pay" ] ;
fhir:definition [ fhir:v "A code representing 45 CFR 164.522 Rights to request privacy protection for protected health information, which is a US Federal law stipulating the privacy rights of an individual to restrict disclosure of information related to health care items or services for which the individual pays out of pocket in full to a health plan or payer.\r\n\r\nSee 45 CFR 164.522 https://www.gpo.gov/fdsys/pkg/CFR-2017-title45-vol1/pdf/CFR-2017-title45-vol1-sec164-522.pdf. (vi) A covered entity must agree to the request of an individual to restrict disclosure of protected health information about the individual to a health plan if: (A) The disclosure is for the purpose of carrying out payment or health care operations and is not otherwise required by law; and (B) The protected health information pertains solely to a health care item or service for which the individual, or person other than the health plan on behalf of the individual, has paid the covered entity in full.\r\n\r\n*Usage Note:* Used to indicate the legal authority for assigning security labels to HIPAA governed information. In this case, the collection, access, use, or disclosure of healthcare information is governed by HIPAA 45 CFR 164.522 https://www.gpo.gov/fdsys/pkg/CFR-2017-title45-vol1/pdf/CFR-2017-title45-vol1-sec164-522.pdf use â€œHIPAASelfPayâ€? as the security label policy code.\r\n\r\nSince information governed by a HIPAA 45 CFR 164.522 has a level of confidentiality protection that is more stringent than the normal level of protection under 45 CFR Section 164.506 Uses and disclosures to carry out treatment, payment, or health care operations https://www.gpo.gov/fdsys/pkg/CFR-2017-title45-vol1/pdf/CFR-2017-title45-vol1-sec164-506.pdf, assign the HL7 Confidentiality code â€œRâ€? (restricted)." ] ;
    ( fhir:property [
fhir:code [ fhir:v "status" ] ;
fhir:value [
a fhir:Code ;
fhir:v "active"       ]     ] [
fhir:code [ fhir:v "internalId" ] ;
fhir:value [
a fhir:Code ;
fhir:v "23765"       ]     ] [
fhir:code [ fhir:v "subsumedBy" ] ;
fhir:value [
a fhir:Code ;
fhir:v "_ActUSPrivacyLaw"       ]     ] )
  ] [
fhir:code [ fhir:v "Title38Section7332" ] ;
fhir:display [ fhir:v "Title 38 Section 7332" ] ;
fhir:definition [ fhir:v "A code representing Title 38 Section 7332, which is a US Federal law stipulating the privacy rights of veterans diagnosed and treated for substance use disorders, infection with the human immunodeficiency virus, or sickle cell anemia.\r\n\r\nhttps://www.gpo.gov/fdsys/granule/USCODE-2011-title38/USCODE-2011-title38-partV-chap73-subchapIII-sec7332/content-detail.html . (1) Records of the identity, diagnosis, prognosis, or treatment of any patient or subject which are maintained in connection with the performance of any program or activity (including education, training, treatment, rehabilitation, or research) relating to drug abuse, alcoholism or alcohol abuse, infection with the human immunodeficiency virus, or sickle cell anemia which is carried out by or for the Department under this title shall, except as provided in subsections (e) and (f), be confidential, and (section 5701 of this title to the contrary notwithstanding) such records may be disclosed only for the purposes and under the circumstances expressly authorized under subsection (b). (2) Paragraph (1) prohibits the disclosure to any person or entity other than the patient or subject concerned of the fact that a special written consent is required in order for such records to be disclosed. (b) (1) The content of any record referred to in subsection (a) may be disclosed by the Secretary in accordance with the prior written consent of the patient or subject with respect to whom such record is maintained, but only to such extent, under such circumstances, and for such purposes as may be allowed in regulations prescribed by the Secretary. (2) Whether or not any patient or subject, with respect to whom any given record referred to in subsection (a) is maintained, gives written consent, the content of such record may be disclosed by the Secretary as follows: (A) To medical personnel to the extent necessary to meet a bona fide medical emergency. (B) To qualified personnel for the purpose of conducting scientific research, management audits, financial audits, or program evaluation, but such personnel may not identify, directly or indirectly, any individual patient or subject in any report of such research, audit, or evaluation, or otherwise disclose patient or subject identities in any manner. (C) (i) In the case of any record which is maintained in connection with the performance of any program or activity relating to infection with the human immunodeficiency virus, to a Federal, State, or local public-health authority charged under Federal or State law with the protection of the public health, and to which Federal or State law requires disclosure of such record, if a qualified representative of such authority has made a written request that such record be provided as required pursuant to such law for a purpose authorized by such law. (ii) A person to whom a record is disclosed under this paragraph may not redisclose or use such record for a purpose other than that for which the disclosure was made. (D) If authorized by an appropriate order of a court of competent jurisdiction granted after application showing good cause therefor. In assessing good cause the court shall weigh the public interest and the need for disclosure against the injury to the patient or subject, to the physician-patient relationship, and to the treatment services. Upon the granting of such order, the court, in determining the extent to which any disclosure of all or any part of any record is necessary, shall impose appropriate safeguards against unauthorized disclosure. (E) To an entity described in paragraph (1)(B) of section 5701(k) of this title, but only to the extent authorized by such section. (F) (i) To a representative of a patient who lacks decision-making capacity, when a practitioner deems the content of the given record necessary for that representative to make an informed decision regarding the patient's treatment. (ii) In this subparagraph, the term Ã¢â‚¬Å“representativeÃ¢â‚¬? means an individual, organization, or other body authorized under section 7331 of this title and its implementing regulations to give informed consent on behalf of a patient who lacks decision-making capacity. (G) To a State controlled substance monitoring program, including a program approved by the Secretary of Health and Human Services under section 399O of the Public Health Service Act (42 U.S.C. 280g-3), to the extent necessary to prevent misuse and diversion of prescription medicines. (H) (i) To a non-Department entity (including private entities and other Federal agencies) for purposes of providing health care, including hospital care, medical services, and extended care services, to Veterans or performing other health care-related activities or functions. (ii) An entity to which a record is disclosed under this subparagraph may not disclose or use such record for a purpose other than that for which the disclosure was made or as permitted by law. (I) To a third party in order to recover or collect reasonable charges for care furnished to, or paid on behalf of, a Veteran in connection with a non-service connected disability as permitted by section 1729 of this title or for a condition for which recovery is authorized or with respect to which the United States is deemed to be a third party beneficiary under the Act entitled 'An Act to provide for the recovery from tortiously liable third persons of the cost of hospital and medical care and treatment furnished by the United States' (Public Law 87-693; 42 U.S.C. 2651 et seq.; commonly known as the 'Federal Medical Care Recovery Act').\r\n\r\n*Usage Note:* Used to indicate the legal authority for assigning security labels to governed information. In this case, where collection, access, use, or disclosure of healthcare information is governed by 38 U.S. Code Section 7332 - Confidentiality of certain medical records https://www.gpo.gov/fdsys/granule/USCODE-2011-title38/USCODE-2011-title38-partV-chap73-subchapIII-sec7332/content-detail.html use \"Title38Section7332\" as the security label policy code.\r\n\r\nSince information governed by a Title 38 Section 7332 has a level of confidentiality protection that is more stringent than the normal level of protection under HIPAA 45 CFR Section 164.506 Uses and disclosures to carry out treatment, payment, or health care operations https://www.gpo.gov/fdsys/pkg/CFR-2017-title45-vol1/pdf/CFR-2017-title45-vol1-sec164-506.pdf, assign the HL7 Confidentiality code \"R\" (restricted)." ] ;
    ( fhir:property [
fhir:code [ fhir:v "status" ] ;
fhir:value [
a fhir:Code ;
fhir:v "active"       ]     ] [
fhir:code [ fhir:v "internalId" ] ;
fhir:value [
a fhir:Code ;
fhir:v "23766"       ]     ] [
fhir:code [ fhir:v "subsumedBy" ] ;
fhir:value [
a fhir:Code ;
fhir:v "_ActUSPrivacyLaw"       ]     ] )
  ] [
fhir:code [ fhir:v "a) HIPAAConsent" ] ;
fhir:display [ fhir:v "HIPAA Consent" ] ;
fhir:definition [ fhir:v "Code retired in December 2019 and replaced by code HIPAAConsent. Originally entered with copy/paste error in code value.\r\n\r\nA code representing U.S. Public Law 104-191 Health Insurance Portability and Accountability Act (HIPAA) Privacy Rule (45 CFR Section 164.522), which stipulates the process by which a covered entity seeks agreement from an individual regarding how it will use and disclose the individual's protected health information for treatment, payment, and health care operations is termed a \"consent.\" The Privacy Rule permits, but does not require, a covered entity to voluntarily obtain patient consent for uses and disclosures of protected health information for treatment, payment, and health care operations. Covered entities that do so have complete discretion to design a process that best suits their needs. From https://www.hhs.gov/hipaa/for-professionals/faq/264/what-is-the-difference-between-consent-and-authorization/index.html. The provisions relating to consent are largely contained in Section 164.522 Rights to request privacy protection for protected health information https://www.gpo.gov/fdsys/pkg/CFR-2017-title45-vol1/pdf/CFR-2017-title45-vol1-sec164-522.pdf.\r\n\r\n*Usage Note:* Used to indicate the legal authority for assigning security labels to governed information. In this case, where collection, access, use, or disclosure of healthcare information is governed by 45 CFR Section 164.522 use Ã¢â‚¬Å“HIPAAConsentÃ¢â‚¬? as the security label policy code.\r\n\r\nSince information governed by a 45 CFR Section 164.522 has a level of confidentiality protection that is more stringent than the normal level of protection under HIPAA 45 CFR Section 164.506 Uses and disclosures to carry out treatment, payment, or health care operations https://www.gpo.gov/fdsys/pkg/CFR-2017-title45-vol1/pdf/CFR-2017-title45-vol1-sec164-506.pdf, assign the HL7 Confidentiality code Ã¢â‚¬Å“RÃ¢â‚¬? (restricted)." ] ;
    ( fhir:property [
fhir:code [ fhir:v "status" ] ;
fhir:value [
a fhir:Code ;
fhir:v "retired"       ]     ] [
fhir:code [ fhir:v "internalId" ] ;
fhir:value [
a fhir:Code ;
fhir:v "24117"       ]     ] [
fhir:code [ fhir:v "subsumedBy" ] ;
fhir:value [
a fhir:Code ;
fhir:v "_ActUSPrivacyLaw"       ]     ] )
  ] [
fhir:code [ fhir:v "USResearchInformedAssent" ] ;
fhir:display [ fhir:v "Informed Assent for Research" ] ;
fhir:definition [ fhir:v "An informed assertion by a minor who is a candidate research subject, of the individual's willingness to participate in research. Assent means a child's affirmative agreement to participate in a clinical investigation. Mere failure to object should not, absent affirmative agreement, be construed as assent. The minor's assent must be accompanied by parental or guardian consent that the minor participate in a specified research. The assent is not legally binding, however, the accompanying consent is legally binding. Background: In the US, informed assent is governed under 21 CFR Part 50, Subpart D - Additional Safeguards for Children in Clinical Investigations. Available at https://www.law.cornell.edu/cfr/text/21/part-50/subpart-D" ] ;
    ( fhir:property [
fhir:code [ fhir:v "status" ] ;
fhir:value [
a fhir:Code ;
fhir:v "active"       ]     ] [
fhir:code [ fhir:v "internalId" ] ;
fhir:value [
a fhir:Code ;
fhir:v "25100"       ]     ] [
fhir:code [ fhir:v "subsumedBy" ] ;
fhir:value [
a fhir:Code ;
fhir:v "_ActUSPrivacyConsentDirective"       ]     ] )
  ] [
fhir:code [ fhir:v "USResearchInformedConsent" ] ;
fhir:display [ fhir:v "Informed Consent for Research" ] ;
fhir:definition [ fhir:v "An informed assertion by an adult, or the parent/guardian of a minor who is a candidate research subject, of the individual's willingness to participate in a specified research study. The consent is legally binding. Background: In the US, informed assent is governed under 49 CFR  (        <a href="en\CodeSystem-v3-ActCode.ttl.html">src</a>
)
      </li>
      <li>
 164.506 Uses and disclosures to carry out treatment, payment, or health care operations https://www.gpo.gov/fdsys/pkg/CFR-2017-title45-vol1/pdf/CFR-2017-title45-vol1-sec164-506.pdf, assign the HL7 Confidentiality code â€œRâ€? (restricted).",
      "property" : [
        {
          "code" : "status",
          "valueCode" : "active"
        },
        {
          "code" : "internalId",
          "valueCode" : "24100"
        },
        {
          "code" : "subsumedBy",
          "valueCode" : "_ActUSPrivacyConsentDirective"
        }
      ]
    },
    {
      "code" : "CompoundResearchCD",
      "display" : "Compound HIPAA Research Authorization and Informed Consent for Research",
      "definition" : "A code representing an individualâ€&trade;s consent directive that complies with HIPAA Privacy rule 45 CFR Section 164.508 Uses and disclosures for which an authorization is required https://www.gpo.gov/fdsys/pkg/CFR-2017-title45-vol1/pdf/CFR-2017-title45-vol1-sec164-508.pdf, which is a US Federal law stipulating the policy elements of a valid authorization under this Section specific to disclosures for purposes of research when combined with a Common Rule or Federal Drug Administration consent to participate in research also known as a compound authorization.\r\n\r\n*Usage Note:* The Agency for Healthcare Research and Quality (AHRQ) has developed the Informed Consent and Authorization Toolkit for Minimal Risk Research to facilitate the process of obtaining informed consent and Health Insurance Portability and Accountability Act (HIPAA) authorization from potential research subjects. This toolkit contains information for people responsible for ensuring that potential research subjects are informed in a manner that is consistent with medical ethics and regulatory guidelines. From https://www.ahrq.gov/sites/default/files/publications/files/ictoolkit.pdf.\r\n\r\nUsed to indicate the legal authority for assigning security labels to governed information. In this case, where collection, access, use, or disclosure of healthcare information is governed by an individualâ€&trade;s right of access directive under 45 CFR Section 164.508 use â€œCompoundResearchCDâ€? as the security label policy code.\r\n\r\nInformation or biospecimen disclosed under the Common Rule are not protected by the HIPAA Privacy Rule. If protected under other laws such as confidentiality provisions under the Common Rule, assign the HL7 Confidentiality code â€œMâ€? (moderate).\r\n\r\nSee ActCode.\\_ActPolicyType.\\_ActPrivacyPolicy.\\_ActPrivacyLaw.\\_ActUSPrivacyLaw.HIPAAAuth (HIPAA Authorization for Disclosure). See: HIPAAAuth and NIH Sample Authorization Language for Research Uses and Disclosures of Individually Identifiable Health Information by a Covered Health Care Provider https://privacyruleandresearch.nih.gov/authorization.asp",
      "property" : [
        {
          "code" : "status",
          "valueCode" : "active"
        },
        {
          "code" : "internalId",
          "valueCode" : "24105"
        },
        {
          "code" : "subsumedBy",
          "valueCode" : "_ActUSPrivacyConsentDirective"
        }
      ]
    },
    {
      "code" : "HIPAAAuthCD",
      "display" : "HIPAA Authorization Consent Directive",
      "definition" : "A code representing an individualâ€&trade;s consent directive that complies with HIPAA Privacy rule 45 CFR Section 164.508 Uses and disclosures for which an authorization is required https://www.gpo.gov/fdsys/pkg/CFR-2017-title45-vol1/pdf/CFR-2017-title45-vol1-sec164-508.pdf, which is a US Federal law stipulating the policy elements of a valid authorization under this Section.\r\n\r\nAn â€œauthorizationâ€? is required by the Privacy Rule for uses and disclosures of protected health information not otherwise allowed by the Rule. Where the Privacy Rule requires patient authorization, voluntary consent is not sufficient to permit a use or disclosure of protected health information unless it also satisfies the requirements of a valid authorization. An authorization is a detailed document that gives covered entities permission to use protected health information for specified purposes, which are generally other than treatment, payment, or health care operations, or to disclose protected health information to a third party specified by the individual.\r\n\r\nAn authorization must specify a number of elements, including a description of the protected health information to be used and disclosed, the person authorized to make the use or disclosure, the person to whom the covered entity may make the disclosure, an expiration date, and, in some cases, the purpose for which the information may be used or disclosed. With limited exceptions, covered entities may not condition treatment or coverage on the individual providing an authorization. https://www.hhs.gov/hipaa/for-professionals/faq/264/what-is-the-difference-between-consent-and-authorization/index.html\r\n\r\nA HIPAA Authorization must comply with 45 CFR Section164.508(c) Implementation specifications: Core elements and requirements â€“ (1) Core elements. A valid authorization under this Section must contain at least the following elements: (i) A description of the information to be used or disclosed that identifies the information in a specific and meaningful fashion. (ii) The name or other specific identification of the person(s), or class of persons, authorized to make the requested use or disclosure. (iii) The name or other specific identification of the person(s), or class of persons, to whom the covered entity may make the requested use or disclosure. (iv) A description of each purpose of the requested use or disclosure. The statement â€œat the request of the individualâ€? is a sufficient description of the purpose when an individual initiates the authorization and does not, or elects not to, provide a statement of the purpose. (v) An expiration date or an expiration event that relates to the individual or the purpose of the use or disclosure. The statement â€œend of the research study,â€? â€œnone,â€? or similar language is sufficient if the authorization is for a use or disclosure of protected health information for research, including for the creation and maintenance of a research database or research repository. (vi) Signature of the individual and date. If the authorization is signed by a personal representative of the individual, a description of such representative's authority to act for the individual must also be provided. (2)Required statements. In addition to the core elements, the authorization must contain statements adequate to place the individual on notice of all of the following: (i) The individual's right to revoke the authorization in writing, and either: (A) The exceptions to the right to revoke and a description of how the individual may revoke the authorization; or (B) To the extent that the information in paragraph (c)(2)(i)(A) of this section is included in the notice required by Section 164.520, a reference to the covered entity's notice. https://www.gpo.gov/fdsys/pkg/CFR-2017-title45-vol1/pdf/CFR-2017-title45-vol1-sec164-508.pdf\r\n\r\n*Usage Note:* Used to indicate the legal authority for assigning security labels to HIPAA governed information. In this case, where collection, access, use, or disclosure of healthcare information is governed by a an individualâ€&trade;s HIPAA Authorization for Disclosure, use â€œHIPAAAuthCDâ€? as the security label policy code.\r\n\r\nInformation governed under a HIPAA Authorization for Disclosure has the level of confidentiality protection afforded under the 45 CFR Section 164.506 - Uses and disclosures to carry out treatment, payment, or health care operations https://www.gpo.gov/fdsys/pkg/CFR-2017-title45-vol1/pdf/CFR-2017-title45-vol1-sec164-506.pdf, which is considered the â€œnormâ€?, assign the HL7 Confidentiality code â€œNâ€? (normal).",
      "property" : [
        {
          "code" : "status",
          "valueCode" : "active"
        },
        {
          "code" : "internalId",
          "valueCode" : "24101"
        },
        {
          "code" : "subsumedBy",
          "valueCode" : "_ActUSPrivacyConsentDirective"
        }
      ]
    },
    {
      "code" : "HIPAAConsentCD",
      "display" : "HIPAA Consent Directive",
      "definition" : "A code representing U.S. Public Law 104-191 Health Insurance Portability and Accountability Act (HIPAA) Privacy Rule 45 CFR Section 164.522 Rights to request privacy protection for protected health information https://www.gpo.gov/fdsys/pkg/CFR-2017-title45-vol1/pdf/CFR-2017-title45-vol1-sec164-522.pdf, which stipulates the process by which a covered entity seeks agreement from an individual regarding how it will use and disclose the individual's protected health information for treatment, payment, and health care operations is termed a \"consent.\"\r\n\r\n*Usage Note:* Used to indicate the legal authority for assigning security labels to governed information. In this case, where collection, access, use, or disclosure of healthcare information is governed by an individualâ€&trade;s consent directive under 45 CFR Section 164.522 use â€œHIPAAConsentCDâ€? as the security label policy code.\r\n\r\nSince information governed by a 45 CFR Section 164.522 has a level of confidentiality protection that is more stringent than the normal level of protection under HIPAA 45 CFR Section 164.506 Uses and disclosures to carry out treatment, payment, or health care operations https://www.gpo.gov/fdsys/pkg/CFR-2017-title45-vol1/pdf/CFR-2017-title45-vol1-sec164-506.pdf, assign the HL7 Confidentiality code â€œRâ€? (restricted).",
      "property" : [
        {
          "code" : "status",
          "valueCode" : "active"
        },
        {
          "code" : "internalId",
          "valueCode" : "24102"
        },
        {
          "code" : "subsumedBy",
          "valueCode" : "_ActUSPrivacyConsentDirective"
        }
      ]
    },
    {
      "code" : "HIPAAResearchAuthCD",
      "display" : "HIPAA Authorization for Disclosure for Research Consent Directive",
      "definition" : "A code representing an individualâ€&trade;s consent directive that complies with HIPAA Privacy rule 45 CFR Section 164.508 Uses and disclosures for which an authorization is required https://www.gpo.gov/fdsys/pkg/CFR-2017-title45-vol1/pdf/CFR-2017-title45-vol1-sec164-508.pdf, which is a US Federal law stipulating the policy elements of a valid authorization under this Section specific to disclosures for purposes of research.\r\n\r\n*Usage Note:* Used to indicate the legal authority for assigning security labels to governed information. In this case, where collection, access, use, or disclosure of healthcare information is governed by an individualâ€&trade;s HIPAA Authorization for Disclosure for Research under 45 CFR Section 164.508 use â€œHIPAAResearchAuthCDâ€? as the security label policy code.\r\n\r\nInformation disclosed under an individualâ€&trade;s HIPAA Authorization for Disclosure for Research are not protected by the HIPAA Privacy Rule. If protected under other laws such as confidentiality provisions under the Common Rule, assign the HL7 Confidentiality code â€œMâ€? (moderate).\r\n\r\nSee ActCode.\\_ActPolicyType.\\_ActPrivacyPolicy.\\_ActPrivacyLaw.\\_ActUSPrivacyLaw.HIPAAAuth (HIPAA Authorization for Disclosure). See: HIPAAAuth and NIH Sample Authorization Language for Research Uses and Disclosures of Individually Identifiable Health Information by a Covered Health Care Provider https://privacyruleandresearch.nih.gov/authorization.asp",
      "property" : [
        {
          "code" : "status",
          "valueCode" : "active"
        },
        {
          "code" : "internalId",
          "valueCode" : "24104"
        },
        {
          "code" : "subsumedBy",
          "valueCode" : "_ActUSPrivacyConsentDirective"
        }
      ]
    },
    {
      "code" : "HIPAAROAD",
      "display" : "HIPAA Right of Access Directive",
      "definition" : "A code representing U.S. Public Law 104-191 Health Insurance Portability and Accountability Act (HIPAA) Privacy Rule 45 CFR Section 164.524 Access of individuals to protected health information https://www.gpo.gov/fdsys/pkg/CFR-2017-title45-vol1/pdf/CFR-2017-title45-vol1-sec164-524.pdf, stipulating the policy elements of an individualâ€&trade;s written and signed right of access directive requesting that a covered entity send the individualâ€&trade;s protected health information (PHI) to a third party.\r\n\r\nSee 45 CFR 164.524(c)(3)(ii) If an individual's request for access directs the covered entity to transmit the copy of protected health information directly to another person designated by the individual, the covered entity must provide the copy to the person designated by the individual. The individual's request must be in writing, signed by the individual, and clearly identify the designated person and where to send the copy of protected health information. https://www.gpo.gov/fdsys/pkg/CFR-2017-title45-vol1/pdf/CFR-2017-title45-vol1-sec164-524.pdf\r\n\r\nThis right applies to PHI in a designated record set, which is defined as â€œDesignated record set means: (1) A group of records maintained by or for a covered entity that is: (i) The medical records and billing records about individuals maintained by or for a covered health care provider; (ii) The enrollment, payment, claims adjudication, and case or medical management record systems maintained by or for a health plan; or (iii) Used, in whole or in part, by or for the covered entity to make decisions about individuals. \\[https://www.law.cornell.edu/cfr/text/45/164.501\\]. Also see HHS Individualsâ€&trade; Right under HIPAA to Access their Health Information 45 CFR Section 164.524 \\[https://www.hhs.gov/hipaa/for-professionals/privacy/guidance/access/index.html\\#maximumflatfee\\].\r\n\r\n*Usage Note:* Used to indicate the legal authority for assigning security labels to governed information. In this case, where collection, access, use, or disclosure of healthcare information is governed by an individualâ€&trade;s right of access directive under 45 CFR Section 164.524 use â€œHIPAAROADâ€? as the security label policy code.\r\n\r\nInformation disclosed under a HIPAA 42 CFR Section 164.524 no longer has the level of confidentiality protection afforded under the 45 CFR Section 164.506 - Uses and disclosures to carry out treatment, payment, or health care operations https://www.gpo.gov/fdsys/pkg/CFR-2017-title45-vol1/pdf/CFR-2017-title45-vol1-sec164-508.pdf, which is considered the â€œnormâ€?, assign the HL7 Confidentiality code â€œMâ€? (moderate), which may be protected under other laws such as the Federal Trade Commission privacy and security regulations.",
      "property" : [
        {
          "code" : "status",
          "valueCode" : "active"
        },
        {
          "code" : "internalId",
          "valueCode" : "24103"
        },
        {
          "code" : "subsumedBy",
          "valueCode" : "_ActUSPrivacyConsentDirective"
        }
      ]
    },
    {
      "code" : "MDHHS-5515",
      "display" : "Michigan Consent to Share Behavioral Health Information for Care Coordination Purposes",
      "definition" : "The State of Michigan standard privacy consent form for sharing of health information specific to behavioral health and substance use treatment in accordance with Public Act 129 of 2014. In Michigan, while providers are not required to use this new standard form (MDHHS-5515), they are required to accept it.\r\n\r\n*Usage Note:* For legislative background, current MDHHS-5515 consent directive form, and provider and patient FAQs see http://www.michigan.gov/mdhhs/0,5885,7-339-71550\\_2941\\_58005-343686--,00.html",
      "property" : [
        {
          "code" : "status",
          "valueCode" : "active"
        },
        {
          "code" : "internalId",
          "valueCode" : "24106"
        },
        {
          "code" : "subsumedBy",
          "valueCode" : "_ActUSPrivacyConsentDirective"
        }
      ]
    },
    {
      "code" : "42CFRPart2",
      "display" : "42 CFR Part2",
      "definition" : "A code representing 42 CFR Part 2 Confidentiality of Substance Use Disorder Patient Records. 42 CFR Part 2 stipulates the privacy rights of an individual who has applied for or been given diagnosis or treatment for alcohol or drug abuse at a federally assisted program, which includes non-disclosure of health information relating to health care paid for by a federally assisted substance use disorder program without patient consent. https://www.gpo.gov/fdsys/pkg/CFR-2010-title42-vol1/pdf/CFR-2010-title42-vol1-part2.pdf\r\n\r\n*Usage Note:* Used to indicate the legal authority for assigning security labels to governed information. In this case, the collection, access, use, and disclosure of healthcare information is governed by 42 CFR Part 2 Confidentiality of Substance Use Disorder Patient Records https://www.gpo.gov/fdsys/pkg/CFR-2010-title42-vol1/pdf/CFR-2010-title42-vol1-part2.pdf use â€œ42CFRPart2â€? as the security label policy code.\r\n\r\nSince information governed by a 42 CFR Part 2 has a level of confidentiality protection that is more stringent than the normal level of protection under HIPAA 45 CFR Section 164.506 Uses and disclosures to carry out treatment, payment, or health care operations https://www.gpo.gov/fdsys/pkg/CFR-2017-title45-vol1/pdf/CFR-2017-title45-vol1-sec164-506.pdf assign the HL7 Confidentiality code â€œRâ€? (restricted).",
      "property" : [
        {
          "code" : "status",
          "valueCode" : "active"
        },
        {
          "code" : "internalId",
          "valueCode" : "23761"
        },
        {
          "code" : "subsumedBy",
          "valueCode" : "_ActUSPrivacyLaw"
        }
      ]
    },
    {
      "code" : "CommonRule",
      "display" : "Common Rule",
      "definition" : "A code representing U.S. Federal laws governing research-related privacy policies known as the â€œCommon Ruleâ€?. The Common Rule is the U.S. Federal regulations governing the protection of human subjects in research (codified at Subpart A of 45 CFR part 46), which has been adopted by 15 U.S. Federal departments and agencies in an effort to promote uniformity, understanding, and compliance with human subject protections. Existing regulations governing the protection of human subjects in Food and Drug Administration (FDA)-regulated research (21 CFR parts 50, 56, 312, and 812) are separate from the Common Rule but include similar requirements.\r\n\r\n*Usage Note:* Used to indicate the legal authority for assigning security labels to governed information. In this case, where collection, access, use, or disclosure of healthcare information or biospecimen is governed by the Common Rule use â€œCOMMONRULEâ€? as the security label policy code. Information or biospecimen disclosed under the Common Rule are not protected by the HIPAA Privacy Rule. If protected under other laws such as confidentiality provisions under the Common Rule, assign the HL7 Confidentiality code â€œMâ€? (moderate).",
      "property" : [
        {
          "code" : "status",
          "valueCode" : "active"
        },
        {
          "code" : "internalId",
          "valueCode" : "23762"
        },
        {
          "code" : "subsumedBy",
          "valueCode" : "_ActUSPrivacyLaw"
        }
      ]
    },
    {
      "code" : "HIPAAAuth",
      "display" : "HIPAA Authorization for Disclosure",
      "definition" : "A code representing U.S. Public Law 104-191 Health Insurance Portability and Accountability Act (HIPAA) Privacy Rule (45 CFR Section 164.508) Uses and disclosures for which an authorization is required https://www.gpo.gov/fdsys/pkg/CFR-2017-title45-vol1/pdf/CFR-2017-title45-vol1-sec164-508.pdf, which stipulates the process by which a covered entity seeks agreement from an individual to use or disclose protected health information for other purposes, or to authorize another covered entity to disclose protected health information to the requesting covered entity, are termed \"authorizations\".\r\n\r\nAn â€œauthorizationâ€? is required by the Privacy Rule for uses and disclosures of protected health information not otherwise allowed by the Rule. Where the Privacy Rule requires patient authorization, voluntary consent is not sufficient to permit a use or disclosure of protected health information unless it also satisfies the requirements of a valid authorization. An authorization is a detailed document that gives covered entities permission to use protected health information for specified purposes, which are generally other than treatment, payment, or health care operations, or to disclose protected health information to a third party specified by the individual.\r\n\r\nAn authorization must specify a number of elements, including a description of the protected health information to be used and disclosed, the person authorized to make the use or disclosure, the person to whom the covered entity may make the disclosure, an expiration date, and, in some cases, the purpose for which the information may be used or disclosed. With limited exceptions, covered entities may not condition treatment or coverage on the individual providing an authorization. https://www.hhs.gov/hipaa/for-professionals/faq/264/what-is-the-difference-between-consent-and-authorization/index.html\r\n\r\n*Usage Note:* Used to indicate the legal authority for assigning security labels to HIPAA governed information. In this case, where use or disclosure of healthcare information is governed by a covered entityâ€&trade;s HIPAA Authorization for Disclosure, use â€œHIPAAAuthâ€? as the security label policy code.\r\n\r\nInformation disclosed under a HIPAA Authorization for Disclosure no longer has the level of confidentiality protection afforded under the 45 CFR Section 164.506 - Uses and disclosures to carry out treatment, payment, or health care operations https://www.gpo.gov/fdsys/pkg/CFR-2017-title45-vol1/pdf/CFR-2017-title45-vol1-sec164-508.pdf, which is considered the â€œnormâ€?, assign the HL7 Confidentiality code â€œMâ€? (moderate), which may be protected under other laws such as the Federal Trade Commission privacy and security regulations.",
      "property" : [
        {
          "code" : "status",
          "valueCode" : "active"
        },
        {
          "code" : "internalId",
          "valueCode" : "24118"
        },
        {
          "code" : "subsumedBy",
          "valueCode" : "_ActUSPrivacyLaw"
        }
      ]
    },
    {
      "code" : "HIPAAConsent",
      "display" : "HIPAA Consent",
      "definition" : "A code representing U.S. Public Law 104-191 Health Insurance Portability and Accountability Act (HIPAA) Privacy Rule (45 CFR Section 164.522), which stipulates the process by which a covered entity seeks agreement from an individual regarding how it will use and disclose the individual's protected health information for treatment, payment, and health care operations is termed a \"consent\".\r\n\r\nThe Privacy Rule permits, but does not require, a covered entity to voluntarily obtain patient consent for uses and disclosures of protected health information for treatment, payment, and health care operations. Covered entities that do so have complete discretion to design a process that best suits their needs. From https://www.hhs.gov/hipaa/for-professionals/faq/264/what-is-the-difference-between-consent-and-authorization/index.html. The provisions relating to consent are largely contained in Section 164.522 Rights to request privacy protection for protected health information https://www.gpo.gov/fdsys/pkg/CFR-2017-title45-vol1/pdf/CFR-2017-title45-vol1-sec164-522.pdf.\r\n\r\n*Usage Note:* Used to indicate the legal authority for assigning security labels to governed information. In this case, where collection, access, use, or disclosure of healthcare information is governed by 45 CFR Section 164.522 use 'HIPAAConsent' as the security label policy code.\r\n\r\nSince information governed by a 45 CFR Section 164.522 has a level of confidentiality protection that is more stringent than the normal level of protection under HIPAA 45 CFR Section 164.506 Uses and disclosures to carry out treatment, payment, or health care operations https://www.gpo.gov/fdsys/pkg/CFR-2017-title45-vol1/pdf/CFR-2017-title45-vol1-sec164-506.pdf, assign the HL7 Confidentiality code 'R' (restricted).",
      "property" : [
        {
          "code" : "status",
          "valueCode" : "active"
        },
        {
          "code" : "internalId",
          "valueCode" : "24135"
        },
        {
          "code" : "subsumedBy",
          "valueCode" : "_ActUSPrivacyLaw"
        }
      ]
    },
    {
      "code" : "HIPAANOPP",
      "display" : "HIPAA notice of privacy practices",
      "definition" : "A code representing U.S. Public Law 104-191 Health Insurance Portability and Accountability Act (HIPAA) Privacy Rule (45 CFR Section 164.520), which stipulates an individualâ€&trade;s right to adequate notice of the uses and disclosures of protected health information that may be made by the covered entity, and of the individual's rights and the covered entity's legal duties with respect to protected health information. Relevant HIPAA Privacy Rule provisions are at Section 164.520 (a) Standard: Notice of privacy practices. https://www.gpo.gov/fdsys/pkg/CFR-2017-title45-vol1/pdf/CFR-2017-title45-vol1-sec164-520.pdf\r\n\r\n*Usage Note:* Used to indicate the legal authority for assigning security labels to HIPAA governed information. In this case, if collection, access, use, or disclosure of healthcare information is governed by a covered entityâ€&trade;s HIPAA Notice of Privacy Practices, use â€œHIPAANOPPâ€? as the security label policy code.\r\n\r\nInformation governed under a HIPAA Notice of Privacy Practices has the level of confidentiality protection afforded under the 45 CFR Section 164.506 - Uses and disclosures to carry out treatment, payment, or health care operations https://www.gpo.gov/fdsys/pkg/CFR-2017-title45-vol1/pdf/CFR-2017-title45-vol1-sec164-506.pdf , which is considered the â€œnormâ€?, assign the HL7 Confidentiality code â€œNâ€? (normal).",
      "property" : [
        {
          "code" : "status",
          "valueCode" : "active"
        },
        {
          "code" : "internalId",
          "valueCode" : "23763"
        },
        {
          "code" : "subsumedBy",
          "valueCode" : "_ActUSPrivacyLaw"
        }
      ]
    },
    {
      "code" : "HIPAAPsyNotes",
      "display" : "HIPAA psychotherapy notes",
      "definition" : "A code representing U.S. Public Law 104-191 Health Insurance Portability and Accountability Act (HIPAA) Privacy Rule (45 CFR Section 164.508), which stipulates the privacy rights of an individual who is the subject of psychotherapy notes, and requires authorization for certain uses and disclosure of that information.\r\n\r\nDefinition of Psychotherapy notes 45 CFR Section 164.501 https://www.gpo.gov/fdsys/pkg/CFR-2017-title45-vol1/pdf/CFR-2017-title45-vol1-sec164-501.pdf: Psychotherapy notes means notes recorded (in any medium) by a health care provider who is a mental health professional documenting or analyzing the contents of conversation during a private counseling session or a group, joint, or family counseling session and that are separated from the rest of the individual's medical record. Psychotherapy notes excludes medication prescription and monitoring, counseling session start and stop times, the modalities and frequencies of treatment furnished, results of clinical tests, and any summary of the following items: Diagnosis, functional status, the treatment plan, symptoms, prognosis, and progress to date.\r\n\r\nSee Section 164.508 Uses and disclosures for which an authorization is required. (2)Authorization required: Psychotherapy notes https://www.gpo.gov/fdsys/pkg/CFR-2017-title45-vol1/pdf/CFR-2017-title45-vol1-sec164-508.pdf: Notwithstanding any provision of this subpart, other than the transition provisions in Section 164.532, a covered entity must obtain an authorization for any use or disclosure of psychotherapy notes, except: (i) To carry out the following treatment, payment, or health care operations: (A) Use by the originator of the psychotherapy notes for treatment; (B) Use or disclosure by the covered entity for its own training programs in which students, trainees, or practitioners in mental health learn under supervision to practice or improve their skills in group, joint, family, or individual counseling; or (C) Use or disclosure by the covered entity to defend itself in a legal action or other proceeding brought by the individual; and (ii) A use or disclosure that is required by Section 164.502(a)(2)(ii) or permitted by Section 164.512(a); Section 164.512(d) with respect to the oversight of the originator of the psychotherapy notes; Section 164.512(g)(1); Section 164.512(j)(1)(i).\r\n\r\n*Usage Note:* Used to indicate the legal authority for assigning security labels to HIPAA governed information. In this case, the collection, access, use, or disclosure of healthcare information is governed by HIPAA 45 CFR 164.508 (2) Authorization required: Psychotherapy notes https://www.gpo.gov/fdsys/pkg/CFR-2017-title45-vol1/pdf/CFR-2017-title45-vol1-sec164-506.pdf , use â€œHIPAAPsyNotesâ€? as the security label policy code.\r\n\r\nSince information governed by a HIPAA 45 CFR 164.508 (2) has a level of confidentiality protection that is more stringent than the normal level of protection under 45 CFR Section 164.506 Uses and disclosures to carry out treatment, payment, or health care operations https://www.gpo.gov/fdsys/pkg/CFR-2017-title45-vol1/pdf/CFR-2017-title45-vol1-sec164-506.pdf, assign the HL7 Confidentiality code â€œRâ€? (restricted).",
      "property" : [
        {
          "code" : "status",
          "valueCode" : "active"
        },
        {
          "code" : "internalId",
          "valueCode" : "23764"
        },
        {
          "code" : "subsumedBy",
          "valueCode" : "_ActUSPrivacyLaw"
        }
      ]
    },
    {
      "code" : "HIPAAROA",
      "display" : "HIPAA Right of Access",
      "definition" : "A code representing U.S. Public Law 104-191 Health Insurance Portability and Accountability Act (HIPAA) Privacy Rule 45 CFR Section 164.524 Access of individuals to protected health information https://www.govinfo.gov/app/details/CFR-2017-title45-vol1/CFR-2017-title45-vol1-sec164-524, which stipulates that an individual has a right of access to inspect and obtain a copy of protected health information about the individual in a designated record set, for as long as the protected health information is maintained in the designated record set with exceptions stipulated in HIPAA Privacy Rule Section 164.524. Exceptions include psychotherapy notes and information compiled in reasonable anticipation of, or for use in, a civil, criminal, or administrative action or proceeding.\r\n\r\nIf an individual's request for access directs the covered entity to transmit the copy of protected health information directly to another person designated by the individual, the covered entity must provide the copy to the person designated by the individual. The individual's request must be in writing, signed by the individual, and clearly identify the designated person and where to send the copy of protected health information.\r\n\r\nFor discussion on extent of right, grounds for denial, and documentation requirements see: HHS Individualsâ€&trade; Right under HIPAA to Access their Health Information 45 CFR Section 164.524 https://www.hhs.gov/hipaa/for-professionals/privacy/guidance/access/index.html and HHS FAQ on Right of Access vs. HIPAA Authorization https://www.hhs.gov/hipaa/for-professionals/faq/2041/why-depend-on-the-individuals-right/index.html\r\n\r\n*Usage Note:* Used to indicate the legal authority for assigning security labels to governed information. In this case, where collection, access, use, or disclosure of healthcare information is governed under 45 CFR Section 164.5224 use â€œHIPAAROAâ€? as the security label policy code.\r\n\r\nInformation disclosed under a HIPAA 42 CFR Section 164.524 no longer has the level of confidentiality protection afforded under the 45 CFR Section 164.506 - Uses and disclosures to carry out treatment, payment, or health care operations https://www.gpo.gov/fdsys/pkg/CFR-2017-title45-vol1/pdf/CFR-2017-title45-vol1-sec164-508.pdf, which is considered the â€œnormâ€?, assign the HL7 Confidentiality code â€œMâ€? (moderate), which may be protected under other laws such as the Federal Trade Commission privacy and security regulations.",
      "property" : [
        {
          "code" : "status",
          "valueCode" : "active"
        },
        {
          "code" : "internalId",
          "valueCode" : "24119"
        },
        {
          "code" : "subsumedBy",
          "valueCode" : "_ActUSPrivacyLaw"
        }
      ]
    },
    {
      "code" : "HIPAASelfPay",
      "display" : "HIPAA self-pay",
      "definition" : "A code representing 45 CFR 164.522 Rights to request privacy protection for protected health information, which is a US Federal law stipulating the privacy rights of an individual to restrict disclosure of information related to health care items or services for which the individual pays out of pocket in full to a health plan or payer.\r\n\r\nSee 45 CFR 164.522 https://www.gpo.gov/fdsys/pkg/CFR-2017-title45-vol1/pdf/CFR-2017-title45-vol1-sec164-522.pdf. (vi) A covered entity must agree to the request of an individual to restrict disclosure of protected health information about the individual to a health plan if: (A) The disclosure is for the purpose of carrying out payment or health care operations and is not otherwise required by law; and (B) The protected health information pertains solely to a health care item or service for which the individual, or person other than the health plan on behalf of the individual, has paid the covered entity in full.\r\n\r\n*Usage Note:* Used to indicate the legal authority for assigning security labels to HIPAA governed information. In this case, the collection, access, use, or disclosure of healthcare information is governed by HIPAA 45 CFR 164.522 https://www.gpo.gov/fdsys/pkg/CFR-2017-title45-vol1/pdf/CFR-2017-title45-vol1-sec164-522.pdf use â€œHIPAASelfPayâ€? as the security label policy code.\r\n\r\nSince information governed by a HIPAA 45 CFR 164.522 has a level of confidentiality protection that is more stringent than the normal level of protection under 45 CFR Section 164.506 Uses and disclosures to carry out treatment, payment, or health care operations https://www.gpo.gov/fdsys/pkg/CFR-2017-title45-vol1/pdf/CFR-2017-title45-vol1-sec164-506.pdf, assign the HL7 Confidentiality code â€œRâ€? (restricted).",
      "property" : [
        {
          "code" : "status",
          "valueCode" : "active"
        },
        {
          "code" : "internalId",
          "valueCode" : "23765"
        },
        {
          "code" : "subsumedBy",
          "valueCode" : "_ActUSPrivacyLaw"
        }
      ]
    },
    {
      "code" : "Title38Section7332",
      "display" : "Title 38 Section 7332",
      "definition" : "A code representing Title 38 Section 7332, which is a US Federal law stipulating the privacy rights of veterans diagnosed and treated for substance use disorders, infection with the human immunodeficiency virus, or sickle cell anemia.\r\n\r\nhttps://www.gpo.gov/fdsys/granule/USCODE-2011-title38/USCODE-2011-title38-partV-chap73-subchapIII-sec7332/content-detail.html . (1) Records of the identity, diagnosis, prognosis, or treatment of any patient or subject which are maintained in connection with the performance of any program or activity (including education, training, treatment, rehabilitation, or research) relating to drug abuse, alcoholism or alcohol abuse, infection with the human immunodeficiency virus, or sickle cell anemia which is carried out by or for the Department under this title shall, except as provided in subsections (e) and (f), be confidential, and (section 5701 of this title to the contrary notwithstanding) such records may be disclosed only for the purposes and under the circumstances expressly authorized under subsection (b). (2) Paragraph (1) prohibits the disclosure to any person or entity other than the patient or subject concerned of the fact that a special written consent is required in order for such records to be disclosed. (b) (1) The content of any record referred to in subsection (a) may be disclosed by the Secretary in accordance with the prior written consent of the patient or subject with respect to whom such record is maintained, but only to such extent, under such circumstances, and for such purposes as may be allowed in regulations prescribed by the Secretary. (2) Whether or not any patient or subject, with respect to whom any given record referred to in subsection (a) is maintained, gives written consent, the content of such record may be disclosed by the Secretary as follows: (A) To medical personnel to the extent necessary to meet a bona fide medical emergency. (B) To qualified personnel for the purpose of conducting scientific research, management audits, financial audits, or program evaluation, but such personnel may not identify, directly or indirectly, any individual patient or subject in any report of such research, audit, or evaluation, or otherwise disclose patient or subject identities in any manner. (C) (i) In the case of any record which is maintained in connection with the performance of any program or activity relating to infection with the human immunodeficiency virus, to a Federal, State, or local public-health authority charged under Federal or State law with the protection of the public health, and to which Federal or State law requires disclosure of such record, if a qualified representative of such authority has made a written request that such record be provided as required pursuant to such law for a purpose authorized by such law. (ii) A person to whom a record is disclosed under this paragraph may not redisclose or use such record for a purpose other than that for which the disclosure was made. (D) If authorized by an appropriate order of a court of competent jurisdiction granted after application showing good cause therefor. In assessing good cause the court shall weigh the public interest and the need for disclosure against the injury to the patient or subject, to the physician-patient relationship, and to the treatment services. Upon the granting of such order, the court, in determining the extent to which any disclosure of all or any part of any record is necessary, shall impose appropriate safeguards against unauthorized disclosure. (E) To an entity described in paragraph (1)(B) of section 5701(k) of this title, but only to the extent authorized by such section. (F) (i) To a representative of a patient who lacks decision-making capacity, when a practitioner deems the content of the given record necessary for that representative to make an informed decision regarding the patient's treatment. (ii) In this subparagraph, the term Ã¢â‚¬Å“representativeÃ¢â‚¬? means an individual, organization, or other body authorized under section 7331 of this title and its implementing regulations to give informed consent on behalf of a patient who lacks decision-making capacity. (G) To a State controlled substance monitoring program, including a program approved by the Secretary of Health and Human Services under section 399O of the Public Health Service Act (42 U.S.C. 280g-3), to the extent necessary to prevent misuse and diversion of prescription medicines. (H) (i) To a non-Department entity (including private entities and other Federal agencies) for purposes of providing health care, including hospital care, medical services, and extended care services, to Veterans or performing other health care-related activities or functions. (ii) An entity to which a record is disclosed under this subparagraph may not disclose or use such record for a purpose other than that for which the disclosure was made or as permitted by law. (I) To a third party in order to recover or collect reasonable charges for care furnished to, or paid on behalf of, a Veteran in connection with a non-service connected disability as permitted by section 1729 of this title or for a condition for which recovery is authorized or with respect to which the United States is deemed to be a third party beneficiary under the Act entitled 'An Act to provide for the recovery from tortiously liable third persons of the cost of hospital and medical care and treatment furnished by the United States' (Public Law 87-693; 42 U.S.C. 2651 et seq.; commonly known as the 'Federal Medical Care Recovery Act').\r\n\r\n*Usage Note:* Used to indicate the legal authority for assigning security labels to governed information. In this case, where collection, access, use, or disclosure of healthcare information is governed by 38 U.S. Code Section 7332 - Confidentiality of certain medical records https://www.gpo.gov/fdsys/granule/USCODE-2011-title38/USCODE-2011-title38-partV-chap73-subchapIII-sec7332/content-detail.html use \"Title38Section7332\" as the security label policy code.\r\n\r\nSince information governed by a Title 38 Section 7332 has a level of confidentiality protection that is more stringent than the normal level of protection under HIPAA 45 CFR Section 164.506 Uses and disclosures to carry out treatment, payment, or health care operations https://www.gpo.gov/fdsys/pkg/CFR-2017-title45-vol1/pdf/CFR-2017-title45-vol1-sec164-506.pdf, assign the HL7 Confidentiality code \"R\" (restricted).",
      "property" : [
        {
          "code" : "status",
          "valueCode" : "active"
        },
        {
          "code" : "internalId",
          "valueCode" : "23766"
        },
        {
          "code" : "subsumedBy",
          "valueCode" : "_ActUSPrivacyLaw"
        }
      ]
    },
    {
      "code" : "a) HIPAAConsent",
      "display" : "HIPAA Consent",
      "definition" : "Code retired in December 2019 and replaced by code HIPAAConsent. Originally entered with copy/paste error in code value.\r\n\r\nA code representing U.S. Public Law 104-191 Health Insurance Portability and Accountability Act (HIPAA) Privacy Rule (45 CFR Section 164.522), which stipulates the process by which a covered entity seeks agreement from an individual regarding how it will use and disclose the individual's protected health information for treatment, payment, and health care operations is termed a \"consent.\" The Privacy Rule permits, but does not require, a covered entity to voluntarily obtain patient consent for uses and disclosures of protected health information for treatment, payment, and health care operations. Covered entities that do so have complete discretion to design a process that best suits their needs. From https://www.hhs.gov/hipaa/for-professionals/faq/264/what-is-the-difference-between-consent-and-authorization/index.html. The provisions relating to consent are largely contained in Section 164.522 Rights to request privacy protection for protected health information https://www.gpo.gov/fdsys/pkg/CFR-2017-title45-vol1/pdf/CFR-2017-title45-vol1-sec164-522.pdf.\r\n\r\n*Usage Note:* Used to indicate the legal authority for assigning security labels to governed information. In this case, where collection, access, use, or disclosure of healthcare information is governed by 45 CFR Section 164.522 use Ã¢â‚¬Å“HIPAAConsentÃ¢â‚¬? as the security label policy code.\r\n\r\nSince information governed by a 45 CFR Section 164.522 has a level of confidentiality protection that is more stringent than the normal level of protection under HIPAA 45 CFR Section 164.506 Uses and disclosures to carry out treatment, payment, or health care operations https://www.gpo.gov/fdsys/pkg/CFR-2017-title45-vol1/pdf/CFR-2017-title45-vol1-sec164-506.pdf, assign the HL7 Confidentiality code Ã¢â‚¬Å“RÃ¢â‚¬? (restricted).",
      "property" : [
        {
          "code" : "status",
          "valueCode" : "retired"
        },
        {
          "code" : "internalId",
          "valueCode" : "24117"
        },
        {
          "code" : "subsumedBy",
          "valueCode" : "_ActUSPrivacyLaw"
        }
      ]
    },
    {
      "code" : "USResearchInformedAssent",
      "display" : "Informed Assent for Research",
      "definition" : "An informed assertion by a minor who is a candidate research subject, of the individual's willingness to participate in research. Assent means a child's affirmative agreement to participate in a clinical investigation. Mere failure to object should not, absent affirmative agreement, be construed as assent. The minor's assent must be accompanied by parental or guardian consent that the minor participate in a specified research. The assent is not legally binding, however, the accompanying consent is legally binding. Background: In the US, informed assent is governed under 21 CFR Part 50, Subpart D - Additional Safeguards for Children in Clinical Investigations. Available at https://www.law.cornell.edu/cfr/text/21/part-50/subpart-D",
      "property" : [
        {
          "code" : "status",
          "valueCode" : "active"
        },
        {
          "code" : "internalId",
          "valueCode" : "25100"
        },
        {
          "code" : "subsumedBy",
          "valueCode" : "_ActUSPrivacyConsentDirective"
        }
      ]
    },
    {
      "code" : "USResearchInformedConsent",
      "display" : "Informed Consent for Research",
      "definition" : "An informed assertion by an adult, or the parent/guardian of a minor who is a candidate research subject, of the individual's willingness to participate in a specified research study. The consent is legally binding. Background: In the US, informed assent is governed under 49 CFR  (        <a href="en\CodeSystem-v3-ActCode.json.html">src</a>
)
      </li>
      <li>
 164.506 Uses and disclosures to carry out treatment, payment, or health care operations https://www.gpo.gov/fdsys/pkg/CFR-2017-title45-vol1/pdf/CFR-2017-title45-vol1-sec164-506.pdf, assign the HL7 Confidentiality code â€œRâ€? (restricted)."/&gt;
    &lt;property&gt;
      &lt;code value="status"/&gt;
      &lt;valueCode value="active"/&gt;
    &lt;/property&gt;
    &lt;property&gt;
      &lt;code value="internalId"/&gt;
      &lt;valueCode value="24100"/&gt;
    &lt;/property&gt;
    &lt;property&gt;
      &lt;code value="subsumedBy"/&gt;
      &lt;valueCode value="_ActUSPrivacyConsentDirective"/&gt;
    &lt;/property&gt;
  &lt;/concept&gt;
  &lt;concept&gt;
    &lt;code value="CompoundResearchCD"/&gt;
    &lt;display
             value="Compound HIPAA Research Authorization and Informed Consent for Research"/&gt;
    &lt;definition
                value="A code representing an individualâ€&trade;s consent directive that complies with HIPAA Privacy rule 45 CFR Section 164.508 Uses and disclosures for which an authorization is required https://www.gpo.gov/fdsys/pkg/CFR-2017-title45-vol1/pdf/CFR-2017-title45-vol1-sec164-508.pdf, which is a US Federal law stipulating the policy elements of a valid authorization under this Section specific to disclosures for purposes of research when combined with a Common Rule or Federal Drug Administration consent to participate in research also known as a compound authorization.

*Usage Note:* The Agency for Healthcare Research and Quality (AHRQ) has developed the Informed Consent and Authorization Toolkit for Minimal Risk Research to facilitate the process of obtaining informed consent and Health Insurance Portability and Accountability Act (HIPAA) authorization from potential research subjects. This toolkit contains information for people responsible for ensuring that potential research subjects are informed in a manner that is consistent with medical ethics and regulatory guidelines. From https://www.ahrq.gov/sites/default/files/publications/files/ictoolkit.pdf.

Used to indicate the legal authority for assigning security labels to governed information. In this case, where collection, access, use, or disclosure of healthcare information is governed by an individualâ€&trade;s right of access directive under 45 CFR Section 164.508 use â€œCompoundResearchCDâ€? as the security label policy code.

Information or biospecimen disclosed under the Common Rule are not protected by the HIPAA Privacy Rule. If protected under other laws such as confidentiality provisions under the Common Rule, assign the HL7 Confidentiality code â€œMâ€? (moderate).

See ActCode.\_ActPolicyType.\_ActPrivacyPolicy.\_ActPrivacyLaw.\_ActUSPrivacyLaw.HIPAAAuth (HIPAA Authorization for Disclosure). See: HIPAAAuth and NIH Sample Authorization Language for Research Uses and Disclosures of Individually Identifiable Health Information by a Covered Health Care Provider https://privacyruleandresearch.nih.gov/authorization.asp"/&gt;
    &lt;property&gt;
      &lt;code value="status"/&gt;
      &lt;valueCode value="active"/&gt;
    &lt;/property&gt;
    &lt;property&gt;
      &lt;code value="internalId"/&gt;
      &lt;valueCode value="24105"/&gt;
    &lt;/property&gt;
    &lt;property&gt;
      &lt;code value="subsumedBy"/&gt;
      &lt;valueCode value="_ActUSPrivacyConsentDirective"/&gt;
    &lt;/property&gt;
  &lt;/concept&gt;
  &lt;concept&gt;
    &lt;code value="HIPAAAuthCD"/&gt;
    &lt;display value="HIPAA Authorization Consent Directive"/&gt;
    &lt;definition
                value="A code representing an individualâ€&trade;s consent directive that complies with HIPAA Privacy rule 45 CFR Section 164.508 Uses and disclosures for which an authorization is required https://www.gpo.gov/fdsys/pkg/CFR-2017-title45-vol1/pdf/CFR-2017-title45-vol1-sec164-508.pdf, which is a US Federal law stipulating the policy elements of a valid authorization under this Section.

An â€œauthorizationâ€? is required by the Privacy Rule for uses and disclosures of protected health information not otherwise allowed by the Rule. Where the Privacy Rule requires patient authorization, voluntary consent is not sufficient to permit a use or disclosure of protected health information unless it also satisfies the requirements of a valid authorization. An authorization is a detailed document that gives covered entities permission to use protected health information for specified purposes, which are generally other than treatment, payment, or health care operations, or to disclose protected health information to a third party specified by the individual.

An authorization must specify a number of elements, including a description of the protected health information to be used and disclosed, the person authorized to make the use or disclosure, the person to whom the covered entity may make the disclosure, an expiration date, and, in some cases, the purpose for which the information may be used or disclosed. With limited exceptions, covered entities may not condition treatment or coverage on the individual providing an authorization. https://www.hhs.gov/hipaa/for-professionals/faq/264/what-is-the-difference-between-consent-and-authorization/index.html

A HIPAA Authorization must comply with 45 CFR Section164.508(c) Implementation specifications: Core elements and requirements â€“ (1) Core elements. A valid authorization under this Section must contain at least the following elements: (i) A description of the information to be used or disclosed that identifies the information in a specific and meaningful fashion. (ii) The name or other specific identification of the person(s), or class of persons, authorized to make the requested use or disclosure. (iii) The name or other specific identification of the person(s), or class of persons, to whom the covered entity may make the requested use or disclosure. (iv) A description of each purpose of the requested use or disclosure. The statement â€œat the request of the individualâ€? is a sufficient description of the purpose when an individual initiates the authorization and does not, or elects not to, provide a statement of the purpose. (v) An expiration date or an expiration event that relates to the individual or the purpose of the use or disclosure. The statement â€œend of the research study,â€? â€œnone,â€? or similar language is sufficient if the authorization is for a use or disclosure of protected health information for research, including for the creation and maintenance of a research database or research repository. (vi) Signature of the individual and date. If the authorization is signed by a personal representative of the individual, a description of such representative's authority to act for the individual must also be provided. (2)Required statements. In addition to the core elements, the authorization must contain statements adequate to place the individual on notice of all of the following: (i) The individual's right to revoke the authorization in writing, and either: (A) The exceptions to the right to revoke and a description of how the individual may revoke the authorization; or (B) To the extent that the information in paragraph (c)(2)(i)(A) of this section is included in the notice required by Section 164.520, a reference to the covered entity's notice. https://www.gpo.gov/fdsys/pkg/CFR-2017-title45-vol1/pdf/CFR-2017-title45-vol1-sec164-508.pdf

*Usage Note:* Used to indicate the legal authority for assigning security labels to HIPAA governed information. In this case, where collection, access, use, or disclosure of healthcare information is governed by a an individualâ€&trade;s HIPAA Authorization for Disclosure, use â€œHIPAAAuthCDâ€? as the security label policy code.

Information governed under a HIPAA Authorization for Disclosure has the level of confidentiality protection afforded under the 45 CFR Section 164.506 - Uses and disclosures to carry out treatment, payment, or health care operations https://www.gpo.gov/fdsys/pkg/CFR-2017-title45-vol1/pdf/CFR-2017-title45-vol1-sec164-506.pdf, which is considered the â€œnormâ€?, assign the HL7 Confidentiality code â€œNâ€? (normal)."/&gt;
    &lt;property&gt;
      &lt;code value="status"/&gt;
      &lt;valueCode value="active"/&gt;
    &lt;/property&gt;
    &lt;property&gt;
      &lt;code value="internalId"/&gt;
      &lt;valueCode value="24101"/&gt;
    &lt;/property&gt;
    &lt;property&gt;
      &lt;code value="subsumedBy"/&gt;
      &lt;valueCode value="_ActUSPrivacyConsentDirective"/&gt;
    &lt;/property&gt;
  &lt;/concept&gt;
  &lt;concept&gt;
    &lt;code value="HIPAAConsentCD"/&gt;
    &lt;display value="HIPAA Consent Directive"/&gt;
    &lt;definition
                value="A code representing U.S. Public Law 104-191 Health Insurance Portability and Accountability Act (HIPAA) Privacy Rule 45 CFR Section 164.522 Rights to request privacy protection for protected health information https://www.gpo.gov/fdsys/pkg/CFR-2017-title45-vol1/pdf/CFR-2017-title45-vol1-sec164-522.pdf, which stipulates the process by which a covered entity seeks agreement from an individual regarding how it will use and disclose the individual's protected health information for treatment, payment, and health care operations is termed a &amp;quot;consent.&amp;quot;

*Usage Note:* Used to indicate the legal authority for assigning security labels to governed information. In this case, where collection, access, use, or disclosure of healthcare information is governed by an individualâ€&trade;s consent directive under 45 CFR Section 164.522 use â€œHIPAAConsentCDâ€? as the security label policy code.

Since information governed by a 45 CFR Section 164.522 has a level of confidentiality protection that is more stringent than the normal level of protection under HIPAA 45 CFR Section 164.506 Uses and disclosures to carry out treatment, payment, or health care operations https://www.gpo.gov/fdsys/pkg/CFR-2017-title45-vol1/pdf/CFR-2017-title45-vol1-sec164-506.pdf, assign the HL7 Confidentiality code â€œRâ€? (restricted)."/&gt;
    &lt;property&gt;
      &lt;code value="status"/&gt;
      &lt;valueCode value="active"/&gt;
    &lt;/property&gt;
    &lt;property&gt;
      &lt;code value="internalId"/&gt;
      &lt;valueCode value="24102"/&gt;
    &lt;/property&gt;
    &lt;property&gt;
      &lt;code value="subsumedBy"/&gt;
      &lt;valueCode value="_ActUSPrivacyConsentDirective"/&gt;
    &lt;/property&gt;
  &lt;/concept&gt;
  &lt;concept&gt;
    &lt;code value="HIPAAResearchAuthCD"/&gt;
    &lt;display
             value="HIPAA Authorization for Disclosure for Research Consent Directive"/&gt;
    &lt;definition
                value="A code representing an individualâ€&trade;s consent directive that complies with HIPAA Privacy rule 45 CFR Section 164.508 Uses and disclosures for which an authorization is required https://www.gpo.gov/fdsys/pkg/CFR-2017-title45-vol1/pdf/CFR-2017-title45-vol1-sec164-508.pdf, which is a US Federal law stipulating the policy elements of a valid authorization under this Section specific to disclosures for purposes of research.

*Usage Note:* Used to indicate the legal authority for assigning security labels to governed information. In this case, where collection, access, use, or disclosure of healthcare information is governed by an individualâ€&trade;s HIPAA Authorization for Disclosure for Research under 45 CFR Section 164.508 use â€œHIPAAResearchAuthCDâ€? as the security label policy code.

Information disclosed under an individualâ€&trade;s HIPAA Authorization for Disclosure for Research are not protected by the HIPAA Privacy Rule. If protected under other laws such as confidentiality provisions under the Common Rule, assign the HL7 Confidentiality code â€œMâ€? (moderate).

See ActCode.\_ActPolicyType.\_ActPrivacyPolicy.\_ActPrivacyLaw.\_ActUSPrivacyLaw.HIPAAAuth (HIPAA Authorization for Disclosure). See: HIPAAAuth and NIH Sample Authorization Language for Research Uses and Disclosures of Individually Identifiable Health Information by a Covered Health Care Provider https://privacyruleandresearch.nih.gov/authorization.asp"/&gt;
    &lt;property&gt;
      &lt;code value="status"/&gt;
      &lt;valueCode value="active"/&gt;
    &lt;/property&gt;
    &lt;property&gt;
      &lt;code value="internalId"/&gt;
      &lt;valueCode value="24104"/&gt;
    &lt;/property&gt;
    &lt;property&gt;
      &lt;code value="subsumedBy"/&gt;
      &lt;valueCode value="_ActUSPrivacyConsentDirective"/&gt;
    &lt;/property&gt;
  &lt;/concept&gt;
  &lt;concept&gt;
    &lt;code value="HIPAAROAD"/&gt;
    &lt;display value="HIPAA Right of Access Directive"/&gt;
    &lt;definition
                value="A code representing U.S. Public Law 104-191 Health Insurance Portability and Accountability Act (HIPAA) Privacy Rule 45 CFR Section 164.524 Access of individuals to protected health information https://www.gpo.gov/fdsys/pkg/CFR-2017-title45-vol1/pdf/CFR-2017-title45-vol1-sec164-524.pdf, stipulating the policy elements of an individualâ€&trade;s written and signed right of access directive requesting that a covered entity send the individualâ€&trade;s protected health information (PHI) to a third party.

See 45 CFR 164.524(c)(3)(ii) If an individual's request for access directs the covered entity to transmit the copy of protected health information directly to another person designated by the individual, the covered entity must provide the copy to the person designated by the individual. The individual's request must be in writing, signed by the individual, and clearly identify the designated person and where to send the copy of protected health information. https://www.gpo.gov/fdsys/pkg/CFR-2017-title45-vol1/pdf/CFR-2017-title45-vol1-sec164-524.pdf

This right applies to PHI in a designated record set, which is defined as â€œDesignated record set means: (1) A group of records maintained by or for a covered entity that is: (i) The medical records and billing records about individuals maintained by or for a covered health care provider; (ii) The enrollment, payment, claims adjudication, and case or medical management record systems maintained by or for a health plan; or (iii) Used, in whole or in part, by or for the covered entity to make decisions about individuals. \[https://www.law.cornell.edu/cfr/text/45/164.501\]. Also see HHS Individualsâ€&trade; Right under HIPAA to Access their Health Information 45 CFR Section 164.524 \[https://www.hhs.gov/hipaa/for-professionals/privacy/guidance/access/index.html\#maximumflatfee\].

*Usage Note:* Used to indicate the legal authority for assigning security labels to governed information. In this case, where collection, access, use, or disclosure of healthcare information is governed by an individualâ€&trade;s right of access directive under 45 CFR Section 164.524 use â€œHIPAAROADâ€? as the security label policy code.

Information disclosed under a HIPAA 42 CFR Section 164.524 no longer has the level of confidentiality protection afforded under the 45 CFR Section 164.506 - Uses and disclosures to carry out treatment, payment, or health care operations https://www.gpo.gov/fdsys/pkg/CFR-2017-title45-vol1/pdf/CFR-2017-title45-vol1-sec164-508.pdf, which is considered the â€œnormâ€?, assign the HL7 Confidentiality code â€œMâ€? (moderate), which may be protected under other laws such as the Federal Trade Commission privacy and security regulations."/&gt;
    &lt;property&gt;
      &lt;code value="status"/&gt;
      &lt;valueCode value="active"/&gt;
    &lt;/property&gt;
    &lt;property&gt;
      &lt;code value="internalId"/&gt;
      &lt;valueCode value="24103"/&gt;
    &lt;/property&gt;
    &lt;property&gt;
      &lt;code value="subsumedBy"/&gt;
      &lt;valueCode value="_ActUSPrivacyConsentDirective"/&gt;
    &lt;/property&gt;
  &lt;/concept&gt;
  &lt;concept&gt;
    &lt;code value="MDHHS-5515"/&gt;
    &lt;display
             value="Michigan Consent to Share Behavioral Health Information for Care Coordination Purposes"/&gt;
    &lt;definition
                value="The State of Michigan standard privacy consent form for sharing of health information specific to behavioral health and substance use treatment in accordance with Public Act 129 of 2014. In Michigan, while providers are not required to use this new standard form (MDHHS-5515), they are required to accept it.

*Usage Note:* For legislative background, current MDHHS-5515 consent directive form, and provider and patient FAQs see http://www.michigan.gov/mdhhs/0,5885,7-339-71550\_2941\_58005-343686--,00.html"/&gt;
    &lt;property&gt;
      &lt;code value="status"/&gt;
      &lt;valueCode value="active"/&gt;
    &lt;/property&gt;
    &lt;property&gt;
      &lt;code value="internalId"/&gt;
      &lt;valueCode value="24106"/&gt;
    &lt;/property&gt;
    &lt;property&gt;
      &lt;code value="subsumedBy"/&gt;
      &lt;valueCode value="_ActUSPrivacyConsentDirective"/&gt;
    &lt;/property&gt;
  &lt;/concept&gt;
  &lt;concept&gt;
    &lt;code value="42CFRPart2"/&gt;
    &lt;display value="42 CFR Part2"/&gt;
    &lt;definition
                value="A code representing 42 CFR Part 2 Confidentiality of Substance Use Disorder Patient Records. 42 CFR Part 2 stipulates the privacy rights of an individual who has applied for or been given diagnosis or treatment for alcohol or drug abuse at a federally assisted program, which includes non-disclosure of health information relating to health care paid for by a federally assisted substance use disorder program without patient consent. https://www.gpo.gov/fdsys/pkg/CFR-2010-title42-vol1/pdf/CFR-2010-title42-vol1-part2.pdf

*Usage Note:* Used to indicate the legal authority for assigning security labels to governed information. In this case, the collection, access, use, and disclosure of healthcare information is governed by 42 CFR Part 2 Confidentiality of Substance Use Disorder Patient Records https://www.gpo.gov/fdsys/pkg/CFR-2010-title42-vol1/pdf/CFR-2010-title42-vol1-part2.pdf use â€œ42CFRPart2â€? as the security label policy code.

Since information governed by a 42 CFR Part 2 has a level of confidentiality protection that is more stringent than the normal level of protection under HIPAA 45 CFR Section 164.506 Uses and disclosures to carry out treatment, payment, or health care operations https://www.gpo.gov/fdsys/pkg/CFR-2017-title45-vol1/pdf/CFR-2017-title45-vol1-sec164-506.pdf assign the HL7 Confidentiality code â€œRâ€? (restricted)."/&gt;
    &lt;property&gt;
      &lt;code value="status"/&gt;
      &lt;valueCode value="active"/&gt;
    &lt;/property&gt;
    &lt;property&gt;
      &lt;code value="internalId"/&gt;
      &lt;valueCode value="23761"/&gt;
    &lt;/property&gt;
    &lt;property&gt;
      &lt;code value="subsumedBy"/&gt;
      &lt;valueCode value="_ActUSPrivacyLaw"/&gt;
    &lt;/property&gt;
  &lt;/concept&gt;
  &lt;concept&gt;
    &lt;code value="CommonRule"/&gt;
    &lt;display value="Common Rule"/&gt;
    &lt;definition
                value="A code representing U.S. Federal laws governing research-related privacy policies known as the â€œCommon Ruleâ€?. The Common Rule is the U.S. Federal regulations governing the protection of human subjects in research (codified at Subpart A of 45 CFR part 46), which has been adopted by 15 U.S. Federal departments and agencies in an effort to promote uniformity, understanding, and compliance with human subject protections. Existing regulations governing the protection of human subjects in Food and Drug Administration (FDA)-regulated research (21 CFR parts 50, 56, 312, and 812) are separate from the Common Rule but include similar requirements.

*Usage Note:* Used to indicate the legal authority for assigning security labels to governed information. In this case, where collection, access, use, or disclosure of healthcare information or biospecimen is governed by the Common Rule use â€œCOMMONRULEâ€? as the security label policy code. Information or biospecimen disclosed under the Common Rule are not protected by the HIPAA Privacy Rule. If protected under other laws such as confidentiality provisions under the Common Rule, assign the HL7 Confidentiality code â€œMâ€? (moderate)."/&gt;
    &lt;property&gt;
      &lt;code value="status"/&gt;
      &lt;valueCode value="active"/&gt;
    &lt;/property&gt;
    &lt;property&gt;
      &lt;code value="internalId"/&gt;
      &lt;valueCode value="23762"/&gt;
    &lt;/property&gt;
    &lt;property&gt;
      &lt;code value="subsumedBy"/&gt;
      &lt;valueCode value="_ActUSPrivacyLaw"/&gt;
    &lt;/property&gt;
  &lt;/concept&gt;
  &lt;concept&gt;
    &lt;code value="HIPAAAuth"/&gt;
    &lt;display value="HIPAA Authorization for Disclosure"/&gt;
    &lt;definition
                value="A code representing U.S. Public Law 104-191 Health Insurance Portability and Accountability Act (HIPAA) Privacy Rule (45 CFR Section 164.508) Uses and disclosures for which an authorization is required https://www.gpo.gov/fdsys/pkg/CFR-2017-title45-vol1/pdf/CFR-2017-title45-vol1-sec164-508.pdf, which stipulates the process by which a covered entity seeks agreement from an individual to use or disclose protected health information for other purposes, or to authorize another covered entity to disclose protected health information to the requesting covered entity, are termed &amp;quot;authorizations&amp;quot;.

An â€œauthorizationâ€? is required by the Privacy Rule for uses and disclosures of protected health information not otherwise allowed by the Rule. Where the Privacy Rule requires patient authorization, voluntary consent is not sufficient to permit a use or disclosure of protected health information unless it also satisfies the requirements of a valid authorization. An authorization is a detailed document that gives covered entities permission to use protected health information for specified purposes, which are generally other than treatment, payment, or health care operations, or to disclose protected health information to a third party specified by the individual.

An authorization must specify a number of elements, including a description of the protected health information to be used and disclosed, the person authorized to make the use or disclosure, the person to whom the covered entity may make the disclosure, an expiration date, and, in some cases, the purpose for which the information may be used or disclosed. With limited exceptions, covered entities may not condition treatment or coverage on the individual providing an authorization. https://www.hhs.gov/hipaa/for-professionals/faq/264/what-is-the-difference-between-consent-and-authorization/index.html

*Usage Note:* Used to indicate the legal authority for assigning security labels to HIPAA governed information. In this case, where use or disclosure of healthcare information is governed by a covered entityâ€&trade;s HIPAA Authorization for Disclosure, use â€œHIPAAAuthâ€? as the security label policy code.

Information disclosed under a HIPAA Authorization for Disclosure no longer has the level of confidentiality protection afforded under the 45 CFR Section 164.506 - Uses and disclosures to carry out treatment, payment, or health care operations https://www.gpo.gov/fdsys/pkg/CFR-2017-title45-vol1/pdf/CFR-2017-title45-vol1-sec164-508.pdf, which is considered the â€œnormâ€?, assign the HL7 Confidentiality code â€œMâ€? (moderate), which may be protected under other laws such as the Federal Trade Commission privacy and security regulations."/&gt;
    &lt;property&gt;
      &lt;code value="status"/&gt;
      &lt;valueCode value="active"/&gt;
    &lt;/property&gt;
    &lt;property&gt;
      &lt;code value="internalId"/&gt;
      &lt;valueCode value="24118"/&gt;
    &lt;/property&gt;
    &lt;property&gt;
      &lt;code value="subsumedBy"/&gt;
      &lt;valueCode value="_ActUSPrivacyLaw"/&gt;
    &lt;/property&gt;
  &lt;/concept&gt;
  &lt;concept&gt;
    &lt;code value="HIPAAConsent"/&gt;
    &lt;display value="HIPAA Consent"/&gt;
    &lt;definition
                value="A code representing U.S. Public Law 104-191 Health Insurance Portability and Accountability Act (HIPAA) Privacy Rule (45 CFR Section 164.522), which stipulates the process by which a covered entity seeks agreement from an individual regarding how it will use and disclose the individual's protected health information for treatment, payment, and health care operations is termed a &amp;quot;consent&amp;quot;.

The Privacy Rule permits, but does not require, a covered entity to voluntarily obtain patient consent for uses and disclosures of protected health information for treatment, payment, and health care operations. Covered entities that do so have complete discretion to design a process that best suits their needs. From https://www.hhs.gov/hipaa/for-professionals/faq/264/what-is-the-difference-between-consent-and-authorization/index.html. The provisions relating to consent are largely contained in Section 164.522 Rights to request privacy protection for protected health information https://www.gpo.gov/fdsys/pkg/CFR-2017-title45-vol1/pdf/CFR-2017-title45-vol1-sec164-522.pdf.

*Usage Note:* Used to indicate the legal authority for assigning security labels to governed information. In this case, where collection, access, use, or disclosure of healthcare information is governed by 45 CFR Section 164.522 use 'HIPAAConsent' as the security label policy code.

Since information governed by a 45 CFR Section 164.522 has a level of confidentiality protection that is more stringent than the normal level of protection under HIPAA 45 CFR Section 164.506 Uses and disclosures to carry out treatment, payment, or health care operations https://www.gpo.gov/fdsys/pkg/CFR-2017-title45-vol1/pdf/CFR-2017-title45-vol1-sec164-506.pdf, assign the HL7 Confidentiality code 'R' (restricted)."/&gt;
    &lt;property&gt;
      &lt;code value="status"/&gt;
      &lt;valueCode value="active"/&gt;
    &lt;/property&gt;
    &lt;property&gt;
      &lt;code value="internalId"/&gt;
      &lt;valueCode value="24135"/&gt;
    &lt;/property&gt;
    &lt;property&gt;
      &lt;code value="subsumedBy"/&gt;
      &lt;valueCode value="_ActUSPrivacyLaw"/&gt;
    &lt;/property&gt;
  &lt;/concept&gt;
  &lt;concept&gt;
    &lt;code value="HIPAANOPP"/&gt;
    &lt;display value="HIPAA notice of privacy practices"/&gt;
    &lt;definition
                value="A code representing U.S. Public Law 104-191 Health Insurance Portability and Accountability Act (HIPAA) Privacy Rule (45 CFR Section 164.520), which stipulates an individualâ€&trade;s right to adequate notice of the uses and disclosures of protected health information that may be made by the covered entity, and of the individual's rights and the covered entity's legal duties with respect to protected health information. Relevant HIPAA Privacy Rule provisions are at Section 164.520 (a) Standard: Notice of privacy practices. https://www.gpo.gov/fdsys/pkg/CFR-2017-title45-vol1/pdf/CFR-2017-title45-vol1-sec164-520.pdf

*Usage Note:* Used to indicate the legal authority for assigning security labels to HIPAA governed information. In this case, if collection, access, use, or disclosure of healthcare information is governed by a covered entityâ€&trade;s HIPAA Notice of Privacy Practices, use â€œHIPAANOPPâ€? as the security label policy code.

Information governed under a HIPAA Notice of Privacy Practices has the level of confidentiality protection afforded under the 45 CFR Section 164.506 - Uses and disclosures to carry out treatment, payment, or health care operations https://www.gpo.gov/fdsys/pkg/CFR-2017-title45-vol1/pdf/CFR-2017-title45-vol1-sec164-506.pdf , which is considered the â€œnormâ€?, assign the HL7 Confidentiality code â€œNâ€? (normal)."/&gt;
    &lt;property&gt;
      &lt;code value="status"/&gt;
      &lt;valueCode value="active"/&gt;
    &lt;/property&gt;
    &lt;property&gt;
      &lt;code value="internalId"/&gt;
      &lt;valueCode value="23763"/&gt;
    &lt;/property&gt;
    &lt;property&gt;
      &lt;code value="subsumedBy"/&gt;
      &lt;valueCode value="_ActUSPrivacyLaw"/&gt;
    &lt;/property&gt;
  &lt;/concept&gt;
  &lt;concept&gt;
    &lt;code value="HIPAAPsyNotes"/&gt;
    &lt;display value="HIPAA psychotherapy notes"/&gt;
    &lt;definition
                value="A code representing U.S. Public Law 104-191 Health Insurance Portability and Accountability Act (HIPAA) Privacy Rule (45 CFR Section 164.508), which stipulates the privacy rights of an individual who is the subject of psychotherapy notes, and requires authorization for certain uses and disclosure of that information.

Definition of Psychotherapy notes 45 CFR Section 164.501 https://www.gpo.gov/fdsys/pkg/CFR-2017-title45-vol1/pdf/CFR-2017-title45-vol1-sec164-501.pdf: Psychotherapy notes means notes recorded (in any medium) by a health care provider who is a mental health professional documenting or analyzing the contents of conversation during a private counseling session or a group, joint, or family counseling session and that are separated from the rest of the individual's medical record. Psychotherapy notes excludes medication prescription and monitoring, counseling session start and stop times, the modalities and frequencies of treatment furnished, results of clinical tests, and any summary of the following items: Diagnosis, functional status, the treatment plan, symptoms, prognosis, and progress to date.

See Section 164.508 Uses and disclosures for which an authorization is required. (2)Authorization required: Psychotherapy notes https://www.gpo.gov/fdsys/pkg/CFR-2017-title45-vol1/pdf/CFR-2017-title45-vol1-sec164-508.pdf: Notwithstanding any provision of this subpart, other than the transition provisions in Section 164.532, a covered entity must obtain an authorization for any use or disclosure of psychotherapy notes, except: (i) To carry out the following treatment, payment, or health care operations: (A) Use by the originator of the psychotherapy notes for treatment; (B) Use or disclosure by the covered entity for its own training programs in which students, trainees, or practitioners in mental health learn under supervision to practice or improve their skills in group, joint, family, or individual counseling; or (C) Use or disclosure by the covered entity to defend itself in a legal action or other proceeding brought by the individual; and (ii) A use or disclosure that is required by Section 164.502(a)(2)(ii) or permitted by Section 164.512(a); Section 164.512(d) with respect to the oversight of the originator of the psychotherapy notes; Section 164.512(g)(1); Section 164.512(j)(1)(i).

*Usage Note:* Used to indicate the legal authority for assigning security labels to HIPAA governed information. In this case, the collection, access, use, or disclosure of healthcare information is governed by HIPAA 45 CFR 164.508 (2) Authorization required: Psychotherapy notes https://www.gpo.gov/fdsys/pkg/CFR-2017-title45-vol1/pdf/CFR-2017-title45-vol1-sec164-506.pdf , use â€œHIPAAPsyNotesâ€? as the security label policy code.

Since information governed by a HIPAA 45 CFR 164.508 (2) has a level of confidentiality protection that is more stringent than the normal level of protection under 45 CFR Section 164.506 Uses and disclosures to carry out treatment, payment, or health care operations https://www.gpo.gov/fdsys/pkg/CFR-2017-title45-vol1/pdf/CFR-2017-title45-vol1-sec164-506.pdf, assign the HL7 Confidentiality code â€œRâ€? (restricted)."/&gt;
    &lt;property&gt;
      &lt;code value="status"/&gt;
      &lt;valueCode value="active"/&gt;
    &lt;/property&gt;
    &lt;property&gt;
      &lt;code value="internalId"/&gt;
      &lt;valueCode value="23764"/&gt;
    &lt;/property&gt;
    &lt;property&gt;
      &lt;code value="subsumedBy"/&gt;
      &lt;valueCode value="_ActUSPrivacyLaw"/&gt;
    &lt;/property&gt;
  &lt;/concept&gt;
  &lt;concept&gt;
    &lt;code value="HIPAAROA"/&gt;
    &lt;display value="HIPAA Right of Access"/&gt;
    &lt;definition
                value="A code representing U.S. Public Law 104-191 Health Insurance Portability and Accountability Act (HIPAA) Privacy Rule 45 CFR Section 164.524 Access of individuals to protected health information https://www.govinfo.gov/app/details/CFR-2017-title45-vol1/CFR-2017-title45-vol1-sec164-524, which stipulates that an individual has a right of access to inspect and obtain a copy of protected health information about the individual in a designated record set, for as long as the protected health information is maintained in the designated record set with exceptions stipulated in HIPAA Privacy Rule Section 164.524. Exceptions include psychotherapy notes and information compiled in reasonable anticipation of, or for use in, a civil, criminal, or administrative action or proceeding.

If an individual's request for access directs the covered entity to transmit the copy of protected health information directly to another person designated by the individual, the covered entity must provide the copy to the person designated by the individual. The individual's request must be in writing, signed by the individual, and clearly identify the designated person and where to send the copy of protected health information.

For discussion on extent of right, grounds for denial, and documentation requirements see: HHS Individualsâ€&trade; Right under HIPAA to Access their Health Information 45 CFR Section 164.524 https://www.hhs.gov/hipaa/for-professionals/privacy/guidance/access/index.html and HHS FAQ on Right of Access vs. HIPAA Authorization https://www.hhs.gov/hipaa/for-professionals/faq/2041/why-depend-on-the-individuals-right/index.html

*Usage Note:* Used to indicate the legal authority for assigning security labels to governed information. In this case, where collection, access, use, or disclosure of healthcare information is governed under 45 CFR Section 164.5224 use â€œHIPAAROAâ€? as the security label policy code.

Information disclosed under a HIPAA 42 CFR Section 164.524 no longer has the level of confidentiality protection afforded under the 45 CFR Section 164.506 - Uses and disclosures to carry out treatment, payment, or health care operations https://www.gpo.gov/fdsys/pkg/CFR-2017-title45-vol1/pdf/CFR-2017-title45-vol1-sec164-508.pdf, which is considered the â€œnormâ€?, assign the HL7 Confidentiality code â€œMâ€? (moderate), which may be protected under other laws such as the Federal Trade Commission privacy and security regulations."/&gt;
    &lt;property&gt;
      &lt;code value="status"/&gt;
      &lt;valueCode value="active"/&gt;
    &lt;/property&gt;
    &lt;property&gt;
      &lt;code value="internalId"/&gt;
      &lt;valueCode value="24119"/&gt;
    &lt;/property&gt;
    &lt;property&gt;
      &lt;code value="subsumedBy"/&gt;
      &lt;valueCode value="_ActUSPrivacyLaw"/&gt;
    &lt;/property&gt;
  &lt;/concept&gt;
  &lt;concept&gt;
    &lt;code value="HIPAASelfPay"/&gt;
    &lt;display value="HIPAA self-pay"/&gt;
    &lt;definition
                value="A code representing 45 CFR 164.522 Rights to request privacy protection for protected health information, which is a US Federal law stipulating the privacy rights of an individual to restrict disclosure of information related to health care items or services for which the individual pays out of pocket in full to a health plan or payer.

See 45 CFR 164.522 https://www.gpo.gov/fdsys/pkg/CFR-2017-title45-vol1/pdf/CFR-2017-title45-vol1-sec164-522.pdf. (vi) A covered entity must agree to the request of an individual to restrict disclosure of protected health information about the individual to a health plan if: (A) The disclosure is for the purpose of carrying out payment or health care operations and is not otherwise required by law; and (B) The protected health information pertains solely to a health care item or service for which the individual, or person other than the health plan on behalf of the individual, has paid the covered entity in full.

*Usage Note:* Used to indicate the legal authority for assigning security labels to HIPAA governed information. In this case, the collection, access, use, or disclosure of healthcare information is governed by HIPAA 45 CFR 164.522 https://www.gpo.gov/fdsys/pkg/CFR-2017-title45-vol1/pdf/CFR-2017-title45-vol1-sec164-522.pdf use â€œHIPAASelfPayâ€? as the security label policy code.

Since information governed by a HIPAA 45 CFR 164.522 has a level of confidentiality protection that is more stringent than the normal level of protection under 45 CFR Section 164.506 Uses and disclosures to carry out treatment, payment, or health care operations https://www.gpo.gov/fdsys/pkg/CFR-2017-title45-vol1/pdf/CFR-2017-title45-vol1-sec164-506.pdf, assign the HL7 Confidentiality code â€œRâ€? (restricted)."/&gt;
    &lt;property&gt;
      &lt;code value="status"/&gt;
      &lt;valueCode value="active"/&gt;
    &lt;/property&gt;
    &lt;property&gt;
      &lt;code value="internalId"/&gt;
      &lt;valueCode value="23765"/&gt;
    &lt;/property&gt;
    &lt;property&gt;
      &lt;code value="subsumedBy"/&gt;
      &lt;valueCode value="_ActUSPrivacyLaw"/&gt;
    &lt;/property&gt;
  &lt;/concept&gt;
  &lt;concept&gt;
    &lt;code value="Title38Section7332"/&gt;
    &lt;display value="Title 38 Section 7332"/&gt;
    &lt;definition
                value="A code representing Title 38 Section 7332, which is a US Federal law stipulating the privacy rights of veterans diagnosed and treated for substance use disorders, infection with the human immunodeficiency virus, or sickle cell anemia.

https://www.gpo.gov/fdsys/granule/USCODE-2011-title38/USCODE-2011-title38-partV-chap73-subchapIII-sec7332/content-detail.html . (1) Records of the identity, diagnosis, prognosis, or treatment of any patient or subject which are maintained in connection with the performance of any program or activity (including education, training, treatment, rehabilitation, or research) relating to drug abuse, alcoholism or alcohol abuse, infection with the human immunodeficiency virus, or sickle cell anemia which is carried out by or for the Department under this title shall, except as provided in subsections (e) and (f), be confidential, and (section 5701 of this title to the contrary notwithstanding) such records may be disclosed only for the purposes and under the circumstances expressly authorized under subsection (b). (2) Paragraph (1) prohibits the disclosure to any person or entity other than the patient or subject concerned of the fact that a special written consent is required in order for such records to be disclosed. (b) (1) The content of any record referred to in subsection (a) may be disclosed by the Secretary in accordance with the prior written consent of the patient or subject with respect to whom such record is maintained, but only to such extent, under such circumstances, and for such purposes as may be allowed in regulations prescribed by the Secretary. (2) Whether or not any patient or subject, with respect to whom any given record referred to in subsection (a) is maintained, gives written consent, the content of such record may be disclosed by the Secretary as follows: (A) To medical personnel to the extent necessary to meet a bona fide medical emergency. (B) To qualified personnel for the purpose of conducting scientific research, management audits, financial audits, or program evaluation, but such personnel may not identify, directly or indirectly, any individual patient or subject in any report of such research, audit, or evaluation, or otherwise disclose patient or subject identities in any manner. (C) (i) In the case of any record which is maintained in connection with the performance of any program or activity relating to infection with the human immunodeficiency virus, to a Federal, State, or local public-health authority charged under Federal or State law with the protection of the public health, and to which Federal or State law requires disclosure of such record, if a qualified representative of such authority has made a written request that such record be provided as required pursuant to such law for a purpose authorized by such law. (ii) A person to whom a record is disclosed under this paragraph may not redisclose or use such record for a purpose other than that for which the disclosure was made. (D) If authorized by an appropriate order of a court of competent jurisdiction granted after application showing good cause therefor. In assessing good cause the court shall weigh the public interest and the need for disclosure against the injury to the patient or subject, to the physician-patient relationship, and to the treatment services. Upon the granting of such order, the court, in determining the extent to which any disclosure of all or any part of any record is necessary, shall impose appropriate safeguards against unauthorized disclosure. (E) To an entity described in paragraph (1)(B) of section 5701(k) of this title, but only to the extent authorized by such section. (F) (i) To a representative of a patient who lacks decision-making capacity, when a practitioner deems the content of the given record necessary for that representative to make an informed decision regarding the patient's treatment. (ii) In this subparagraph, the term Ã¢â‚¬Å“representativeÃ¢â‚¬? means an individual, organization, or other body authorized under section 7331 of this title and its implementing regulations to give informed consent on behalf of a patient who lacks decision-making capacity. (G) To a State controlled substance monitoring program, including a program approved by the Secretary of Health and Human Services under section 399O of the Public Health Service Act (42 U.S.C. 280g-3), to the extent necessary to prevent misuse and diversion of prescription medicines. (H) (i) To a non-Department entity (including private entities and other Federal agencies) for purposes of providing health care, including hospital care, medical services, and extended care services, to Veterans or performing other health care-related activities or functions. (ii) An entity to which a record is disclosed under this subparagraph may not disclose or use such record for a purpose other than that for which the disclosure was made or as permitted by law. (I) To a third party in order to recover or collect reasonable charges for care furnished to, or paid on behalf of, a Veteran in connection with a non-service connected disability as permitted by section 1729 of this title or for a condition for which recovery is authorized or with respect to which the United States is deemed to be a third party beneficiary under the Act entitled 'An Act to provide for the recovery from tortiously liable third persons of the cost of hospital and medical care and treatment furnished by the United States' (Public Law 87-693; 42 U.S.C. 2651 et seq.; commonly known as the 'Federal Medical Care Recovery Act').

*Usage Note:* Used to indicate the legal authority for assigning security labels to governed information. In this case, where collection, access, use, or disclosure of healthcare information is governed by 38 U.S. Code Section 7332 - Confidentiality of certain medical records https://www.gpo.gov/fdsys/granule/USCODE-2011-title38/USCODE-2011-title38-partV-chap73-subchapIII-sec7332/content-detail.html use &amp;quot;Title38Section7332&amp;quot; as the security label policy code.

Since information governed by a Title 38 Section 7332 has a level of confidentiality protection that is more stringent than the normal level of protection under HIPAA 45 CFR Section 164.506 Uses and disclosures to carry out treatment, payment, or health care operations https://www.gpo.gov/fdsys/pkg/CFR-2017-title45-vol1/pdf/CFR-2017-title45-vol1-sec164-506.pdf, assign the HL7 Confidentiality code &amp;quot;R&amp;quot; (restricted)."/&gt;
    &lt;property&gt;
      &lt;code value="status"/&gt;
      &lt;valueCode value="active"/&gt;
    &lt;/property&gt;
    &lt;property&gt;
      &lt;code value="internalId"/&gt;
      &lt;valueCode value="23766"/&gt;
    &lt;/property&gt;
    &lt;property&gt;
      &lt;code value="subsumedBy"/&gt;
      &lt;valueCode value="_ActUSPrivacyLaw"/&gt;
    &lt;/property&gt;
  &lt;/concept&gt;
  &lt;concept&gt;
    &lt;code value="a) HIPAAConsent"/&gt;
    &lt;display value="HIPAA Consent"/&gt;
    &lt;definition
                value="Code retired in December 2019 and replaced by code HIPAAConsent. Originally entered with copy/paste error in code value.

A code representing U.S. Public Law 104-191 Health Insurance Portability and Accountability Act (HIPAA) Privacy Rule (45 CFR Section 164.522), which stipulates the process by which a covered entity seeks agreement from an individual regarding how it will use and disclose the individual's protected health information for treatment, payment, and health care operations is termed a &amp;quot;consent.&amp;quot; The Privacy Rule permits, but does not require, a covered entity to voluntarily obtain patient consent for uses and disclosures of protected health information for treatment, payment, and health care operations. Covered entities that do so have complete discretion to design a process that best suits their needs. From https://www.hhs.gov/hipaa/for-professionals/faq/264/what-is-the-difference-between-consent-and-authorization/index.html. The provisions relating to consent are largely contained in Section 164.522 Rights to request privacy protection for protected health information https://www.gpo.gov/fdsys/pkg/CFR-2017-title45-vol1/pdf/CFR-2017-title45-vol1-sec164-522.pdf.

*Usage Note:* Used to indicate the legal authority for assigning security labels to governed information. In this case, where collection, access, use, or disclosure of healthcare information is governed by 45 CFR Section 164.522 use Ã¢â‚¬Å“HIPAAConsentÃ¢â‚¬? as the security label policy code.

Since information governed by a 45 CFR Section 164.522 has a level of confidentiality protection that is more stringent than the normal level of protection under HIPAA 45 CFR Section 164.506 Uses and disclosures to carry out treatment, payment, or health care operations https://www.gpo.gov/fdsys/pkg/CFR-2017-title45-vol1/pdf/CFR-2017-title45-vol1-sec164-506.pdf, assign the HL7 Confidentiality code Ã¢â‚¬Å“RÃ¢â‚¬? (restricted)."/&gt;
    &lt;property&gt;
      &lt;code value="status"/&gt;
      &lt;valueCode value="retired"/&gt;
    &lt;/property&gt;
    &lt;property&gt;
      &lt;code value="internalId"/&gt;
      &lt;valueCode value="24117"/&gt;
    &lt;/property&gt;
    &lt;property&gt;
      &lt;code value="subsumedBy"/&gt;
      &lt;valueCode value="_ActUSPrivacyLaw"/&gt;
    &lt;/property&gt;
  &lt;/concept&gt;
  &lt;concept&gt;
    &lt;code value="USResearchInformedAssent"/&gt;
    &lt;display value="Informed Assent for Research"/&gt;
    &lt;definition
                value="An informed assertion by a minor who is a candidate research subject, of the individual's willingness to participate in research. Assent means a child's affirmative agreement to participate in a clinical investigation. Mere failure to object should not, absent affirmative agreement, be construed as assent. The minor's assent must be accompanied by parental or guardian consent that the minor participate in a specified research. The assent is not legally binding, however, the accompanying consent is legally binding. Background: In the US, informed assent is governed under 21 CFR Part 50, Subpart D - Additional Safeguards for Children in Clinical Investigations. Available at https://www.law.cornell.edu/cfr/text/21/part-50/subpart-D"/&gt;
    &lt;property&gt;
      &lt;code value="status"/&gt;
      &lt;valueCode value="active"/&gt;
    &lt;/property&gt;
    &lt;property&gt;
      &lt;code value="internalId"/&gt;
      &lt;valueCode value="25100"/&gt;
    &lt;/property&gt;
    &lt;property&gt;
      &lt;code value="subsumedBy"/&gt;
      &lt;valueCode value="_ActUSPrivacyConsentDirective"/&gt;
    &lt;/property&gt;
  &lt;/concept&gt;
  &lt;concept&gt;
    &lt;code value="USResearchInformedConsent"/&gt;
    &lt;display value="Informed Consent for Research"/&gt;
    &lt;definition
                value="An informed assertion by an adult, or the parent/guardian of a minor who is a candidate research subject, of the individual's willingness to participate in a specified research study. The consent is legally binding. Background: In the US, informed assent is governed under 49 CFR  (        <a href="en\CodeSystem-v3-ActCode.xml.html">src</a>
)
      </li>
      <li>
 164.506 Uses and disclosures to carry out treatment, payment, or health care operations https://www.gpo.gov/fdsys/pkg/CFR-2017-title45-vol1/pdf/CFR-2017-title45-vol1-sec164-506.pdf, assign the HL7 Confidentiality code â€œRâ€? (restricted).&lt;/td&gt;&lt;td/&gt;&lt;td&gt;24100&lt;/td&gt;&lt;td&gt;active&lt;/td&gt;&lt;td/&gt;&lt;td/&gt;&lt;td/&gt;&lt;td&gt;_ActUSPrivacyConsentDirective&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td&gt;5&lt;/td&gt;&lt;td style="white-space:nowrap"&gt;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;CompoundResearchCD&lt;a name="v3-ActCode-CompoundResearchCD"&gt; &lt;/a&gt;&lt;/td&gt;&lt;td&gt;Compound HIPAA Research Authorization and Informed Consent for Research&lt;/td&gt;&lt;td&gt;A code representing an individualâ€&trade;s consent directive that complies with HIPAA Privacy rule 45 CFR Section 164.508 Uses and disclosures for which an authorization is required https://www.gpo.gov/fdsys/pkg/CFR-2017-title45-vol1/pdf/CFR-2017-title45-vol1-sec164-508.pdf, which is a US Federal law stipulating the policy elements of a valid authorization under this Section specific to disclosures for purposes of research when combined with a Common Rule or Federal Drug Administration consent to participate in research also known as a compound authorization.

*Usage Note:* The Agency for Healthcare Research and Quality (AHRQ) has developed the Informed Consent and Authorization Toolkit for Minimal Risk Research to facilitate the process of obtaining informed consent and Health Insurance Portability and Accountability Act (HIPAA) authorization from potential research subjects. This toolkit contains information for people responsible for ensuring that potential research subjects are informed in a manner that is consistent with medical ethics and regulatory guidelines. From https://www.ahrq.gov/sites/default/files/publications/files/ictoolkit.pdf.

Used to indicate the legal authority for assigning security labels to governed information. In this case, where collection, access, use, or disclosure of healthcare information is governed by an individualâ€&trade;s right of access directive under 45 CFR Section 164.508 use â€œCompoundResearchCDâ€? as the security label policy code.

Information or biospecimen disclosed under the Common Rule are not protected by the HIPAA Privacy Rule. If protected under other laws such as confidentiality provisions under the Common Rule, assign the HL7 Confidentiality code â€œMâ€? (moderate).

See ActCode.\_ActPolicyType.\_ActPrivacyPolicy.\_ActPrivacyLaw.\_ActUSPrivacyLaw.HIPAAAuth (HIPAA Authorization for Disclosure). See: HIPAAAuth and NIH Sample Authorization Language for Research Uses and Disclosures of Individually Identifiable Health Information by a Covered Health Care Provider https://privacyruleandresearch.nih.gov/authorization.asp&lt;/td&gt;&lt;td/&gt;&lt;td&gt;24105&lt;/td&gt;&lt;td&gt;active&lt;/td&gt;&lt;td/&gt;&lt;td/&gt;&lt;td/&gt;&lt;td&gt;_ActUSPrivacyConsentDirective&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td&gt;5&lt;/td&gt;&lt;td style="white-space:nowrap"&gt;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;HIPAAAuthCD&lt;a name="v3-ActCode-HIPAAAuthCD"&gt; &lt;/a&gt;&lt;/td&gt;&lt;td&gt;HIPAA Authorization Consent Directive&lt;/td&gt;&lt;td&gt;A code representing an individualâ€&trade;s consent directive that complies with HIPAA Privacy rule 45 CFR Section 164.508 Uses and disclosures for which an authorization is required https://www.gpo.gov/fdsys/pkg/CFR-2017-title45-vol1/pdf/CFR-2017-title45-vol1-sec164-508.pdf, which is a US Federal law stipulating the policy elements of a valid authorization under this Section.

An â€œauthorizationâ€? is required by the Privacy Rule for uses and disclosures of protected health information not otherwise allowed by the Rule. Where the Privacy Rule requires patient authorization, voluntary consent is not sufficient to permit a use or disclosure of protected health information unless it also satisfies the requirements of a valid authorization. An authorization is a detailed document that gives covered entities permission to use protected health information for specified purposes, which are generally other than treatment, payment, or health care operations, or to disclose protected health information to a third party specified by the individual.

An authorization must specify a number of elements, including a description of the protected health information to be used and disclosed, the person authorized to make the use or disclosure, the person to whom the covered entity may make the disclosure, an expiration date, and, in some cases, the purpose for which the information may be used or disclosed. With limited exceptions, covered entities may not condition treatment or coverage on the individual providing an authorization. https://www.hhs.gov/hipaa/for-professionals/faq/264/what-is-the-difference-between-consent-and-authorization/index.html

A HIPAA Authorization must comply with 45 CFR Section164.508(c) Implementation specifications: Core elements and requirements â€“ (1) Core elements. A valid authorization under this Section must contain at least the following elements: (i) A description of the information to be used or disclosed that identifies the information in a specific and meaningful fashion. (ii) The name or other specific identification of the person(s), or class of persons, authorized to make the requested use or disclosure. (iii) The name or other specific identification of the person(s), or class of persons, to whom the covered entity may make the requested use or disclosure. (iv) A description of each purpose of the requested use or disclosure. The statement â€œat the request of the individualâ€? is a sufficient description of the purpose when an individual initiates the authorization and does not, or elects not to, provide a statement of the purpose. (v) An expiration date or an expiration event that relates to the individual or the purpose of the use or disclosure. The statement â€œend of the research study,â€? â€œnone,â€? or similar language is sufficient if the authorization is for a use or disclosure of protected health information for research, including for the creation and maintenance of a research database or research repository. (vi) Signature of the individual and date. If the authorization is signed by a personal representative of the individual, a description of such representative's authority to act for the individual must also be provided. (2)Required statements. In addition to the core elements, the authorization must contain statements adequate to place the individual on notice of all of the following: (i) The individual's right to revoke the authorization in writing, and either: (A) The exceptions to the right to revoke and a description of how the individual may revoke the authorization; or (B) To the extent that the information in paragraph (c)(2)(i)(A) of this section is included in the notice required by Section 164.520, a reference to the covered entity's notice. https://www.gpo.gov/fdsys/pkg/CFR-2017-title45-vol1/pdf/CFR-2017-title45-vol1-sec164-508.pdf

*Usage Note:* Used to indicate the legal authority for assigning security labels to HIPAA governed information. In this case, where collection, access, use, or disclosure of healthcare information is governed by a an individualâ€&trade;s HIPAA Authorization for Disclosure, use â€œHIPAAAuthCDâ€? as the security label policy code.

Information governed under a HIPAA Authorization for Disclosure has the level of confidentiality protection afforded under the 45 CFR Section 164.506 - Uses and disclosures to carry out treatment, payment, or health care operations https://www.gpo.gov/fdsys/pkg/CFR-2017-title45-vol1/pdf/CFR-2017-title45-vol1-sec164-506.pdf, which is considered the â€œnormâ€?, assign the HL7 Confidentiality code â€œNâ€? (normal).&lt;/td&gt;&lt;td/&gt;&lt;td&gt;24101&lt;/td&gt;&lt;td&gt;active&lt;/td&gt;&lt;td/&gt;&lt;td/&gt;&lt;td/&gt;&lt;td&gt;_ActUSPrivacyConsentDirective&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td&gt;5&lt;/td&gt;&lt;td style="white-space:nowrap"&gt;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;HIPAAConsentCD&lt;a name="v3-ActCode-HIPAAConsentCD"&gt; &lt;/a&gt;&lt;/td&gt;&lt;td&gt;HIPAA Consent Directive&lt;/td&gt;&lt;td&gt;A code representing U.S. Public Law 104-191 Health Insurance Portability and Accountability Act (HIPAA) Privacy Rule 45 CFR Section 164.522 Rights to request privacy protection for protected health information https://www.gpo.gov/fdsys/pkg/CFR-2017-title45-vol1/pdf/CFR-2017-title45-vol1-sec164-522.pdf, which stipulates the process by which a covered entity seeks agreement from an individual regarding how it will use and disclose the individual's protected health information for treatment, payment, and health care operations is termed a &amp;quot;consent.&amp;quot;

*Usage Note:* Used to indicate the legal authority for assigning security labels to governed information. In this case, where collection, access, use, or disclosure of healthcare information is governed by an individualâ€&trade;s consent directive under 45 CFR Section 164.522 use â€œHIPAAConsentCDâ€? as the security label policy code.

Since information governed by a 45 CFR Section 164.522 has a level of confidentiality protection that is more stringent than the normal level of protection under HIPAA 45 CFR Section 164.506 Uses and disclosures to carry out treatment, payment, or health care operations https://www.gpo.gov/fdsys/pkg/CFR-2017-title45-vol1/pdf/CFR-2017-title45-vol1-sec164-506.pdf, assign the HL7 Confidentiality code â€œRâ€? (restricted).&lt;/td&gt;&lt;td/&gt;&lt;td&gt;24102&lt;/td&gt;&lt;td&gt;active&lt;/td&gt;&lt;td/&gt;&lt;td/&gt;&lt;td/&gt;&lt;td&gt;_ActUSPrivacyConsentDirective&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td&gt;5&lt;/td&gt;&lt;td style="white-space:nowrap"&gt;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;HIPAAResearchAuthCD&lt;a name="v3-ActCode-HIPAAResearchAuthCD"&gt; &lt;/a&gt;&lt;/td&gt;&lt;td&gt;HIPAA Authorization for Disclosure for Research Consent Directive&lt;/td&gt;&lt;td&gt;A code representing an individualâ€&trade;s consent directive that complies with HIPAA Privacy rule 45 CFR Section 164.508 Uses and disclosures for which an authorization is required https://www.gpo.gov/fdsys/pkg/CFR-2017-title45-vol1/pdf/CFR-2017-title45-vol1-sec164-508.pdf, which is a US Federal law stipulating the policy elements of a valid authorization under this Section specific to disclosures for purposes of research.

*Usage Note:* Used to indicate the legal authority for assigning security labels to governed information. In this case, where collection, access, use, or disclosure of healthcare information is governed by an individualâ€&trade;s HIPAA Authorization for Disclosure for Research under 45 CFR Section 164.508 use â€œHIPAAResearchAuthCDâ€? as the security label policy code.

Information disclosed under an individualâ€&trade;s HIPAA Authorization for Disclosure for Research are not protected by the HIPAA Privacy Rule. If protected under other laws such as confidentiality provisions under the Common Rule, assign the HL7 Confidentiality code â€œMâ€? (moderate).

See ActCode.\_ActPolicyType.\_ActPrivacyPolicy.\_ActPrivacyLaw.\_ActUSPrivacyLaw.HIPAAAuth (HIPAA Authorization for Disclosure). See: HIPAAAuth and NIH Sample Authorization Language for Research Uses and Disclosures of Individually Identifiable Health Information by a Covered Health Care Provider https://privacyruleandresearch.nih.gov/authorization.asp&lt;/td&gt;&lt;td/&gt;&lt;td&gt;24104&lt;/td&gt;&lt;td&gt;active&lt;/td&gt;&lt;td/&gt;&lt;td/&gt;&lt;td/&gt;&lt;td&gt;_ActUSPrivacyConsentDirective&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td&gt;5&lt;/td&gt;&lt;td style="white-space:nowrap"&gt;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;HIPAAROAD&lt;a name="v3-ActCode-HIPAAROAD"&gt; &lt;/a&gt;&lt;/td&gt;&lt;td&gt;HIPAA Right of Access Directive&lt;/td&gt;&lt;td&gt;A code representing U.S. Public Law 104-191 Health Insurance Portability and Accountability Act (HIPAA) Privacy Rule 45 CFR Section 164.524 Access of individuals to protected health information https://www.gpo.gov/fdsys/pkg/CFR-2017-title45-vol1/pdf/CFR-2017-title45-vol1-sec164-524.pdf, stipulating the policy elements of an individualâ€&trade;s written and signed right of access directive requesting that a covered entity send the individualâ€&trade;s protected health information (PHI) to a third party.

See 45 CFR 164.524(c)(3)(ii) If an individual's request for access directs the covered entity to transmit the copy of protected health information directly to another person designated by the individual, the covered entity must provide the copy to the person designated by the individual. The individual's request must be in writing, signed by the individual, and clearly identify the designated person and where to send the copy of protected health information. https://www.gpo.gov/fdsys/pkg/CFR-2017-title45-vol1/pdf/CFR-2017-title45-vol1-sec164-524.pdf

This right applies to PHI in a designated record set, which is defined as â€œDesignated record set means: (1) A group of records maintained by or for a covered entity that is: (i) The medical records and billing records about individuals maintained by or for a covered health care provider; (ii) The enrollment, payment, claims adjudication, and case or medical management record systems maintained by or for a health plan; or (iii) Used, in whole or in part, by or for the covered entity to make decisions about individuals. \[https://www.law.cornell.edu/cfr/text/45/164.501\]. Also see HHS Individualsâ€&trade; Right under HIPAA to Access their Health Information 45 CFR Section 164.524 \[https://www.hhs.gov/hipaa/for-professionals/privacy/guidance/access/index.html\#maximumflatfee\].

*Usage Note:* Used to indicate the legal authority for assigning security labels to governed information. In this case, where collection, access, use, or disclosure of healthcare information is governed by an individualâ€&trade;s right of access directive under 45 CFR Section 164.524 use â€œHIPAAROADâ€? as the security label policy code.

Information disclosed under a HIPAA 42 CFR Section 164.524 no longer has the level of confidentiality protection afforded under the 45 CFR Section 164.506 - Uses and disclosures to carry out treatment, payment, or health care operations https://www.gpo.gov/fdsys/pkg/CFR-2017-title45-vol1/pdf/CFR-2017-title45-vol1-sec164-508.pdf, which is considered the â€œnormâ€?, assign the HL7 Confidentiality code â€œMâ€? (moderate), which may be protected under other laws such as the Federal Trade Commission privacy and security regulations.&lt;/td&gt;&lt;td/&gt;&lt;td&gt;24103&lt;/td&gt;&lt;td&gt;active&lt;/td&gt;&lt;td/&gt;&lt;td/&gt;&lt;td/&gt;&lt;td&gt;_ActUSPrivacyConsentDirective&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td&gt;5&lt;/td&gt;&lt;td style="white-space:nowrap"&gt;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;MDHHS-5515&lt;a name="v3-ActCode-MDHHS-5515"&gt; &lt;/a&gt;&lt;/td&gt;&lt;td&gt;Michigan Consent to Share Behavioral Health Information for Care Coordination Purposes&lt;/td&gt;&lt;td&gt;The State of Michigan standard privacy consent form for sharing of health information specific to behavioral health and substance use treatment in accordance with Public Act 129 of 2014. In Michigan, while providers are not required to use this new standard form (MDHHS-5515), they are required to accept it.

*Usage Note:* For legislative background, current MDHHS-5515 consent directive form, and provider and patient FAQs see http://www.michigan.gov/mdhhs/0,5885,7-339-71550\_2941\_58005-343686--,00.html&lt;/td&gt;&lt;td/&gt;&lt;td&gt;24106&lt;/td&gt;&lt;td&gt;active&lt;/td&gt;&lt;td/&gt;&lt;td/&gt;&lt;td/&gt;&lt;td&gt;_ActUSPrivacyConsentDirective&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td&gt;6&lt;/td&gt;&lt;td style="white-space:nowrap"&gt;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;MDHHS-5515MMHC&lt;a name="v3-ActCode-MDHHS-5515MMHC"&gt; &lt;/a&gt;&lt;/td&gt;&lt;td&gt;Michigan Consent to Share Behavioral Health Information for Care Coordination Purposes-Michigan Mental Health Code&lt;/td&gt;&lt;td&gt;The State of Michigan standard privacy consent form for sharing of health information specific to behavioral health governed by the Michigan Mental Health Code Act 258 of 1974, which require patient authorization for purposes other than treatment, payment, and coordination of care, in accordance with Public Act 129 of 2014.

*Usage Note:* For legislative background, current MDHHS-5515 consent directive form, and provider and patient FAQs see http://www.michigan.gov/mdhhs/0,5885,7-339-71550\_2941\_58005-343686--,00.html&lt;/td&gt;&lt;td/&gt;&lt;td&gt;24134&lt;/td&gt;&lt;td&gt;active&lt;/td&gt;&lt;td/&gt;&lt;td/&gt;&lt;td/&gt;&lt;td&gt;MDHHS-5515&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td&gt;6&lt;/td&gt;&lt;td style="white-space:nowrap"&gt;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;MDHHS-5515Part2&lt;a name="v3-ActCode-MDHHS-5515Part2"&gt; &lt;/a&gt;&lt;/td&gt;&lt;td&gt;Michigan Consent to Share Behavioral Health Information for Care Coordination Purposes-US 42 CFR Part 2&lt;/td&gt;&lt;td&gt;The State of Michigan standard privacy consent form for sharing of health information specific to substance use information governed under US 42 CFR Part 2 in accordance with Public Act 129 of 2014.

*Usage Note:* For legislative background, current MDHHS-5515 consent directive form, and provider and patient FAQs see http://www.michigan.gov/mdhhs/0,5885,7-339-71550\_2941\_58005-343686--,00.html&lt;/td&gt;&lt;td/&gt;&lt;td&gt;24133&lt;/td&gt;&lt;td&gt;active&lt;/td&gt;&lt;td/&gt;&lt;td/&gt;&lt;td/&gt;&lt;td&gt;MDHHS-5515&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td&gt;5&lt;/td&gt;&lt;td style="white-space:nowrap"&gt;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;USResearchInformedAssent&lt;a name="v3-ActCode-USResearchInformedAssent"&gt; &lt;/a&gt;&lt;/td&gt;&lt;td&gt;Informed Assent for Research&lt;/td&gt;&lt;td&gt;An informed assertion by a minor who is a candidate research subject, of the individual's willingness to participate in research. Assent means a child's affirmative agreement to participate in a clinical investigation. Mere failure to object should not, absent affirmative agreement, be construed as assent. The minor's assent must be accompanied by parental or guardian consent that the minor participate in a specified research. The assent is not legally binding, however, the accompanying consent is legally binding. Background: In the US, informed assent is governed under 21 CFR Part 50, Subpart D - Additional Safeguards for Children in Clinical Investigations. Available at https://www.law.cornell.edu/cfr/text/21/part-50/subpart-D&lt;/td&gt;&lt;td/&gt;&lt;td&gt;25100&lt;/td&gt;&lt;td&gt;active&lt;/td&gt;&lt;td/&gt;&lt;td/&gt;&lt;td/&gt;&lt;td&gt;_ActUSPrivacyConsentDirective&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td&gt;5&lt;/td&gt;&lt;td style="white-space:nowrap"&gt;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;USResearchInformedConsent&lt;a name="v3-ActCode-USResearchInformedConsent"&gt; &lt;/a&gt;&lt;/td&gt;&lt;td&gt;Informed Consent for Research&lt;/td&gt;&lt;td&gt;An informed assertion by an adult, or the parent/guardian of a minor who is a candidate research subject, of the individual's willingness to participate in a specified research study. The consent is legally binding. Background: In the US, informed assent is governed under 49 CFR  (        <a href="en\CodeSystem-v3-ActCode.xml.html">src</a>
)
      </li>
      <li>
 164.506 Uses and disclosures to carry out treatment, payment, or health care operations https://www.gpo.gov/fdsys/pkg/CFR-2017-title45-vol1/pdf/CFR-2017-title45-vol1-sec164-506.pdf, assign the HL7 Confidentiality code â€œRâ€? (restricted).&lt;/td&gt;&lt;td/&gt;&lt;td&gt;24100&lt;/td&gt;&lt;td&gt;active&lt;/td&gt;&lt;td/&gt;&lt;td/&gt;&lt;td/&gt;&lt;td&gt;_ActUSPrivacyConsentDirective&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td&gt;5&lt;/td&gt;&lt;td style=\"white-space:nowrap\"&gt;\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0CompoundResearchCD&lt;a name=\"v3-ActCode-CompoundResearchCD\"&gt; &lt;/a&gt;&lt;/td&gt;&lt;td&gt;Compound HIPAA Research Authorization and Informed Consent for Research&lt;/td&gt;&lt;td&gt;A code representing an individualâ€&trade;s consent directive that complies with HIPAA Privacy rule 45 CFR Section 164.508 Uses and disclosures for which an authorization is required https://www.gpo.gov/fdsys/pkg/CFR-2017-title45-vol1/pdf/CFR-2017-title45-vol1-sec164-508.pdf, which is a US Federal law stipulating the policy elements of a valid authorization under this Section specific to disclosures for purposes of research when combined with a Common Rule or Federal Drug Administration consent to participate in research also known as a compound authorization.\r\n\r\n*Usage Note:* The Agency for Healthcare Research and Quality (AHRQ) has developed the Informed Consent and Authorization Toolkit for Minimal Risk Research to facilitate the process of obtaining informed consent and Health Insurance Portability and Accountability Act (HIPAA) authorization from potential research subjects. This toolkit contains information for people responsible for ensuring that potential research subjects are informed in a manner that is consistent with medical ethics and regulatory guidelines. From https://www.ahrq.gov/sites/default/files/publications/files/ictoolkit.pdf.\r\n\r\nUsed to indicate the legal authority for assigning security labels to governed information. In this case, where collection, access, use, or disclosure of healthcare information is governed by an individualâ€&trade;s right of access directive under 45 CFR Section 164.508 use â€œCompoundResearchCDâ€? as the security label policy code.\r\n\r\nInformation or biospecimen disclosed under the Common Rule are not protected by the HIPAA Privacy Rule. If protected under other laws such as confidentiality provisions under the Common Rule, assign the HL7 Confidentiality code â€œMâ€? (moderate).\r\n\r\nSee ActCode.\\_ActPolicyType.\\_ActPrivacyPolicy.\\_ActPrivacyLaw.\\_ActUSPrivacyLaw.HIPAAAuth (HIPAA Authorization for Disclosure). See: HIPAAAuth and NIH Sample Authorization Language for Research Uses and Disclosures of Individually Identifiable Health Information by a Covered Health Care Provider https://privacyruleandresearch.nih.gov/authorization.asp&lt;/td&gt;&lt;td/&gt;&lt;td&gt;24105&lt;/td&gt;&lt;td&gt;active&lt;/td&gt;&lt;td/&gt;&lt;td/&gt;&lt;td/&gt;&lt;td&gt;_ActUSPrivacyConsentDirective&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td&gt;5&lt;/td&gt;&lt;td style=\"white-space:nowrap\"&gt;\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0HIPAAAuthCD&lt;a name=\"v3-ActCode-HIPAAAuthCD\"&gt; &lt;/a&gt;&lt;/td&gt;&lt;td&gt;HIPAA Authorization Consent Directive&lt;/td&gt;&lt;td&gt;A code representing an individualâ€&trade;s consent directive that complies with HIPAA Privacy rule 45 CFR Section 164.508 Uses and disclosures for which an authorization is required https://www.gpo.gov/fdsys/pkg/CFR-2017-title45-vol1/pdf/CFR-2017-title45-vol1-sec164-508.pdf, which is a US Federal law stipulating the policy elements of a valid authorization under this Section.\r\n\r\nAn â€œauthorizationâ€? is required by the Privacy Rule for uses and disclosures of protected health information not otherwise allowed by the Rule. Where the Privacy Rule requires patient authorization, voluntary consent is not sufficient to permit a use or disclosure of protected health information unless it also satisfies the requirements of a valid authorization. An authorization is a detailed document that gives covered entities permission to use protected health information for specified purposes, which are generally other than treatment, payment, or health care operations, or to disclose protected health information to a third party specified by the individual.\r\n\r\nAn authorization must specify a number of elements, including a description of the protected health information to be used and disclosed, the person authorized to make the use or disclosure, the person to whom the covered entity may make the disclosure, an expiration date, and, in some cases, the purpose for which the information may be used or disclosed. With limited exceptions, covered entities may not condition treatment or coverage on the individual providing an authorization. https://www.hhs.gov/hipaa/for-professionals/faq/264/what-is-the-difference-between-consent-and-authorization/index.html\r\n\r\nA HIPAA Authorization must comply with 45 CFR Section164.508(c) Implementation specifications: Core elements and requirements â€“ (1) Core elements. A valid authorization under this Section must contain at least the following elements: (i) A description of the information to be used or disclosed that identifies the information in a specific and meaningful fashion. (ii) The name or other specific identification of the person(s), or class of persons, authorized to make the requested use or disclosure. (iii) The name or other specific identification of the person(s), or class of persons, to whom the covered entity may make the requested use or disclosure. (iv) A description of each purpose of the requested use or disclosure. The statement â€œat the request of the individualâ€? is a sufficient description of the purpose when an individual initiates the authorization and does not, or elects not to, provide a statement of the purpose. (v) An expiration date or an expiration event that relates to the individual or the purpose of the use or disclosure. The statement â€œend of the research study,â€? â€œnone,â€? or similar language is sufficient if the authorization is for a use or disclosure of protected health information for research, including for the creation and maintenance of a research database or research repository. (vi) Signature of the individual and date. If the authorization is signed by a personal representative of the individual, a description of such representative's authority to act for the individual must also be provided. (2)Required statements. In addition to the core elements, the authorization must contain statements adequate to place the individual on notice of all of the following: (i) The individual's right to revoke the authorization in writing, and either: (A) The exceptions to the right to revoke and a description of how the individual may revoke the authorization; or (B) To the extent that the information in paragraph (c)(2)(i)(A) of this section is included in the notice required by Section 164.520, a reference to the covered entity's notice. https://www.gpo.gov/fdsys/pkg/CFR-2017-title45-vol1/pdf/CFR-2017-title45-vol1-sec164-508.pdf\r\n\r\n*Usage Note:* Used to indicate the legal authority for assigning security labels to HIPAA governed information. In this case, where collection, access, use, or disclosure of healthcare information is governed by a an individualâ€&trade;s HIPAA Authorization for Disclosure, use â€œHIPAAAuthCDâ€? as the security label policy code.\r\n\r\nInformation governed under a HIPAA Authorization for Disclosure has the level of confidentiality protection afforded under the 45 CFR Section 164.506 - Uses and disclosures to carry out treatment, payment, or health care operations https://www.gpo.gov/fdsys/pkg/CFR-2017-title45-vol1/pdf/CFR-2017-title45-vol1-sec164-506.pdf, which is considered the â€œnormâ€?, assign the HL7 Confidentiality code â€œNâ€? (normal).&lt;/td&gt;&lt;td/&gt;&lt;td&gt;24101&lt;/td&gt;&lt;td&gt;active&lt;/td&gt;&lt;td/&gt;&lt;td/&gt;&lt;td/&gt;&lt;td&gt;_ActUSPrivacyConsentDirective&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td&gt;5&lt;/td&gt;&lt;td style=\"white-space:nowrap\"&gt;\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0HIPAAConsentCD&lt;a name=\"v3-ActCode-HIPAAConsentCD\"&gt; &lt;/a&gt;&lt;/td&gt;&lt;td&gt;HIPAA Consent Directive&lt;/td&gt;&lt;td&gt;A code representing U.S. Public Law 104-191 Health Insurance Portability and Accountability Act (HIPAA) Privacy Rule 45 CFR Section 164.522 Rights to request privacy protection for protected health information https://www.gpo.gov/fdsys/pkg/CFR-2017-title45-vol1/pdf/CFR-2017-title45-vol1-sec164-522.pdf, which stipulates the process by which a covered entity seeks agreement from an individual regarding how it will use and disclose the individual's protected health information for treatment, payment, and health care operations is termed a &amp;quot;consent.&amp;quot;\r\n\r\n*Usage Note:* Used to indicate the legal authority for assigning security labels to governed information. In this case, where collection, access, use, or disclosure of healthcare information is governed by an individualâ€&trade;s consent directive under 45 CFR Section 164.522 use â€œHIPAAConsentCDâ€? as the security label policy code.\r\n\r\nSince information governed by a 45 CFR Section 164.522 has a level of confidentiality protection that is more stringent than the normal level of protection under HIPAA 45 CFR Section 164.506 Uses and disclosures to carry out treatment, payment, or health care operations https://www.gpo.gov/fdsys/pkg/CFR-2017-title45-vol1/pdf/CFR-2017-title45-vol1-sec164-506.pdf, assign the HL7 Confidentiality code â€œRâ€? (restricted).&lt;/td&gt;&lt;td/&gt;&lt;td&gt;24102&lt;/td&gt;&lt;td&gt;active&lt;/td&gt;&lt;td/&gt;&lt;td/&gt;&lt;td/&gt;&lt;td&gt;_ActUSPrivacyConsentDirective&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td&gt;5&lt;/td&gt;&lt;td style=\"white-space:nowrap\"&gt;\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0HIPAAResearchAuthCD&lt;a name=\"v3-ActCode-HIPAAResearchAuthCD\"&gt; &lt;/a&gt;&lt;/td&gt;&lt;td&gt;HIPAA Authorization for Disclosure for Research Consent Directive&lt;/td&gt;&lt;td&gt;A code representing an individualâ€&trade;s consent directive that complies with HIPAA Privacy rule 45 CFR Section 164.508 Uses and disclosures for which an authorization is required https://www.gpo.gov/fdsys/pkg/CFR-2017-title45-vol1/pdf/CFR-2017-title45-vol1-sec164-508.pdf, which is a US Federal law stipulating the policy elements of a valid authorization under this Section specific to disclosures for purposes of research.\r\n\r\n*Usage Note:* Used to indicate the legal authority for assigning security labels to governed information. In this case, where collection, access, use, or disclosure of healthcare information is governed by an individualâ€&trade;s HIPAA Authorization for Disclosure for Research under 45 CFR Section 164.508 use â€œHIPAAResearchAuthCDâ€? as the security label policy code.\r\n\r\nInformation disclosed under an individualâ€&trade;s HIPAA Authorization for Disclosure for Research are not protected by the HIPAA Privacy Rule. If protected under other laws such as confidentiality provisions under the Common Rule, assign the HL7 Confidentiality code â€œMâ€? (moderate).\r\n\r\nSee ActCode.\\_ActPolicyType.\\_ActPrivacyPolicy.\\_ActPrivacyLaw.\\_ActUSPrivacyLaw.HIPAAAuth (HIPAA Authorization for Disclosure). See: HIPAAAuth and NIH Sample Authorization Language for Research Uses and Disclosures of Individually Identifiable Health Information by a Covered Health Care Provider https://privacyruleandresearch.nih.gov/authorization.asp&lt;/td&gt;&lt;td/&gt;&lt;td&gt;24104&lt;/td&gt;&lt;td&gt;active&lt;/td&gt;&lt;td/&gt;&lt;td/&gt;&lt;td/&gt;&lt;td&gt;_ActUSPrivacyConsentDirective&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td&gt;5&lt;/td&gt;&lt;td style=\"white-space:nowrap\"&gt;\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0HIPAAROAD&lt;a name=\"v3-ActCode-HIPAAROAD\"&gt; &lt;/a&gt;&lt;/td&gt;&lt;td&gt;HIPAA Right of Access Directive&lt;/td&gt;&lt;td&gt;A code representing U.S. Public Law 104-191 Health Insurance Portability and Accountability Act (HIPAA) Privacy Rule 45 CFR Section 164.524 Access of individuals to protected health information https://www.gpo.gov/fdsys/pkg/CFR-2017-title45-vol1/pdf/CFR-2017-title45-vol1-sec164-524.pdf, stipulating the policy elements of an individualâ€&trade;s written and signed right of access directive requesting that a covered entity send the individualâ€&trade;s protected health information (PHI) to a third party.\r\n\r\nSee 45 CFR 164.524(c)(3)(ii) If an individual's request for access directs the covered entity to transmit the copy of protected health information directly to another person designated by the individual, the covered entity must provide the copy to the person designated by the individual. The individual's request must be in writing, signed by the individual, and clearly identify the designated person and where to send the copy of protected health information. https://www.gpo.gov/fdsys/pkg/CFR-2017-title45-vol1/pdf/CFR-2017-title45-vol1-sec164-524.pdf\r\n\r\nThis right applies to PHI in a designated record set, which is defined as â€œDesignated record set means: (1) A group of records maintained by or for a covered entity that is: (i) The medical records and billing records about individuals maintained by or for a covered health care provider; (ii) The enrollment, payment, claims adjudication, and case or medical management record systems maintained by or for a health plan; or (iii) Used, in whole or in part, by or for the covered entity to make decisions about individuals. \\[https://www.law.cornell.edu/cfr/text/45/164.501\\]. Also see HHS Individualsâ€&trade; Right under HIPAA to Access their Health Information 45 CFR Section 164.524 \\[https://www.hhs.gov/hipaa/for-professionals/privacy/guidance/access/index.html\\#maximumflatfee\\].\r\n\r\n*Usage Note:* Used to indicate the legal authority for assigning security labels to governed information. In this case, where collection, access, use, or disclosure of healthcare information is governed by an individualâ€&trade;s right of access directive under 45 CFR Section 164.524 use â€œHIPAAROADâ€? as the security label policy code.\r\n\r\nInformation disclosed under a HIPAA 42 CFR Section 164.524 no longer has the level of confidentiality protection afforded under the 45 CFR Section 164.506 - Uses and disclosures to carry out treatment, payment, or health care operations https://www.gpo.gov/fdsys/pkg/CFR-2017-title45-vol1/pdf/CFR-2017-title45-vol1-sec164-508.pdf, which is considered the â€œnormâ€?, assign the HL7 Confidentiality code â€œMâ€? (moderate), which may be protected under other laws such as the Federal Trade Commission privacy and security regulations.&lt;/td&gt;&lt;td/&gt;&lt;td&gt;24103&lt;/td&gt;&lt;td&gt;active&lt;/td&gt;&lt;td/&gt;&lt;td/&gt;&lt;td/&gt;&lt;td&gt;_ActUSPrivacyConsentDirective&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td&gt;5&lt;/td&gt;&lt;td style=\"white-space:nowrap\"&gt;\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0MDHHS-5515&lt;a name=\"v3-ActCode-MDHHS-5515\"&gt; &lt;/a&gt;&lt;/td&gt;&lt;td&gt;Michigan Consent to Share Behavioral Health Information for Care Coordination Purposes&lt;/td&gt;&lt;td&gt;The State of Michigan standard privacy consent form for sharing of health information specific to behavioral health and substance use treatment in accordance with Public Act 129 of 2014. In Michigan, while providers are not required to use this new standard form (MDHHS-5515), they are required to accept it.\r\n\r\n*Usage Note:* For legislative background, current MDHHS-5515 consent directive form, and provider and patient FAQs see http://www.michigan.gov/mdhhs/0,5885,7-339-71550\\_2941\\_58005-343686--,00.html&lt;/td&gt;&lt;td/&gt;&lt;td&gt;24106&lt;/td&gt;&lt;td&gt;active&lt;/td&gt;&lt;td/&gt;&lt;td/&gt;&lt;td/&gt;&lt;td&gt;_ActUSPrivacyConsentDirective&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td&gt;6&lt;/td&gt;&lt;td style=\"white-space:nowrap\"&gt;\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0MDHHS-5515MMHC&lt;a name=\"v3-ActCode-MDHHS-5515MMHC\"&gt; &lt;/a&gt;&lt;/td&gt;&lt;td&gt;Michigan Consent to Share Behavioral Health Information for Care Coordination Purposes-Michigan Mental Health Code&lt;/td&gt;&lt;td&gt;The State of Michigan standard privacy consent form for sharing of health information specific to behavioral health governed by the Michigan Mental Health Code Act 258 of 1974, which require patient authorization for purposes other than treatment, payment, and coordination of care, in accordance with Public Act 129 of 2014.\r\n\r\n*Usage Note:* For legislative background, current MDHHS-5515 consent directive form, and provider and patient FAQs see http://www.michigan.gov/mdhhs/0,5885,7-339-71550\\_2941\\_58005-343686--,00.html&lt;/td&gt;&lt;td/&gt;&lt;td&gt;24134&lt;/td&gt;&lt;td&gt;active&lt;/td&gt;&lt;td/&gt;&lt;td/&gt;&lt;td/&gt;&lt;td&gt;MDHHS-5515&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td&gt;6&lt;/td&gt;&lt;td style=\"white-space:nowrap\"&gt;\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0MDHHS-5515Part2&lt;a name=\"v3-ActCode-MDHHS-5515Part2\"&gt; &lt;/a&gt;&lt;/td&gt;&lt;td&gt;Michigan Consent to Share Behavioral Health Information for Care Coordination Purposes-US 42 CFR Part 2&lt;/td&gt;&lt;td&gt;The State of Michigan standard privacy consent form for sharing of health information specific to substance use information governed under US 42 CFR Part 2 in accordance with Public Act 129 of 2014.\r\n\r\n*Usage Note:* For legislative background, current MDHHS-5515 consent directive form, and provider and patient FAQs see http://www.michigan.gov/mdhhs/0,5885,7-339-71550\\_2941\\_58005-343686--,00.html&lt;/td&gt;&lt;td/&gt;&lt;td&gt;24133&lt;/td&gt;&lt;td&gt;active&lt;/td&gt;&lt;td/&gt;&lt;td/&gt;&lt;td/&gt;&lt;td&gt;MDHHS-5515&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td&gt;5&lt;/td&gt;&lt;td style=\"white-space:nowrap\"&gt;\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0USResearchInformedAssent&lt;a name=\"v3-ActCode-USResearchInformedAssent\"&gt; &lt;/a&gt;&lt;/td&gt;&lt;td&gt;Informed Assent for Research&lt;/td&gt;&lt;td&gt;An informed assertion by a minor who is a candidate research subject, of the individual's willingness to participate in research. Assent means a child's affirmative agreement to participate in a clinical investigation. Mere failure to object should not, absent affirmative agreement, be construed as assent. The minor's assent must be accompanied by parental or guardian consent that the minor participate in a specified research. The assent is not legally binding, however, the accompanying consent is legally binding. Background: In the US, informed assent is governed under 21 CFR Part 50, Subpart D - Additional Safeguards for Children in Clinical Investigations. Available at https://www.law.cornell.edu/cfr/text/21/part-50/subpart-D&lt;/td&gt;&lt;td/&gt;&lt;td&gt;25100&lt;/td&gt;&lt;td&gt;active&lt;/td&gt;&lt;td/&gt;&lt;td/&gt;&lt;td/&gt;&lt;td&gt;_ActUSPrivacyConsentDirective&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td&gt;5&lt;/td&gt;&lt;td style=\"white-space:nowrap\"&gt;\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0USResearchInformedConsent&lt;a name=\"v3-ActCode-USResearchInformedConsent\"&gt; &lt;/a&gt;&lt;/td&gt;&lt;td&gt;Informed Consent for Research&lt;/td&gt;&lt;td&gt;An informed assertion by an adult, or the parent/guardian of a minor who is a candidate research subject, of the individual's willingness to participate in a specified research study. The consent is legally binding. Background: In the US, informed assent is governed under 49 CFR  (        <a href="en\CodeSystem-v3-ActCode.json.html">src</a>
)
      </li>
      <li>
 164.506 Uses and disclosures to carry out treatment, payment, or health care operations https://www.gpo.gov/fdsys/pkg/CFR-2017-title45-vol1/pdf/CFR-2017-title45-vol1-sec164-506.pdf, assign the HL7 Confidentiality code â€œRâ€? (restricted).&lt;/td&gt;&lt;td/&gt;&lt;td&gt;24100&lt;/td&gt;&lt;td&gt;active&lt;/td&gt;&lt;td/&gt;&lt;td/&gt;&lt;td/&gt;&lt;td&gt;_ActUSPrivacyConsentDirective&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td&gt;5&lt;/td&gt;&lt;td style=\"white-space:nowrap\"&gt;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;CompoundResearchCD&lt;a name=\"v3-ActCode-CompoundResearchCD\"&gt; &lt;/a&gt;&lt;/td&gt;&lt;td&gt;Compound HIPAA Research Authorization and Informed Consent for Research&lt;/td&gt;&lt;td&gt;A code representing an individualâ€&trade;s consent directive that complies with HIPAA Privacy rule 45 CFR Section 164.508 Uses and disclosures for which an authorization is required https://www.gpo.gov/fdsys/pkg/CFR-2017-title45-vol1/pdf/CFR-2017-title45-vol1-sec164-508.pdf, which is a US Federal law stipulating the policy elements of a valid authorization under this Section specific to disclosures for purposes of research when combined with a Common Rule or Federal Drug Administration consent to participate in research also known as a compound authorization.#xD;\n#xD;\n*Usage Note:* The Agency for Healthcare Research and Quality (AHRQ) has developed the Informed Consent and Authorization Toolkit for Minimal Risk Research to facilitate the process of obtaining informed consent and Health Insurance Portability and Accountability Act (HIPAA) authorization from potential research subjects. This toolkit contains information for people responsible for ensuring that potential research subjects are informed in a manner that is consistent with medical ethics and regulatory guidelines. From https://www.ahrq.gov/sites/default/files/publications/files/ictoolkit.pdf.#xD;\n#xD;\nUsed to indicate the legal authority for assigning security labels to governed information. In this case, where collection, access, use, or disclosure of healthcare information is governed by an individualâ€&trade;s right of access directive under 45 CFR Section 164.508 use â€œCompoundResearchCDâ€? as the security label policy code.#xD;\n#xD;\nInformation or biospecimen disclosed under the Common Rule are not protected by the HIPAA Privacy Rule. If protected under other laws such as confidentiality provisions under the Common Rule, assign the HL7 Confidentiality code â€œMâ€? (moderate).#xD;\n#xD;\nSee ActCode.\\_ActPolicyType.\\_ActPrivacyPolicy.\\_ActPrivacyLaw.\\_ActUSPrivacyLaw.HIPAAAuth (HIPAA Authorization for Disclosure). See: HIPAAAuth and NIH Sample Authorization Language for Research Uses and Disclosures of Individually Identifiable Health Information by a Covered Health Care Provider https://privacyruleandresearch.nih.gov/authorization.asp&lt;/td&gt;&lt;td/&gt;&lt;td&gt;24105&lt;/td&gt;&lt;td&gt;active&lt;/td&gt;&lt;td/&gt;&lt;td/&gt;&lt;td/&gt;&lt;td&gt;_ActUSPrivacyConsentDirective&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td&gt;5&lt;/td&gt;&lt;td style=\"white-space:nowrap\"&gt;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;HIPAAAuthCD&lt;a name=\"v3-ActCode-HIPAAAuthCD\"&gt; &lt;/a&gt;&lt;/td&gt;&lt;td&gt;HIPAA Authorization Consent Directive&lt;/td&gt;&lt;td&gt;A code representing an individualâ€&trade;s consent directive that complies with HIPAA Privacy rule 45 CFR Section 164.508 Uses and disclosures for which an authorization is required https://www.gpo.gov/fdsys/pkg/CFR-2017-title45-vol1/pdf/CFR-2017-title45-vol1-sec164-508.pdf, which is a US Federal law stipulating the policy elements of a valid authorization under this Section.#xD;\n#xD;\nAn â€œauthorizationâ€? is required by the Privacy Rule for uses and disclosures of protected health information not otherwise allowed by the Rule. Where the Privacy Rule requires patient authorization, voluntary consent is not sufficient to permit a use or disclosure of protected health information unless it also satisfies the requirements of a valid authorization. An authorization is a detailed document that gives covered entities permission to use protected health information for specified purposes, which are generally other than treatment, payment, or health care operations, or to disclose protected health information to a third party specified by the individual.#xD;\n#xD;\nAn authorization must specify a number of elements, including a description of the protected health information to be used and disclosed, the person authorized to make the use or disclosure, the person to whom the covered entity may make the disclosure, an expiration date, and, in some cases, the purpose for which the information may be used or disclosed. With limited exceptions, covered entities may not condition treatment or coverage on the individual providing an authorization. https://www.hhs.gov/hipaa/for-professionals/faq/264/what-is-the-difference-between-consent-and-authorization/index.html#xD;\n#xD;\nA HIPAA Authorization must comply with 45 CFR Section164.508(c) Implementation specifications: Core elements and requirements â€“ (1) Core elements. A valid authorization under this Section must contain at least the following elements: (i) A description of the information to be used or disclosed that identifies the information in a specific and meaningful fashion. (ii) The name or other specific identification of the person(s), or class of persons, authorized to make the requested use or disclosure. (iii) The name or other specific identification of the person(s), or class of persons, to whom the covered entity may make the requested use or disclosure. (iv) A description of each purpose of the requested use or disclosure. The statement â€œat the request of the individualâ€? is a sufficient description of the purpose when an individual initiates the authorization and does not, or elects not to, provide a statement of the purpose. (v) An expiration date or an expiration event that relates to the individual or the purpose of the use or disclosure. The statement â€œend of the research study,â€? â€œnone,â€? or similar language is sufficient if the authorization is for a use or disclosure of protected health information for research, including for the creation and maintenance of a research database or research repository. (vi) Signature of the individual and date. If the authorization is signed by a personal representative of the individual, a description of such representative's authority to act for the individual must also be provided. (2)Required statements. In addition to the core elements, the authorization must contain statements adequate to place the individual on notice of all of the following: (i) The individual's right to revoke the authorization in writing, and either: (A) The exceptions to the right to revoke and a description of how the individual may revoke the authorization; or (B) To the extent that the information in paragraph (c)(2)(i)(A) of this section is included in the notice required by Section 164.520, a reference to the covered entity's notice. https://www.gpo.gov/fdsys/pkg/CFR-2017-title45-vol1/pdf/CFR-2017-title45-vol1-sec164-508.pdf#xD;\n#xD;\n*Usage Note:* Used to indicate the legal authority for assigning security labels to HIPAA governed information. In this case, where collection, access, use, or disclosure of healthcare information is governed by a an individualâ€&trade;s HIPAA Authorization for Disclosure, use â€œHIPAAAuthCDâ€? as the security label policy code.#xD;\n#xD;\nInformation governed under a HIPAA Authorization for Disclosure has the level of confidentiality protection afforded under the 45 CFR Section 164.506 - Uses and disclosures to carry out treatment, payment, or health care operations https://www.gpo.gov/fdsys/pkg/CFR-2017-title45-vol1/pdf/CFR-2017-title45-vol1-sec164-506.pdf, which is considered the â€œnormâ€?, assign the HL7 Confidentiality code â€œNâ€? (normal).&lt;/td&gt;&lt;td/&gt;&lt;td&gt;24101&lt;/td&gt;&lt;td&gt;active&lt;/td&gt;&lt;td/&gt;&lt;td/&gt;&lt;td/&gt;&lt;td&gt;_ActUSPrivacyConsentDirective&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td&gt;5&lt;/td&gt;&lt;td style=\"white-space:nowrap\"&gt;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;HIPAAConsentCD&lt;a name=\"v3-ActCode-HIPAAConsentCD\"&gt; &lt;/a&gt;&lt;/td&gt;&lt;td&gt;HIPAA Consent Directive&lt;/td&gt;&lt;td&gt;A code representing U.S. Public Law 104-191 Health Insurance Portability and Accountability Act (HIPAA) Privacy Rule 45 CFR Section 164.522 Rights to request privacy protection for protected health information https://www.gpo.gov/fdsys/pkg/CFR-2017-title45-vol1/pdf/CFR-2017-title45-vol1-sec164-522.pdf, which stipulates the process by which a covered entity seeks agreement from an individual regarding how it will use and disclose the individual's protected health information for treatment, payment, and health care operations is termed a \"consent.\"#xD;\n#xD;\n*Usage Note:* Used to indicate the legal authority for assigning security labels to governed information. In this case, where collection, access, use, or disclosure of healthcare information is governed by an individualâ€&trade;s consent directive under 45 CFR Section 164.522 use â€œHIPAAConsentCDâ€? as the security label policy code.#xD;\n#xD;\nSince information governed by a 45 CFR Section 164.522 has a level of confidentiality protection that is more stringent than the normal level of protection under HIPAA 45 CFR Section 164.506 Uses and disclosures to carry out treatment, payment, or health care operations https://www.gpo.gov/fdsys/pkg/CFR-2017-title45-vol1/pdf/CFR-2017-title45-vol1-sec164-506.pdf, assign the HL7 Confidentiality code â€œRâ€? (restricted).&lt;/td&gt;&lt;td/&gt;&lt;td&gt;24102&lt;/td&gt;&lt;td&gt;active&lt;/td&gt;&lt;td/&gt;&lt;td/&gt;&lt;td/&gt;&lt;td&gt;_ActUSPrivacyConsentDirective&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td&gt;5&lt;/td&gt;&lt;td style=\"white-space:nowrap\"&gt;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;HIPAAResearchAuthCD&lt;a name=\"v3-ActCode-HIPAAResearchAuthCD\"&gt; &lt;/a&gt;&lt;/td&gt;&lt;td&gt;HIPAA Authorization for Disclosure for Research Consent Directive&lt;/td&gt;&lt;td&gt;A code representing an individualâ€&trade;s consent directive that complies with HIPAA Privacy rule 45 CFR Section 164.508 Uses and disclosures for which an authorization is required https://www.gpo.gov/fdsys/pkg/CFR-2017-title45-vol1/pdf/CFR-2017-title45-vol1-sec164-508.pdf, which is a US Federal law stipulating the policy elements of a valid authorization under this Section specific to disclosures for purposes of research.#xD;\n#xD;\n*Usage Note:* Used to indicate the legal authority for assigning security labels to governed information. In this case, where collection, access, use, or disclosure of healthcare information is governed by an individualâ€&trade;s HIPAA Authorization for Disclosure for Research under 45 CFR Section 164.508 use â€œHIPAAResearchAuthCDâ€? as the security label policy code.#xD;\n#xD;\nInformation disclosed under an individualâ€&trade;s HIPAA Authorization for Disclosure for Research are not protected by the HIPAA Privacy Rule. If protected under other laws such as confidentiality provisions under the Common Rule, assign the HL7 Confidentiality code â€œMâ€? (moderate).#xD;\n#xD;\nSee ActCode.\\_ActPolicyType.\\_ActPrivacyPolicy.\\_ActPrivacyLaw.\\_ActUSPrivacyLaw.HIPAAAuth (HIPAA Authorization for Disclosure). See: HIPAAAuth and NIH Sample Authorization Language for Research Uses and Disclosures of Individually Identifiable Health Information by a Covered Health Care Provider https://privacyruleandresearch.nih.gov/authorization.asp&lt;/td&gt;&lt;td/&gt;&lt;td&gt;24104&lt;/td&gt;&lt;td&gt;active&lt;/td&gt;&lt;td/&gt;&lt;td/&gt;&lt;td/&gt;&lt;td&gt;_ActUSPrivacyConsentDirective&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td&gt;5&lt;/td&gt;&lt;td style=\"white-space:nowrap\"&gt;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;HIPAAROAD&lt;a name=\"v3-ActCode-HIPAAROAD\"&gt; &lt;/a&gt;&lt;/td&gt;&lt;td&gt;HIPAA Right of Access Directive&lt;/td&gt;&lt;td&gt;A code representing U.S. Public Law 104-191 Health Insurance Portability and Accountability Act (HIPAA) Privacy Rule 45 CFR Section 164.524 Access of individuals to protected health information https://www.gpo.gov/fdsys/pkg/CFR-2017-title45-vol1/pdf/CFR-2017-title45-vol1-sec164-524.pdf, stipulating the policy elements of an individualâ€&trade;s written and signed right of access directive requesting that a covered entity send the individualâ€&trade;s protected health information (PHI) to a third party.#xD;\n#xD;\nSee 45 CFR 164.524(c)(3)(ii) If an individual's request for access directs the covered entity to transmit the copy of protected health information directly to another person designated by the individual, the covered entity must provide the copy to the person designated by the individual. The individual's request must be in writing, signed by the individual, and clearly identify the designated person and where to send the copy of protected health information. https://www.gpo.gov/fdsys/pkg/CFR-2017-title45-vol1/pdf/CFR-2017-title45-vol1-sec164-524.pdf#xD;\n#xD;\nThis right applies to PHI in a designated record set, which is defined as â€œDesignated record set means: (1) A group of records maintained by or for a covered entity that is: (i) The medical records and billing records about individuals maintained by or for a covered health care provider; (ii) The enrollment, payment, claims adjudication, and case or medical management record systems maintained by or for a health plan; or (iii) Used, in whole or in part, by or for the covered entity to make decisions about individuals. \\[https://www.law.cornell.edu/cfr/text/45/164.501\\]. Also see HHS Individualsâ€&trade; Right under HIPAA to Access their Health Information 45 CFR Section 164.524 \\[https://www.hhs.gov/hipaa/for-professionals/privacy/guidance/access/index.html\\#maximumflatfee\\].#xD;\n#xD;\n*Usage Note:* Used to indicate the legal authority for assigning security labels to governed information. In this case, where collection, access, use, or disclosure of healthcare information is governed by an individualâ€&trade;s right of access directive under 45 CFR Section 164.524 use â€œHIPAAROADâ€? as the security label policy code.#xD;\n#xD;\nInformation disclosed under a HIPAA 42 CFR Section 164.524 no longer has the level of confidentiality protection afforded under the 45 CFR Section 164.506 - Uses and disclosures to carry out treatment, payment, or health care operations https://www.gpo.gov/fdsys/pkg/CFR-2017-title45-vol1/pdf/CFR-2017-title45-vol1-sec164-508.pdf, which is considered the â€œnormâ€?, assign the HL7 Confidentiality code â€œMâ€? (moderate), which may be protected under other laws such as the Federal Trade Commission privacy and security regulations.&lt;/td&gt;&lt;td/&gt;&lt;td&gt;24103&lt;/td&gt;&lt;td&gt;active&lt;/td&gt;&lt;td/&gt;&lt;td/&gt;&lt;td/&gt;&lt;td&gt;_ActUSPrivacyConsentDirective&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td&gt;5&lt;/td&gt;&lt;td style=\"white-space:nowrap\"&gt;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;MDHHS-5515&lt;a name=\"v3-ActCode-MDHHS-5515\"&gt; &lt;/a&gt;&lt;/td&gt;&lt;td&gt;Michigan Consent to Share Behavioral Health Information for Care Coordination Purposes&lt;/td&gt;&lt;td&gt;The State of Michigan standard privacy consent form for sharing of health information specific to behavioral health and substance use treatment in accordance with Public Act 129 of 2014. In Michigan, while providers are not required to use this new standard form (MDHHS-5515), they are required to accept it.#xD;\n#xD;\n*Usage Note:* For legislative background, current MDHHS-5515 consent directive form, and provider and patient FAQs see http://www.michigan.gov/mdhhs/0,5885,7-339-71550\\_2941\\_58005-343686--,00.html&lt;/td&gt;&lt;td/&gt;&lt;td&gt;24106&lt;/td&gt;&lt;td&gt;active&lt;/td&gt;&lt;td/&gt;&lt;td/&gt;&lt;td/&gt;&lt;td&gt;_ActUSPrivacyConsentDirective&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td&gt;6&lt;/td&gt;&lt;td style=\"white-space:nowrap\"&gt;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;MDHHS-5515MMHC&lt;a name=\"v3-ActCode-MDHHS-5515MMHC\"&gt; &lt;/a&gt;&lt;/td&gt;&lt;td&gt;Michigan Consent to Share Behavioral Health Information for Care Coordination Purposes-Michigan Mental Health Code&lt;/td&gt;&lt;td&gt;The State of Michigan standard privacy consent form for sharing of health information specific to behavioral health governed by the Michigan Mental Health Code Act 258 of 1974, which require patient authorization for purposes other than treatment, payment, and coordination of care, in accordance with Public Act 129 of 2014.#xD;\n#xD;\n*Usage Note:* For legislative background, current MDHHS-5515 consent directive form, and provider and patient FAQs see http://www.michigan.gov/mdhhs/0,5885,7-339-71550\\_2941\\_58005-343686--,00.html&lt;/td&gt;&lt;td/&gt;&lt;td&gt;24134&lt;/td&gt;&lt;td&gt;active&lt;/td&gt;&lt;td/&gt;&lt;td/&gt;&lt;td/&gt;&lt;td&gt;MDHHS-5515&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td&gt;6&lt;/td&gt;&lt;td style=\"white-space:nowrap\"&gt;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;MDHHS-5515Part2&lt;a name=\"v3-ActCode-MDHHS-5515Part2\"&gt; &lt;/a&gt;&lt;/td&gt;&lt;td&gt;Michigan Consent to Share Behavioral Health Information for Care Coordination Purposes-US 42 CFR Part 2&lt;/td&gt;&lt;td&gt;The State of Michigan standard privacy consent form for sharing of health information specific to substance use information governed under US 42 CFR Part 2 in accordance with Public Act 129 of 2014.#xD;\n#xD;\n*Usage Note:* For legislative background, current MDHHS-5515 consent directive form, and provider and patient FAQs see http://www.michigan.gov/mdhhs/0,5885,7-339-71550\\_2941\\_58005-343686--,00.html&lt;/td&gt;&lt;td/&gt;&lt;td&gt;24133&lt;/td&gt;&lt;td&gt;active&lt;/td&gt;&lt;td/&gt;&lt;td/&gt;&lt;td/&gt;&lt;td&gt;MDHHS-5515&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td&gt;5&lt;/td&gt;&lt;td style=\"white-space:nowrap\"&gt;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;USResearchInformedAssent&lt;a name=\"v3-ActCode-USResearchInformedAssent\"&gt; &lt;/a&gt;&lt;/td&gt;&lt;td&gt;Informed Assent for Research&lt;/td&gt;&lt;td&gt;An informed assertion by a minor who is a candidate research subject, of the individual's willingness to participate in research. Assent means a child's affirmative agreement to participate in a clinical investigation. Mere failure to object should not, absent affirmative agreement, be construed as assent. The minor's assent must be accompanied by parental or guardian consent that the minor participate in a specified research. The assent is not legally binding, however, the accompanying consent is legally binding. Background: In the US, informed assent is governed under 21 CFR Part 50, Subpart D - Additional Safeguards for Children in Clinical Investigations. Available at https://www.law.cornell.edu/cfr/text/21/part-50/subpart-D&lt;/td&gt;&lt;td/&gt;&lt;td&gt;25100&lt;/td&gt;&lt;td&gt;active&lt;/td&gt;&lt;td/&gt;&lt;td/&gt;&lt;td/&gt;&lt;td&gt;_ActUSPrivacyConsentDirective&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td&gt;5&lt;/td&gt;&lt;td style=\"white-space:nowrap\"&gt;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;USResearchInformedConsent&lt;a name=\"v3-ActCode-USResearchInformedConsent\"&gt; &lt;/a&gt;&lt;/td&gt;&lt;td&gt;Informed Consent for Research&lt;/td&gt;&lt;td&gt;An informed assertion by an adult, or the parent/guardian of a minor who is a candidate research subject, of the individual's willingness to participate in a specified research study. The consent is legally binding. Background: In the US, informed assent is governed under 49 CFR  (        <a href="en\CodeSystem-v3-ActCode.ttl.html">src</a>
)
      </li>
      <li>
A HIPAA Authorization must comply with 45 CFR Section164.508(c) Implementation specifications: Core elements and requirements â€“ (1) Core elements. A valid authorization under this Section must contain at least the following elements: (i) A description of the information to be used or disclosed that identifies the information in a specific and meaningful fashion. (ii) The name or other specific identification of the person(s), or class of persons, authorized to make the requested use or disclosure. (iii) The name or other specific identification of the person(s), or class of persons, to whom the covered entity may make the requested use or disclosure. (iv) A description of each purpose of the requested use or disclosure. The statement â€œat the request of the individualâ€? is a sufficient description of the purpose when an individual initiates the authorization and does not, or elects not to, provide a statement of the purpose. (v) An expiration date or an expiration event that relates to the individual or the purpose of the use or disclosure. The statement â€œend of the research study,â€? â€œnone,â€? or similar language is sufficient if the authorization is for a use or disclosure of protected health information for research, including for the creation and maintenance of a research database or research repository. (vi) Signature of the individual and date. If the authorization is signed by a personal representative of the individual, a description of such representative's authority to act for the individual must also be provided. (2)Required statements. In addition to the core elements, the authorization must contain statements adequate to place the individual on notice of all of the following: (i) The individual's right to revoke the authorization in writing, and either: (A) The exceptions to the right to revoke and a description of how the individual may revoke the authorization; or (B) To the extent that the information in paragraph (c)(2)(i)(A) of this section is included in the notice required by Section 164.520, a reference to the covered entity's notice. https://www.gpo.gov/fdsys/pkg/CFR-2017-title45-vol1/pdf/CFR-2017-title45-vol1-sec164-508.pdf (        <a href="en\CodeSystem-v3-ActCode.html">src</a>
)
      </li>
      <li>
A copyright statement relating to the test plan and/or its contents. Copyright statements are generally legal restrictions on the use and publishing of the test plan. The short copyright declaration (e.g. (c) '2015+ xyz organization' should be sent in the copyrightLabel element. (        <a href="en\StructureDefinition-ext-R5-TestPlan-definitions.html">src</a>
)
      </li>
      <li>
Code of Federal Regulation 21CFR&sect;1271.290(c) (        <a href="en\StructureDefinition-profile-DeviceAssociation-for-Device-definitions.html">src</a>
)
      </li>
      <li>
Confidentiality code total order hierarchy: Restricted (R) is less protective than V, and subsumes all other protection levels (i.e., N, M, L, and U). (        <a href="en\CodeSystem-v3-Confidentiality.html">src</a>
)
      </li>
      <li>
Copyright/Legal: Copyright &copy; 2012-2013 National E-Health Transition Authority Ltd : This document contains information which is protected by copyright. All Rights Reserved. No part of this work may be reproduced or used in any form or by any means–graphic, electronic, or mechanical, including photocopying,  recording, taping, or information storage and retrieval systems–without the permission of NEHTA. All copies of this  document must include the copyright and other information contained on this page.  Revision 1  Telephone: 1300 901 001 or email: servicedesk@nehta.gov.au  Disclaimer: The National E-Health Transition Authority Ltd (NEHTA) makes the information and other material ('Information') in  this document available in good faith but without any representation or warranty as to its accuracy or completeness.  NEHTA cannot accept any responsibility for the consequences of any use of the Information. As the Information is of a  general nature only, it is up to any person using or relying on the Information to ensure that it is accurate, complete  and suitable for the circumstances of its use. (        <a href="en\CodeSystem-list-item-flag.html">src</a>
)
      </li>
      <li>
Copyright/Legal: Copyright &copy;2022 World Wide Web Consortium. All Rights Reserved. This work is distributed under the W3C&reg; Software and Document License in the hope that it will be useful, but WITHOUT ANY WARRANTY; without even the implied warranty of MERCHANTABILITY or FITNESS FOR A PARTICULAR PURPOSE. (        <a href="en\CodeSystem-color-rgb.html">src</a>
)
      </li>
      <li>
Copyright/Legal: These codes are excerpted from Digital Imaging and Communications in Medicine (DICOM) Standard, Part 16: Content Mapping Resource, Copyright &copy; 2011 by the National Electrical Manufacturers Association. (        <a href="en\CodeSystem-audit-event-type.html">src</a>
)
      </li>
      <li>
Discussion: Part is defined in opposition to (a) ingredient (not separable), (b) content (not a functional component), and (c) member (not functionally distinct from other members). (        <a href="en\CodeSystem-v3-RoleClass.html">src</a>
)
      </li>
      <li>
FHIR Cross-Version Extensions package to use FHIR R5 in FHIR R4 - Local Development build (v0.0.1-snapshot-3) built by the FHIR (HL7&reg; FHIR&reg; Standard) Build Tools. See the Directory of published versions (        <a href="toc.html">src</a>
)
      </li>
      <li>
See 45 CFR 164.524(c)(3)(ii) If an individual's request for access directs the covered entity to transmit the copy of protected health information directly to another person designated by the individual, the covered entity must provide the copy to the person designated by the individual. The individual's request must be in writing, signed by the individual, and clearly identify the designated person and where to send the copy of protected health information. https://www.gpo.gov/fdsys/pkg/CFR-2017-title45-vol1/pdf/CFR-2017-title45-vol1-sec164-524.pdf (        <a href="en\CodeSystem-v3-ActCode.html">src</a>
)
      </li>
      <li>
See Section 164.508 Uses and disclosures for which an authorization is required. (2)Authorization required: Psychotherapy notes https://www.gpo.gov/fdsys/pkg/CFR-2017-title45-vol1/pdf/CFR-2017-title45-vol1-sec164-508.pdf: Notwithstanding any provision of this subpart, other than the transition provisions in Section 164.532, a covered entity must obtain an authorization for any use or disclosure of psychotherapy notes, except: (i) To carry out the following treatment, payment, or health care operations: (A) Use by the originator of the psychotherapy notes for treatment; (B) Use or disclosure by the covered entity for its own training programs in which students, trainees, or practitioners in mental health learn under supervision to practice or improve their skills in group, joint, family, or individual counseling; or (C) Use or disclosure by the covered entity to defend itself in a legal action or other proceeding brought by the individual; and (ii) A use or disclosure that is required by Section 164.502(a)(2)(ii) or permitted by Section 164.512(a); Section 164.512(d) with respect to the oversight of the originator of the psychotherapy notes; Section 164.512(g)(1); Section 164.512(j)(1)(i). (        <a href="en\CodeSystem-v3-ActCode.html">src</a>
)
      </li>
      <li>
Some content from IHE&reg; Copyright &copy; 2015 IHE International, Inc
. Show Usage 


* IHE Format Code set for use with Document Sharing: ExtensionEndpoint_Payload_Type and ValueSetR5EndpointPayloadTypeForR4




 (        <a href="en\index.html">src</a>
)
      </li>
      <li>
The (c) symbol should NOT be included in this string. It will be added by software when rendering the notation. Full details about licensing, restrictions, warrantees, etc. goes in the more general 'copyright' element. (        <a href="en\StructureDefinition-ext-R5-ValueSet.copyrightLabel-definitions.html">src</a>
)
      </li>
      <li>
The short copyright declaration (e.g. (c) '2015+ xyz organization' should be sent in the copyrightLabel element. (        <a href="en\StructureDefinition-ext-R5-Evidence.copyright-definitions.html">src</a>
)
      </li>
      <li>
There are examples where a medication request may include the option of an oral dose or an Intravenous or Intramuscular dose.  For example, "Ondansetron 8mg orally or IV twice a day as needed for nausea" or "Compazine&reg; (prochlorperazine) 5-10mg PO or 25mg PR bid prn nausea or vomiting".  In these cases, two medication requests would be created that could be grouped together.  The decision on which dose and route of administration to use is based on the patient's condition at the time the dose is needed. (        <a href="en\StructureDefinition-profile-MedicationRequest-definitions.html">src</a>
)
      </li>
      <li>
This code system is a subset of ISBT 128 Product Description Codes&copy; published by ICCBBA as a part of the ISBT 128 standard. These codes support characterization and classification of medical products of human origin inclusive of processing conditions such as additives, volumes and handling conditions. (        <a href="en\artifacts.html">src</a>
)
      </li>
      <li>
This material contains content from LOINC. LOINC is copyright &copy; 1995-2020, Regenstrief Institute, Inc. and the Logical Observation Identifiers Names and Codes (LOINC) Committee and is available at no cost under the license. LOINC&reg; is a registered United States trademark of Regenstrief Institute, Inc. Show Usage 


* LOINC: ValueSetR5V3LoincDocumentOntologyInternationalForR4




 (        <a href="en\index.html">src</a>
)
      </li>
      <li>
This material derives from the HL7 Terminology (THO). THO is copyright &copy;1989+ Health Level Seven International and is made available under the CC0 designation. For more licensing information see: https://terminology.hl7.org/license.html Show Usage 


* StatisticAttribute Estimate Type: ValueSetR5AttributeEstimateTypeForR4

* CharacteristicMethod: ValueSetR5CharacteristicMethodForR4

* EvidenceDirectness: ExtensionEvidence_VariableDefinition and ValueSetR5DirectnessForR4

* HL7 Terminology Maintenance Infrastructure Vocabulary: BedStatus, ContactRole2... Show 8 more  , DiagnosticServiceSectionId, EventType, IdentifierType, MessageStructure, OperationOutcomeTHO, ProviderRole, ReAdmissionIndicator and SpecimenType 

* StatisticStatisticType: ExtensionEvidence_Statistic and ValueSetR5StatisticTypeForR4

* Subscription Error Codes: ExtensionSubscriptionStatus and ValueSetR5SubscriptionErrorForR4

* ActClass: ActCode

* EntityNamePartQualifier: ValueSetR5V3EntityNamePartQualifierForR4NamePartQualifier

* HL7 Document Format Codes: ExtensionEndpoint_Payload_Type and ValueSetR5EndpointPayloadTypeForR4

* ObservationInterpretation: ValueSetR5ObservationInterpretationForR4

* RoleClass: RoleCode

* Media Type: ValueSetR5V3MediaTypeForR4MediaType

* EvidenceVariableRole: ExtensionEvidence_VariableDefinition and ValueSetR5VariableRoleForR4




 (        <a href="en\index.html">src</a>
)
      </li>
      <li>
W3C&reg; Software and Document License (        <a href="en\CodeSystem-color-rgb.html">src</a>
)
      </li>
      <li>
copyright: markdown: A copyright statement relating to the test plan and/or its contents. Copyright statements are generally legal restrictions on the use and publishing of the test plan. The short copyright declaration (e.g. (c) '2015+ xyz organization' should be sent in the copyrightLabel element. (        <a href="en\StructureDefinition-ext-R5-TestPlan.html">src</a>
)
      </li>
      <li>
https://www.gpo.gov/fdsys/granule/USCODE-2011-title38/USCODE-2011-title38-partV-chap73-subchapIII-sec7332/content-detail.html . (1) Records of the identity, diagnosis, prognosis, or treatment of any patient or subject which are maintained in connection with the performance of any program or activity (including education, training, treatment, rehabilitation, or research) relating to drug abuse, alcoholism or alcohol abuse, infection with the human immunodeficiency virus, or sickle cell anemia which is carried out by or for the Department under this title shall, except as provided in subsections (e) and (f), be confidential, and (section 5701 of this title to the contrary notwithstanding) such records may be disclosed only for the purposes and under the circumstances expressly authorized under subsection (b). (2) Paragraph (1) prohibits the disclosure to any person or entity other than the patient or subject concerned of the fact that a special written consent is required in order for such records to be disclosed. (b) (1) The content of any record referred to in subsection (a) may be disclosed by the Secretary in accordance with the prior written consent of the patient or subject with respect to whom such record is maintained, but only to such extent, under such circumstances, and for such purposes as may be allowed in regulations prescribed by the Secretary. (2) Whether or not any patient or subject, with respect to whom any given record referred to in subsection (a) is maintained, gives written consent, the content of such record may be disclosed by the Secretary as follows: (A) To medical personnel to the extent necessary to meet a bona fide medical emergency. (B) To qualified personnel for the purpose of conducting scientific research, management audits, financial audits, or program evaluation, but such personnel may not identify, directly or indirectly, any individual patient or subject in any report of such research, audit, or evaluation, or otherwise disclose patient or subject identities in any manner. (C) (i) In the case of any record which is maintained in connection with the performance of any program or activity relating to infection with the human immunodeficiency virus, to a Federal, State, or local public-health authority charged under Federal or State law with the protection of the public health, and to which Federal or State law requires disclosure of such record, if a qualified representative of such authority has made a written request that such record be provided as required pursuant to such law for a purpose authorized by such law. (ii) A person to whom a record is disclosed under this paragraph may not redisclose or use such record for a purpose other than that for which the disclosure was made. (D) If authorized by an appropriate order of a court of competent jurisdiction granted after application showing good cause therefor. In assessing good cause the court shall weigh the public interest and the need for disclosure against the injury to the patient or subject, to the physician-patient relationship, and to the treatment services. Upon the granting of such order, the court, in determining the extent to which any disclosure of all or any part of any record is necessary, shall impose appropriate safeguards against unauthorized disclosure. (E) To an entity described in paragraph (1)(B) of section 5701(k) of this title, but only to the extent authorized by such section. (F) (i) To a representative of a patient who lacks decision-making capacity, when a practitioner deems the content of the given record necessary for that representative to make an informed decision regarding the patient's treatment. (ii) In this subparagraph, the term Ã¢â‚¬Å“representativeÃ¢â‚¬? means an individual, organization, or other body authorized under section 7331 of this title and its implementing regulations to give informed consent on behalf of a patient who lacks decision-making capacity. (G) To a State controlled substance monitoring program, including a program approved by the Secretary of Health and Human Services under section 399O of the Public Health Service Act (42 U.S.C. 280g-3), to the extent necessary to prevent misuse and diversion of prescription medicines. (H) (i) To a non-Department entity (including private entities and other Federal agencies) for purposes of providing health care, including hospital care, medical services, and extended care services, to Veterans or performing other health care-related activities or functions. (ii) An entity to which a record is disclosed under this subparagraph may not disclose or use such record for a purpose other than that for which the disclosure was made or as permitted by law. (I) To a third party in order to recover or collect reasonable charges for care furnished to, or paid on behalf of, a Veteran in connection with a non-service connected disability as permitted by section 1729 of this title or for a condition for which recovery is authorized or with respect to which the United States is deemed to be a third party beneficiary under the Act entitled 'An Act to provide for the recovery from tortiously liable third persons of the cost of hospital and medical care and treatment furnished by the United States' (Public Law 87-693; 42 U.S.C. 2651 et seq.; commonly known as the 'Federal Medical Care Recovery Act'). (        <a href="en\CodeSystem-v3-ActCode.html">src</a>
)
      </li>
    </ul>
    <h2>External References</h2>
    <table class="grid">
      <tr>
        <th>
          <b>Type</b>
        </th>
        <th>
          <b>Reference</b>
        </th>
        <th>
          <b>Content</b>
        </th>
      </tr>
      <tr>
        <td>
          <a href="en\CodeSystem-genomicstudy-dataformat.html">web</a>
        </td>
        <td>
          <a href="https://software.broadinstitute.org/software/igv/FileFormats">software.broadinstitute.org</a>
        </td>
        <td>
The data format relevant to genomics. These formats and relevant codes were pulled from           <a href="https://software.broadinstitute.org/software/igv/FileFormats">Integrative Genomics Viewer Documentation</a>
 by Broad Institute.
        </td>
      </tr>
      <tr>
        <td>
          <a href="en\CodeSystem-observation-statistics.html">web</a>
        </td>
        <td>
          <a href="https://en.wikipedia.org/wiki/Arithmetic_mean">en.wikipedia.org</a>
        </td>
        <td>
The           <a href="https://en.wikipedia.org/wiki/Arithmetic_mean">mean</a>
 of N measurements over the stated period.
        </td>
      </tr>
      <tr>
        <td>
          <a href="en\CodeSystem-observation-statistics.html">web</a>
        </td>
        <td>
          <a href="https://en.wikipedia.org/wiki/Maximal_element">en.wikipedia.org</a>
        </td>
        <td>
The           <a href="https://en.wikipedia.org/wiki/Maximal_element">maximum</a>
 value of N measurements over the stated period.
        </td>
      </tr>
      <tr>
        <td>
          <a href="en\CodeSystem-observation-statistics.html">web</a>
        </td>
        <td>
          <a href="https://en.wikipedia.org/wiki/Minimal_element">en.wikipedia.org</a>
        </td>
        <td>
The           <a href="https://en.wikipedia.org/wiki/Minimal_element">minimum</a>
 value of N measurements over the stated period.
        </td>
      </tr>
      <tr>
        <td>
          <a href="en\CodeSystem-observation-statistics.html">web</a>
        </td>
        <td>
          <a href="https://en.wikipedia.org/wiki/Median">en.wikipedia.org</a>
        </td>
        <td>
The           <a href="https://en.wikipedia.org/wiki/Median">median</a>
 of N measurements over the stated period.
        </td>
      </tr>
      <tr>
        <td>
          <a href="en\CodeSystem-observation-statistics.html">web</a>
        </td>
        <td>
          <a href="https://en.wikipedia.org/wiki/Standard_deviation">en.wikipedia.org</a>
        </td>
        <td>
The           <a href="https://en.wikipedia.org/wiki/Standard_deviation">standard deviation</a>
 of N measurements over the stated period.
        </td>
      </tr>
      <tr>
        <td>
          <a href="en\CodeSystem-observation-statistics.html">web</a>
        </td>
        <td>
          <a href="https://en.wikipedia.org/wiki/Summation">en.wikipedia.org</a>
        </td>
        <td>
The           <a href="https://en.wikipedia.org/wiki/Summation">sum</a>
 of N measurements over the stated period.
        </td>
      </tr>
      <tr>
        <td>
          <a href="en\CodeSystem-observation-statistics.html">web</a>
        </td>
        <td>
          <a href="https://en.wikipedia.org/wiki/Variance">en.wikipedia.org</a>
        </td>
        <td>
The           <a href="https://en.wikipedia.org/wiki/Variance">variance</a>
 of N measurements over the stated period.
        </td>
      </tr>
      <tr>
        <td>
          <a href="en\CodeSystem-observation-statistics.html">web</a>
        </td>
        <td>
          <a href="https://en.wikipedia.org/wiki/Percentile">en.wikipedia.org</a>
        </td>
        <td>
The 20th           <a href="https://en.wikipedia.org/wiki/Percentile">Percentile</a>
 of N measurements over the stated period.
        </td>
      </tr>
      <tr>
        <td>
          <a href="en\CodeSystem-observation-statistics.html">web</a>
        </td>
        <td>
          <a href="https://en.wikipedia.org/wiki/Percentile">en.wikipedia.org</a>
        </td>
        <td>
The 80th           <a href="https://en.wikipedia.org/wiki/Percentile">Percentile</a>
 of N measurements over the stated period.
        </td>
      </tr>
      <tr>
        <td>
          <a href="en\CodeSystem-observation-statistics.html">web</a>
        </td>
        <td>
          <a href="https://en.wikipedia.org/wiki/Quartile">en.wikipedia.org</a>
        </td>
        <td>
The lower           <a href="https://en.wikipedia.org/wiki/Quartile">Quartile</a>
 Boundary of N measurements over the stated period.
        </td>
      </tr>
      <tr>
        <td>
          <a href="en\CodeSystem-observation-statistics.html">web</a>
        </td>
        <td>
          <a href="https://en.wikipedia.org/wiki/Quartile">en.wikipedia.org</a>
        </td>
        <td>
The upper           <a href="https://en.wikipedia.org/wiki/Quartile">Quartile</a>
 Boundary of N measurements over the stated period.
        </td>
      </tr>
      <tr>
        <td>
          <a href="en\CodeSystem-observation-statistics.html">web</a>
        </td>
        <td>
          <a href="https://en.wikipedia.org/wiki/Quartile">en.wikipedia.org</a>
        </td>
        <td>
The difference between the upper and lower           <a href="https://en.wikipedia.org/wiki/Quartile">Quartiles</a>
 is called the Interquartile range. (IQR = Q3-Q1) Quartile deviation or Semi-interquartile range is one-half the difference between the first and the third quartiles.
        </td>
      </tr>
      <tr>
        <td>
          <a href="en\CodeSystem-observation-statistics.html">web</a>
        </td>
        <td>
          <a href="https://en.wikipedia.org/wiki/Skewness">en.wikipedia.org</a>
        </td>
        <td>
Skewness is a measure of the asymmetry of the probability distribution of a real-valued random variable about its mean. The skewness value can be positive or negative, or even undefined.  Source:           <a href="https://en.wikipedia.org/wiki/Skewness">Wikipedia</a>
.
        </td>
      </tr>
      <tr>
        <td>
          <a href="en\CodeSystem-observation-statistics.html">web</a>
        </td>
        <td>
          <a href="https://en.wikipedia.org/wiki/Kurtosis">en.wikipedia.org</a>
        </td>
        <td>
Kurtosis  is a measure of the "tailedness" of the probability distribution of a real-valued random variable.   Source:           <a href="https://en.wikipedia.org/wiki/Kurtosis">Wikipedia</a>
.
        </td>
      </tr>
      <tr>
        <td>
          <a href="en\CodeSystem-observation-statistics.html">web</a>
        </td>
        <td>
          <a href="https://en.wikipedia.org/wiki/Simple_linear_regression">en.wikipedia.org</a>
        </td>
        <td>
Linear regression is an approach for modeling two-dimensional sample points with one independent variable and one dependent variable (conventionally, the x and y coordinates in a Cartesian coordinate system) and finds a linear function (a non-vertical straight line) that, as accurately as possible, predicts the dependent variable values as a function of the independent variables. Source:           <a href="https://en.wikipedia.org/wiki/Simple_linear_regression">Wikipedia</a>
  This Statistic code will return both a gradient and an intercept value.
        </td>
      </tr>
      <tr>
        <td>
          <a href="en\CodeSystem-safety-entries.html">web</a>
        </td>
        <td>
          <a href="https://en.wikipedia.org/wiki/Transport_Layer_Security">en.wikipedia.org</a>
        </td>
        <td>
Where resources are exchanged using           <a href="https://hl7.org/fhir/secur.html#http">HTTP</a>
,           <a href="https://en.wikipedia.org/wiki/Transport_Layer_Security">TLS</a>
 should be utilized to protect the communications channel
        </td>
      </tr>
      <tr>
        <td>
          <a href="en\CodeSystem-safety-entries.html">web</a>
        </td>
        <td>
          <a href="https://en.wikipedia.org/wiki/S/MIME">en.wikipedia.org</a>
        </td>
        <td>
Where resources are exchanged using email,           <a href="https://en.wikipedia.org/wiki/S/MIME">S/MIME</a>
 should be used to protect the end-to-end communication
        </td>
      </tr>
      <tr>
        <td>
          <a href="en\CodeSystem-safety-entries.html">web</a>
        </td>
        <td>
          <a href="https://openid.net/connect/">openid.net</a>
        </td>
        <td>
My system uses           <a href="https://openid.net/connect/">OpenID Connect</a>
 (or other suitable authentication protocol) to verify identity of end user, where it is necessary that end-users be identified to the client application, and has a clear policy on           <a href="https://hl7.org/fhir/secpr.html#user">identity proofing</a>
        </td>
      </tr>
      <tr>
        <td>
          <a href="en\CodeSystem-safety-entries.html">web</a>
        </td>
        <td>
          <a href="http://enable-cors.org/">enable-cors.org</a>
        </td>
        <td>
Server: CORS (          <a href="http://enable-cors.org/">cross-origin resource sharing</a>
) is appropriately enabled (many clients are Javascript apps running in a browser)
        </td>
      </tr>
      <tr>
        <td>
          <a href="en\CodeSystem-version-algorithm.html">web</a>
        </td>
        <td>
          <a href="http://semver.org">semver.org</a>
        </td>
        <td>
Uses the semantic versioning scheme as defined in           <a href="http://semver.org">semver.org</a>
.
        </td>
      </tr>
      <tr>
        <td>
          <a href="en\CodeSystem-version-algorithm.html">web</a>
        </td>
        <td>
          <a href="http://www.naturalordersort.org/">www.naturalordersort.org</a>
        </td>
        <td>
Sorted according to the algorithm defined here:           <a href="http://www.naturalordersort.org/">naturalordersort.org</a>
        </td>
      </tr>
      <tr>
        <td>
          <a href="en\StructureDefinition-ext-R5-Bundle.link-definitions.html">web</a>
        </td>
        <td>
          <a href="http://en.wikipedia.org/wiki/HATEOAS">en.wikipedia.org</a>
        </td>
        <td>
Both Bundle.link and Bundle.entry.link are defined to support providing additional context when Bundles are used (e.g.           <a href="http://en.wikipedia.org/wiki/HATEOAS">HATEOAS</a>
).
        </td>
      </tr>
      <tr>
        <td>
          <a href="en\StructureDefinition-ext-R5-ImagingSelection-definitions.html">web</a>
        </td>
        <td>
          <a href="http://dicom.nema.org/medical/dicom/current/output/chtml/part03/sect_C.7.2.html">dicom.nema.org</a>
        </td>
        <td>
See           <a href="http://dicom.nema.org/medical/dicom/current/output/chtml/part03/sect_C.7.2.html">DICOM PS3.3 C.7.2</a>
.
        </td>
      </tr>
      <tr>
        <td>
          <a href="en\StructureDefinition-ext-R5-ImagingSelection-definitions.html">web</a>
        </td>
        <td>
          <a href="http://dicom.nema.org/medical/dicom/current/output/chtml/part03/sect_C.7.3.html">dicom.nema.org</a>
        </td>
        <td>
See           <a href="http://dicom.nema.org/medical/dicom/current/output/chtml/part03/sect_C.7.3.html">DICOM PS3.3 C.7.3</a>
.
        </td>
      </tr>
      <tr>
        <td>
          <a href="en\StructureDefinition-ext-R5-ImagingSelection-definitions.html">web</a>
        </td>
        <td>
          <a href="http://dicom.nema.org/medical/dicom/current/output/chtml/part03/sect_C.7.4.html">dicom.nema.org</a>
        </td>
        <td>
See           <a href="http://dicom.nema.org/medical/dicom/current/output/chtml/part03/sect_C.7.4.html">DICOM PS3.3 C.7.4.1</a>
.
        </td>
      </tr>
      <tr>
        <td>
          <a href="en\StructureDefinition-ext-R5-ImagingSelection-definitions.html">web</a>
        </td>
        <td>
          <a href="http://dicom.nema.org/medical/dicom/current/output/chtml/part03/sect_C.12.html">dicom.nema.org</a>
        </td>
        <td>
See           <a href="http://dicom.nema.org/medical/dicom/current/output/chtml/part03/sect_C.12.html">DICOM PS3.3 C.12.1</a>
.
        </td>
      </tr>
      <tr>
        <td>
          <a href="en\StructureDefinition-ext-R5-ImagingSelection-definitions.html">web</a>
        </td>
        <td>
          <a href="https://dicom.nema.org/medical/dicom/current/output/chtml/part03/sect_C.7.6.html#sect_C.7.6.1">dicom.nema.org</a>
        </td>
        <td>
See           <a href="https://dicom.nema.org/medical/dicom/current/output/chtml/part03/sect_C.7.6.html#sect_C.7.6.1">DICOM PS3.3 C.7.6.1</a>
.
Note: A multiframe instance has a single instance number with each frame identified by a frame number.
        </td>
      </tr>
      <tr>
        <td>
          <a href="en\StructureDefinition-ext-R5-ImagingSelection-definitions.html">web</a>
        </td>
        <td>
          <a href="https://dicom.nema.org/medical/dicom/current/output/chtml/part03/sect_C.10.5.html#sect_C.10.5.1.2">dicom.nema.org</a>
        </td>
        <td>
See           <a href="https://dicom.nema.org/medical/dicom/current/output/chtml/part03/sect_C.10.5.html#sect_C.10.5.1.2">DICOM PS3.3 C.10.5.1.2</a>
.
        </td>
      </tr>
      <tr>
        <td>
          <a href="en\StructureDefinition-ext-R5-ImagingSelection-definitions.html">web</a>
        </td>
        <td>
          <a href="http://dicom.nema.org/medical/dicom/current/output/chtml/part03/sect_C.18.6.html">dicom.nema.org</a>
        </td>
        <td>
For a description of how 2D coordinates are encoded, see           <a href="http://dicom.nema.org/medical/dicom/current/output/chtml/part03/sect_C.18.6.html">DICOM PS3.3 C.18.6</a>
.
        </td>
      </tr>
      <tr>
        <td>
          <a href="en\StructureDefinition-ext-R5-ImagingSelection-definitions.html">web</a>
        </td>
        <td>
          <a href="http://dicom.nema.org/medical/dicom/current/output/chtml/part03/sect_C.18.9.html#sect_C.18.9.1.2">dicom.nema.org</a>
        </td>
        <td>
See           <a href="http://dicom.nema.org/medical/dicom/current/output/chtml/part03/sect_C.18.9.html#sect_C.18.9.1.2">DICOM PS3.3 C.18.9.1.2</a>
.
        </td>
      </tr>
      <tr>
        <td>
          <a href="en\StructureDefinition-ext-R5-ImagingSelection-definitions.html">web</a>
        </td>
        <td>
          <a href="http://dicom.nema.org/medical/dicom/current/output/chtml/part03/sect_C.18.9.html">dicom.nema.org</a>
        </td>
        <td>
For a description of how 3D coordinates are encoded, see           <a href="http://dicom.nema.org/medical/dicom/current/output/chtml/part03/sect_C.18.9.html">DICOM PS3.3 C.18.9</a>
.
        </td>
      </tr>
      <tr>
        <td>
          <a href="en\StructureDefinition-ext-R5-MolecularSequence.rel.sta.chromosome-definitions.html">web</a>
        </td>
        <td>
          <a href="http://www.sequenceontology.org/browser/current_svn/term/SO:0000340">www.sequenceontology.org</a>
        </td>
        <td>
Structural unit composed of a nucleic acid molecule which controls its own replication through the interaction of specific proteins at one or more origins of replication (          <a href="http://www.sequenceontology.org/browser/current_svn/term/SO:0000340">SO:0000340</a>
).
        </td>
      </tr>
      <tr>
        <td>
          <a href="en\StructureDefinition-ext-R5-Permission-definitions.html">web</a>
        </td>
        <td>
          <a href="http://docs.oasis-open.org/xacml/3.0/xacml-3.0-core-spec-cos01-en.html#_Toc325047267">docs.oasis-open.org</a>
        </td>
        <td>
see           <a href="http://docs.oasis-open.org/xacml/3.0/xacml-3.0-core-spec-cos01-en.html#_Toc325047267">XACML Combining Rules</a>
        </td>
      </tr>
      <tr>
        <td>
          <a href="en\StructureDefinition-profile-Composition-definitions.html">web</a>
        </td>
        <td>
          <a href="http://wiki.ihe.net/index.php?title=Mobile_access_to_Health_Documents_(MHD)">wiki.ihe.net</a>
        </td>
        <td>
This is a metadata field from           <a href="http://wiki.ihe.net/index.php?title=Mobile_access_to_Health_Documents_(MHD)">XDS/MHD</a>
.
        </td>
      </tr>
      <tr>
        <td>
          <a href="en\StructureDefinition-profile-ImagingStudy-definitions.html">web</a>
        </td>
        <td>
          <a href="http://dicom.nema.org/medical/dicom/current/output/chtml/part03/sect_C.7.2.html">dicom.nema.org</a>
        </td>
        <td>
If one or more series elements are present in the ImagingStudy, then there shall be one DICOM Study UID identifier (see           <a href="http://dicom.nema.org/medical/dicom/current/output/chtml/part03/sect_C.7.2.html">DICOM PS 3.3 C.7.2</a>
.
        </td>
      </tr>
      <tr>
        <td>
          <a href="en\StructureDefinition-profile-ImagingStudy-definitions.html">web</a>
        </td>
        <td>
          <a href="http://www.rsna.org/RadLex_Playbook.aspx">www.rsna.org</a>
        </td>
        <td>
Unless not suitable, these codes SHALL be taken from            <a href="http://www.rsna.org/RadLex_Playbook.aspx">http://www.rsna.org/RadLex_Playbook.aspx</a>
          <br/>
(          <a href="http://hl7.org/fhir/R4/terminologies.html#extensible">extensible</a>
 to           <span class="copy-text-inline">
<code>http://www.rsna.org/RadLex_Playbook.aspx</code><button data-clipboard-text="http://www.rsna.org/RadLex_Playbook.aspx" title="Click to Copy URL" class="btn-copy"></button>          </span>
)
        </td>
      </tr>
      <tr>
        <td>
          <a href="en\StructureDefinition-profile-ImagingStudy-definitions.html">web</a>
        </td>
        <td>
          <a href="http://dicom.nema.org/medical/dicom/current/output/chtml/part03/sect_C.12.html#sect_C.12.1">dicom.nema.org</a>
        </td>
        <td>
See            <a href="http://dicom.nema.org/medical/dicom/current/output/chtml/part03/sect_C.12.html#sect_C.12.1">DICOM PS3.3 C.12.1</a>
.
        </td>
      </tr>
      <tr>
        <td>
          <a href="en\StructureDefinition-profile-ImagingStudy-definitions.html">web</a>
        </td>
        <td>
          <a href="http://dicom.nema.org/medical/dicom/current/output/chtml/part04/sect_B.5.html#table_B.5-1">dicom.nema.org</a>
        </td>
        <td>
Unless not suitable, these codes SHALL be taken from            <a href="http://dicom.nema.org/medical/dicom/current/output/chtml/part04/sect_B.5.html#table_B.5-1">http://dicom.nema.org/medical/dicom/current/output/chtml/part04/sect_B.5.html#table_B.5-1</a>
          <br/>
(          <a href="http://hl7.org/fhir/R4/terminologies.html#extensible">extensible</a>
 to           <span class="copy-text-inline">
<code>http://dicom.nema.org/medical/dicom/current/output/chtml/part04/sect_B.5.html#table_B.5-1</code><button data-clipboard-text="http://dicom.nema.org/medical/dicom/current/output/chtml/part04/sect_B.5.html#table_B.5-1" title="Click to Copy URL" class="btn-copy"></button>          </span>
)
        </td>
      </tr>
      <tr>
        <td>
          <a href="en\StructureDefinition-profile-ImagingStudy.html">web</a>
        </td>
        <td>
          <a href="http://www.rsna.org/RadLex_Playbook.aspx">www.rsna.org</a>
        </td>
        <td>
The performed procedure code          <br class="binding"/>
          <span style="font-weight:bold" title="null" class="binding">Binding: </span>
          <a href="http://www.rsna.org/RadLex_Playbook.aspx" class="binding">http://www.rsna.org/RadLex_Playbook.aspx</a>
          <span title="null" class="binding"> (</span>
          <a href="http://hl7.org/fhir/R4/terminologies.html#extensible" title="To be conformant, the concept in this element SHALL be from the specified value set if any of the codes within the value set can apply to the concept being communicated.  If the value set does not cover the concept (based on human review), alternate codings (or, data type allowing, text) may be included instead." class="binding">extensible</a>
          <span title="null" class="binding">)</span>
          <span title="null" class="binding">: </span>
          <span title="null" class="binding">The performed procedure type.</span>
          <br/>
        </td>
      </tr>
      <tr>
        <td>
          <a href="en\StructureDefinition-profile-ImagingStudy.html">web</a>
        </td>
        <td>
          <a href="http://dicom.nema.org/medical/dicom/current/output/chtml/part04/sect_B.5.html#table_B.5-1">dicom.nema.org</a>
        </td>
        <td>
DICOM class type          <br class="binding"/>
          <span style="font-weight:bold" title="null" class="binding">Binding: </span>
          <a href="http://dicom.nema.org/medical/dicom/current/output/chtml/part04/sect_B.5.html#table_B.5-1" class="binding">http://dicom.nema.org/medical/dicom/current/output/chtml/part04/sect_B.5.html#table_B.5-1</a>
          <span title="null" class="binding"> (</span>
          <a href="http://hl7.org/fhir/R4/terminologies.html#extensible" title="To be conformant, the concept in this element SHALL be from the specified value set if any of the codes within the value set can apply to the concept being communicated.  If the value set does not cover the concept (based on human review), alternate codings (or, data type allowing, text) may be included instead." class="binding">extensible</a>
          <span title="null" class="binding">)</span>
          <span title="null" class="binding">: </span>
          <span title="null" class="binding">The sopClass for the instance.</span>
        </td>
      </tr>
      <tr>
        <td>
          <a href="en\StructureDefinition-profile-ImagingStudy.html">web</a>
        </td>
        <td>
          <a href="http://www.rsna.org/RadLex_Playbook.aspx">www.rsna.org</a>
        </td>
        <td>

                <a style="opacity: 1.0" href="http://www.rsna.org/RadLex_Playbook.aspx">http://www.rsna.org/RadLex_Playbook.aspx</a>

                <button data-clipboard-text="http://www.rsna.org/RadLex_Playbook.aspx" title="Click to copy URL" class="btn-copy"></button>

    
        </td>
      </tr>
      <tr>
        <td>
          <a href="en\StructureDefinition-profile-ImagingStudy.html">web</a>
        </td>
        <td>
          <a href="http://dicom.nema.org/medical/dicom/current/output/chtml/part04/sect_B.5.html#table_B.5-1">dicom.nema.org</a>
        </td>
        <td>

                <a style="opacity: 1.0" href="http://dicom.nema.org/medical/dicom/current/output/chtml/part04/sect_B.5.html#table_B.5-1">http://dicom.nema.org/medical/dicom/current/output/chtml/part04/sect_B.5.html#table_B.5-1</a>

                <button data-clipboard-text="http://dicom.nema.org/medical/dicom/current/output/chtml/part04/sect_B.5.html#table_B.5-1" title="Click to copy URL" class="btn-copy"></button>

    
        </td>
      </tr>
      <tr>
        <td>
          <a href="en\StructureDefinition-profile-MolecularSequence-definitions.html">web</a>
        </td>
        <td>
          <a href="http://www.sequenceontology.org/browser/current_svn/term/variant_of">www.sequenceontology.org</a>
        </td>
        <td>
The definition of variant here originates from Sequence ontology (          <a href="http://www.sequenceontology.org/browser/current_svn/term/variant_of">variant_of</a>
). This element can represent amino acid or nucleic sequence change(including insertion,deletion,SNP,etc.)  It can represent some complex mutation or segment variation with the assist of CIGAR string.
        </td>
      </tr>
      <tr>
        <td>
          <a href="en\StructureDefinition-profile-MolecularSequence-definitions.html">web</a>
        </td>
        <td>
          <a href="http://www.sequenceontology.org/browser/current_svn/term/SO:0001023">www.sequenceontology.org</a>
        </td>
        <td>
An allele is one of a set of coexisting sequence variants of a gene (          <a href="http://www.sequenceontology.org/browser/current_svn/term/SO:0001023">SO:0001023</a>
).  Nucleotide(s)/amino acids from start position of sequence to stop position of sequence on the positive (+) strand of the observed  sequence. When the sequence  type is DNA, it should be the sequence on the positive (+) strand. This will lay in the range between variant.start and variant.end.
        </td>
      </tr>
      <tr>
        <td>
          <a href="en\StructureDefinition-profile-MolecularSequence-definitions.html">web</a>
        </td>
        <td>
          <a href="http://www.sequenceontology.org/browser/current_svn/term/SO:0001023">www.sequenceontology.org</a>
        </td>
        <td>
An allele is one of a set of coexisting sequence variants of a gene (          <a href="http://www.sequenceontology.org/browser/current_svn/term/SO:0001023">SO:0001023</a>
). Nucleotide(s)/amino acids from start position of sequence to stop position of sequence on the positive (+) strand of the reference sequence. When the sequence  type is DNA, it should be the sequence on the positive (+) strand. This will lay in the range between variant.start and variant.end.
        </td>
      </tr>
      <tr>
        <td>
          <a href="en\StructureDefinition-profile-MolecularSequence-definitions.html">web</a>
        </td>
        <td>
          <a href="http://support.illumina.com/help/SequencingAnalysisWorkflow/Content/Vault/Informatics/Sequencing_Analysis/CASAVA/swSEQ_mCA_ExtendedCIGARFormat.htm">support.illumina.com</a>
        </td>
        <td>
Extended CIGAR string for aligning the sequence with reference bases. See detailed documentation           <a href="http://support.illumina.com/help/SequencingAnalysisWorkflow/Content/Vault/Informatics/Sequencing_Analysis/CASAVA/swSEQ_mCA_ExtendedCIGARFormat.htm">here</a>
.
        </td>
      </tr>
      <tr>
        <td>
          <a href="en\StructureDefinition-profile-MolecularSequence-definitions.html">web</a>
        </td>
        <td>
          <a href="http://www.sequenceontology.org/browser/current_svn/term/SO:0001686">www.sequenceontology.org</a>
        </td>
        <td>
An experimental feature attribute that defines the quality of the feature in a quantitative way, such as a phred quality score (          <a href="http://www.sequenceontology.org/browser/current_svn/term/SO:0001686">SO:0001686</a>
).
        </td>
      </tr>
      <tr>
        <td>
          <a href="en\StructureDefinition-profile-MolecularSequence-definitions.html">web</a>
        </td>
        <td>
          <a href="http://www.sequenceontology.org/browser/current_svn/term/SO:0001685">www.sequenceontology.org</a>
        </td>
        <td>
The score of an experimentally derived feature such as a p-value (          <a href="http://www.sequenceontology.org/browser/current_svn/term/SO:0001685">SO:0001685</a>
).
        </td>
      </tr>
      <tr>
        <td>
          <a href="en\ValueSet-ValueSet-R5-ucum-common-for-R4.html">web</a>
        </td>
        <td>
          <a href="http://unitsofmeasure.org">unitsofmeasure.org</a>
        </td>
        <td>
Include these codes as defined in           <a href="http://unitsofmeasure.org">
<code>http://unitsofmeasure.org</code>          </a>
          <span title="Version is explicitly stated to be 3.0.1"> version &#x1F4CD;</span>
          <table class="none" data-fhir="generated">
            <tr>
              <td style="white-space:nowrap">
                <b>Code</b>
              </td>
              <td>
                <b>Display</b>
              </td>
            </tr>
            <tr>
              <td>%/100</td>
              <td>percent / 100</td>
            </tr>
            <tr>
              <td>/(2.h)</td>
              <td>per 2 hour</td>
            </tr>
            <tr>
              <td>/10*4</td>
              <td>per 10 thousand</td>
            </tr>
            <tr>
              <td>/100.g</td>
              <td>per 100 gram</td>
            </tr>
            <tr>
              <td>/min/10*3</td>
              <td>per minute per thousand</td>
            </tr>
            <tr>
              <td>10*-3</td>
              <td>(the number ten for arbitrary powers ^ -3)</td>
            </tr>
            <tr>
              <td>10*-6</td>
              <td>the number ten for arbitrary powers ^ -6</td>
            </tr>
            <tr>
              <td>U/(10.g)</td>
              <td>enzyme unit per 10 gram</td>
            </tr>
            <tr>
              <td>U/kg</td>
              <td>enzyme unit per kilogram</td>
            </tr>
            <tr>
              <td>U/mmol</td>
              <td>enzyme unit per millimole</td>
            </tr>
            <tr>
              <td>[IU]/10*9</td>
              <td>international unit per billion</td>
            </tr>
            <tr>
              <td>[kp_C]</td>
              <td>HOMEOPATHIC POTENCY OF CENTESIMAL KORSAKOVIAN SERIES</td>
            </tr>
            <tr>
              <td>ag</td>
              <td>attogram</td>
            </tr>
            <tr>
              <td>mL/min/1.73.m2</td>
              <td>milliliter per minute per 1.73 square meter</td>
            </tr>
            <tr>
              <td>mU/mmol</td>
              <td>millienzyme Unit per millimole</td>
            </tr>
            <tr>
              <td>mg/d/1.73.m2</td>
              <td>milligram per day per 1.73 square meter</td>
            </tr>
            <tr>
              <td>mmol/h/mg</td>
              <td>millimole per hour per milligram</td>
            </tr>
            <tr>
              <td>nU</td>
              <td>nanoenzyme unit</td>
            </tr>
            <tr>
              <td>nmol/L/mmol</td>
              <td>nanomole per liter per millimole</td>
            </tr>
            <tr>
              <td>nmol/h/mg</td>
              <td>nanomole per hour per milligram</td>
            </tr>
            <tr>
              <td>nmol/m/mg</td>
              <td>nanomole per meter per milligram</td>
            </tr>
            <tr>
              <td>nmol/min/10*6</td>
              <td>nanomole per minute per million</td>
            </tr>
            <tr>
              <td>nmol/min/mg</td>
              <td>nanomole per minute per milligram</td>
            </tr>
            <tr>
              <td>pmol/h/mg</td>
              <td>picomole per hour per milligram</td>
            </tr>
            <tr>
              <td>pmol/mg</td>
              <td>picomole per milligram</td>
            </tr>
            <tr>
              <td>pmol/min/mg</td>
              <td>picomole per minute per milligram</td>
            </tr>
            <tr>
              <td>umol/h/mg</td>
              <td>micromole per hour per milligram</td>
            </tr>
          </table>
        </td>
      </tr>
      <tr>
        <td>
          <a href="en\faqs.html">web</a>
        </td>
        <td>
          <a href="https://github.com/HL7/fhir-cross-version/">github.com</a>
        </td>
        <td>
In order to track the relationships of resource between versions, a set of           <code class="language-plaintext highlighter-rouge">ConceptMaps</code>
 are used. The content below is from the current version at the time of writing, but is not authoritative. The ultimate source-of-truth are the maps that are maintained at: in the           <a href="https://github.com/HL7/fhir-cross-version/">HL7 FHIR-Cross-Version GitHub Repository</a>
, specifically in the           <a href="https://github.com/HL7/fhir-cross-version/tree/main/input/resources">
<code class="language-plaintext highlighter-rouge">input/resources</code> directory
          </a>
.
        </td>
      </tr>
      <tr>
        <td>
          <a href="en\faqs.html">web</a>
        </td>
        <td>
          <a href="https://github.com/HL7/fhir-cross-version/tree/main/input/resources">github.com</a>
        </td>
        <td>
In order to track the relationships of resource between versions, a set of           <code class="language-plaintext highlighter-rouge">ConceptMaps</code>
 are used. The content below is from the current version at the time of writing, but is not authoritative. The ultimate source-of-truth are the maps that are maintained at: in the           <a href="https://github.com/HL7/fhir-cross-version/">HL7 FHIR-Cross-Version GitHub Repository</a>
, specifically in the           <a href="https://github.com/HL7/fhir-cross-version/tree/main/input/resources">
<code class="language-plaintext highlighter-rouge">input/resources</code> directory
          </a>
.
        </td>
      </tr>
      <tr>
        <td>
          <a href="en\faqs.html">web</a>
        </td>
        <td>
          <a href="https://github.com/HL7/fhir-cross-version/">github.com</a>
        </td>
        <td>
In order to manage the type mappings, a set of           <code class="language-plaintext highlighter-rouge">ConceptMaps</code>
 are used. The content below is from the current version at the time of writing, but is not authoritative. The ultimate source-of-truth are the maps that are maintained at: in the           <a href="https://github.com/HL7/fhir-cross-version/">HL7 FHIR-Cross-Version GitHub Repository</a>
, specifically in the           <a href="https://github.com/HL7/fhir-cross-version/tree/main/input/types">
<code class="language-plaintext highlighter-rouge">input/types</code> directory
          </a>
.
        </td>
      </tr>
      <tr>
        <td>
          <a href="en\faqs.html">web</a>
        </td>
        <td>
          <a href="https://github.com/HL7/fhir-cross-version/tree/main/input/types">github.com</a>
        </td>
        <td>
In order to manage the type mappings, a set of           <code class="language-plaintext highlighter-rouge">ConceptMaps</code>
 are used. The content below is from the current version at the time of writing, but is not authoritative. The ultimate source-of-truth are the maps that are maintained at: in the           <a href="https://github.com/HL7/fhir-cross-version/">HL7 FHIR-Cross-Version GitHub Repository</a>
, specifically in the           <a href="https://github.com/HL7/fhir-cross-version/tree/main/input/types">
<code class="language-plaintext highlighter-rouge">input/types</code> directory
          </a>
.
        </td>
      </tr>
      <tr>
        <td>
          <a href="en\faqs.html">web</a>
        </td>
        <td>
          <a href="https://github.com/HL7/fhir-cross-version/tree/main/input/types/ConceptMap-types-fallback.json">github.com</a>
        </td>
        <td>
The second part of type-mapping primitives are a set of mappings that indicate what is           <em>allowed</em>
 to map, based on element context. For example, an element might move between           <code class="language-plaintext highlighter-rouge">string</code>
,           <code class="language-plaintext highlighter-rouge">code</code>
, and           <code class="language-plaintext highlighter-rouge">id</code>
 over the course of development. Understanding how primitives related to each-other is purely based on their "value domain" (the set of values that can be represented by the type). Primitive types do not hold the context required to evaluate a "concept domain" (what the contained value           <em>means</em>
) - that context must be provided by the element that uses a type. The source-of-truth for the primitive mappings are defined in the           <a href="https://github.com/HL7/fhir-cross-version/tree/main/input/types/ConceptMap-types-fallback.json">
<code class="language-plaintext highlighter-rouge">input/types/ConceptMap-types-fallback.json</code>          </a>
 ConceptMap, which applies across all versions.
        </td>
      </tr>
      <tr>
        <td>
          <a href="en\faqs.html">web</a>
        </td>
        <td>
          <a href="https://github.com/HL7/fhir-cross-version/tree/main/input/types">github.com</a>
        </td>
        <td>
Note that the relationships between types across versions are also managed as version-to-version ConceptMap resources in the files at           <a href="https://github.com/HL7/fhir-cross-version/tree/main/input/types">
<code class="language-plaintext highlighter-rouge">input/types</code>          </a>
. This tracks (for example) when a type is renamed, so that it can be usefully used across versions.
        </td>
      </tr>
      <tr>
        <td>
          <a href="en\index.html">web</a>
        </td>
        <td>
          <a href="http://www.ihe.net/Governance/#Intellectual_Property">www.ihe.net</a>
        </td>
        <td>
Some content from IHE&reg; Copyright &copy; 2015           <a href="http://www.ihe.net/Governance/#Intellectual_Property">IHE International, Inc</a>

.          <div onclick="if (document.getElementById('ipp2_1').innerHTML != '') {document.getElementById('ipp_1').innerHTML = document.getElementById('ipp2_1').innerHTML; document.getElementById('ipp2_1').innerHTML = ''}" id="ipp_1" data-fhir="generated">
             <span style="cursor: pointer; border: 1px grey solid; background-color: #fcdcb3; padding-left: 3px; padding-right: 3px; color: black">Show Usage</span>
          </div>
          <div style="display: none" id="ipp2_1">

            <ul>

              <li>
                <a href="http://tx.fhir.org/r4/ValueSet/formatcode">IHE Format Code set for use with Document Sharing</a>
:                 <a href="StructureDefinition-ext-R5-Endpoint.pay.type.html">ExtensionEndpoint_Payload_Type</a>
 and                 <a href="ValueSet-ValueSet-R5-endpoint-payload-type-for-R4.html">ValueSetR5EndpointPayloadTypeForR4</a>
              </li>


            </ul>


          </div>
        </td>
      </tr>
      <tr>
        <td>
          <a href="en\index.html">web</a>
        </td>
        <td>
          <a href="https://ucum.org/trac/wiki/TermsOfUse">ucum.org</a>
        </td>
        <td>
The UCUM codes, UCUM table (regardless of format), and UCUM Specification are copyright 1999-2009, Regenstrief Institute, Inc. and the Unified Codes for Units of Measures (UCUM) Organization. All rights reserved.           <a href="https://ucum.org/trac/wiki/TermsOfUse">https://ucum.org/trac/wiki/TermsOfUse</a>
          <div onclick="if (document.getElementById('ipp2_2').innerHTML != '') {document.getElementById('ipp_2').innerHTML = document.getElementById('ipp2_2').innerHTML; document.getElementById('ipp2_2').innerHTML = ''}" id="ipp_2" data-fhir="generated">
             <span style="cursor: pointer; border: 1px grey solid; background-color: #fcdcb3; padding-left: 3px; padding-right: 3px; color: black">Show Usage</span>
          </div>
          <div style="display: none" id="ipp2_2">

            <ul>

              <li>
                <a href="CodeSystem-v3-ucum.html">Unified Code for Units of Measure (UCUM)</a>
:                 <a href="ValueSet-ValueSet-R5-ucum-common-for-R4.html">ValueSetR5UcumCommonForR4</a>
              </li>


            </ul>


          </div>
        </td>
      </tr>
    </table>
    <h2>Internal Images</h2>
    <table class="grid">
      <tr>
        <td>
../assets/images/001.svg          <br/>
          <img src="../assets/images/001.svg" alt="../assets/images/001.svg" width="600px" height="auto"/>
        </td>
      </tr>
      <tr>
        <td>
tree-filter.png          <br/>
          <img src="tree-filter.png" alt="tree-filter.png" width="600px" height="auto"/>
        </td>
      </tr>
    </table>
  </body>
</html>
